0001683168-24-003353.txt : 20240514 0001683168-24-003353.hdr.sgml : 20240514 20240514090034 ACCESSION NUMBER: 0001683168-24-003353 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 72 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240514 DATE AS OF CHANGE: 20240514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lifeway Foods, Inc. CENTRAL INDEX KEY: 0000814586 STANDARD INDUSTRIAL CLASSIFICATION: DAIRY PRODUCTS [2020] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 363442829 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-17363 FILM NUMBER: 24941632 BUSINESS ADDRESS: STREET 1: 6431 W OAKTON CITY: MORTON GROVE STATE: IL ZIP: 60053 BUSINESS PHONE: 847-967-1010 MAIL ADDRESS: STREET 1: 6431 W OAKTON CITY: MORTON GROVE STATE: IL ZIP: 60053 FORMER COMPANY: FORMER CONFORMED NAME: LIFEWAY FOODS INC DATE OF NAME CHANGE: 19920703 10-Q 1 lifeway_i10q-033124.htm FORM 10-Q LIFEWAY FOODS, INC. Form 10-Q
false --12-31 Q1 2024 0000814586 0000814586 2024-01-01 2024-03-31 0000814586 2024-05-06 0000814586 2024-03-31 0000814586 2023-12-31 0000814586 2023-01-01 2023-03-31 0000814586 us-gaap:CommonStockMember 2022-12-31 0000814586 us-gaap:TreasuryStockCommonMember 2022-12-31 0000814586 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000814586 us-gaap:RetainedEarningsMember 2022-12-31 0000814586 2022-12-31 0000814586 us-gaap:CommonStockMember 2023-12-31 0000814586 us-gaap:TreasuryStockCommonMember 2023-12-31 0000814586 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000814586 us-gaap:RetainedEarningsMember 2023-12-31 0000814586 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000814586 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0000814586 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000814586 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000814586 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000814586 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0000814586 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000814586 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000814586 us-gaap:CommonStockMember 2023-03-31 0000814586 us-gaap:TreasuryStockCommonMember 2023-03-31 0000814586 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000814586 us-gaap:RetainedEarningsMember 2023-03-31 0000814586 2023-03-31 0000814586 us-gaap:CommonStockMember 2024-03-31 0000814586 us-gaap:TreasuryStockCommonMember 2024-03-31 0000814586 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000814586 us-gaap:RetainedEarningsMember 2024-03-31 0000814586 us-gaap:LandMember 2024-03-31 0000814586 us-gaap:LandMember 2023-12-31 0000814586 us-gaap:BuildingAndBuildingImprovementsMember 2024-03-31 0000814586 us-gaap:BuildingAndBuildingImprovementsMember 2023-12-31 0000814586 us-gaap:MachineryAndEquipmentMember 2024-03-31 0000814586 us-gaap:MachineryAndEquipmentMember 2023-12-31 0000814586 us-gaap:VehiclesMember 2024-03-31 0000814586 us-gaap:VehiclesMember 2023-12-31 0000814586 us-gaap:OfficeEquipmentMember 2024-03-31 0000814586 us-gaap:OfficeEquipmentMember 2023-12-31 0000814586 us-gaap:ConstructionInProgressMember 2024-03-31 0000814586 us-gaap:ConstructionInProgressMember 2023-12-31 0000814586 LWAY:RecipesMember 2024-03-31 0000814586 LWAY:RecipesMember 2023-12-31 0000814586 LWAY:CustomerListsAndOtherCustomerRelatedIntangiblesMember 2024-03-31 0000814586 LWAY:CustomerListsAndOtherCustomerRelatedIntangiblesMember 2023-12-31 0000814586 us-gaap:CustomerRelationshipsMember 2024-03-31 0000814586 us-gaap:CustomerRelationshipsMember 2023-12-31 0000814586 LWAY:BrandNamesMember 2024-03-31 0000814586 LWAY:BrandNamesMember 2023-12-31 0000814586 LWAY:FormulaMember 2024-03-31 0000814586 LWAY:FormulaMember 2023-12-31 0000814586 us-gaap:CustomerRelationshipsMember 2024-01-01 2024-03-31 0000814586 LWAY:BrandNamesMember 2024-01-01 2024-03-31 0000814586 LWAY:CreditAgreementTermLoanMember 2024-03-31 0000814586 us-gaap:RevolvingCreditFacilityMember 2024-03-31 0000814586 LWAY:IncrementalFacilityMember 2024-03-31 0000814586 LWAY:CreditAgreementTermLoanMember 2024-01-01 2024-03-31 0000814586 us-gaap:RevolvingCreditFacilityMember 2024-01-01 2024-03-31 0000814586 LWAY:CreditAgreementMember 2024-01-01 2024-03-31 0000814586 LWAY:Omnibus2015Member 2015-12-31 0000814586 LWAY:Omnibus2022PlanMember 2022-08-31 0000814586 LWAY:Omnibus2022PlanMember 2024-03-31 0000814586 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0000814586 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0000814586 us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 0000814586 LWAY:CEO2020AwardMember 2020-10-01 2020-12-31 0000814586 LWAY:CEO2020AwardMember 2024-01-01 2024-03-31 0000814586 LWAY:CEO2020AwardMember 2023-01-01 2023-03-31 0000814586 LWAY:CEO2020AwardMember 2024-03-31 0000814586 LWAY:Plan2021Member 2024-01-01 2024-03-31 0000814586 LWAY:Plan2021Member 2023-01-01 2023-03-31 0000814586 LWAY:Plan2021Member 2024-03-31 0000814586 LWAY:Plan2022Member 2024-01-01 2024-03-31 0000814586 LWAY:Plan2022Member 2023-01-01 2023-03-31 0000814586 LWAY:Plan2023Member 2024-01-01 2024-03-31 0000814586 LWAY:Plan2023Member 2023-01-01 2023-03-31 0000814586 LWAY:Plan2024Member 2024-01-01 2024-03-31 0000814586 LWAY:Plan2024Member 2023-01-01 2023-03-31 0000814586 LWAY:Director2022PlanMember 2024-03-31 0000814586 LWAY:DefinedContributionPlanMember 2024-01-01 2024-03-31 0000814586 LWAY:DefinedContributionPlanMember 2023-01-01 2023-03-31 0000814586 us-gaap:StockOptionMember 2023-12-31 0000814586 us-gaap:StockOptionMember 2023-01-01 2023-12-31 0000814586 us-gaap:StockOptionMember 2024-01-01 2024-03-31 0000814586 us-gaap:StockOptionMember 2024-03-31 0000814586 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0000814586 LWAY:DrinkableKefirotherthanProBugsMember 2024-01-01 2024-03-31 0000814586 LWAY:DrinkableKefirotherthanProBugsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000814586 LWAY:DrinkableKefirotherthanProBugsMember 2023-01-01 2023-03-31 0000814586 LWAY:DrinkableKefirotherthanProBugsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000814586 LWAY:CheeseMember 2024-01-01 2024-03-31 0000814586 LWAY:CheeseMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000814586 LWAY:CheeseMember 2023-01-01 2023-03-31 0000814586 LWAY:CheeseMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000814586 LWAY:CreamAndOtherMember 2024-01-01 2024-03-31 0000814586 LWAY:CreamAndOtherMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000814586 LWAY:CreamAndOtherMember 2023-01-01 2023-03-31 0000814586 LWAY:CreamAndOtherMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000814586 LWAY:DrinkableYogurtMember 2024-01-01 2024-03-31 0000814586 LWAY:DrinkableYogurtMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000814586 LWAY:DrinkableYogurtMember 2023-01-01 2023-03-31 0000814586 LWAY:DrinkableYogurtMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000814586 LWAY:ProBugsKefirMember 2024-01-01 2024-03-31 0000814586 LWAY:ProBugsKefirMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000814586 LWAY:ProBugsKefirMember 2023-01-01 2023-03-31 0000814586 LWAY:ProBugsKefirMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000814586 LWAY:OtherDairyMember 2024-01-01 2024-03-31 0000814586 LWAY:OtherDairyMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000814586 LWAY:OtherDairyMember 2023-01-01 2023-03-31 0000814586 LWAY:OtherDairyMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000814586 LWAY:NetSalesMember 2024-01-01 2024-03-31 0000814586 LWAY:NetSalesMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000814586 LWAY:NetSalesMember 2023-01-01 2023-03-31 0000814586 LWAY:NetSalesMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000814586 us-gaap:SalesRevenueNetMember LWAY:TwoCustomersMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000814586 us-gaap:SalesRevenueNetMember LWAY:TwoCustomersMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

       QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: March 31, 2024

 

       TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________

 

Commission File Number: 000-17363

 

LIFEWAY FOODS, INC.

(Exact name of registrant as specified in its charter)

 

Illinois 36-3442829

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

 

6431 West Oakton, Morton Grove, IL 60053

(Address of principal executive offices, zip code)

 

(847) 967-1010

(Registrant’s telephone number, including area code)

 

Securities registered under Section 12(b) of the Exchange Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, No Par Value LWAY NASDAQ Global Market

 

Securities registered under Section 12(g) of the Exchange Act:

None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data file required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one)

 

  Large accelerated Filer ☐ Accelerated Filer ☐
  Non-accelerated Filer Smaller reporting company
  Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

Number of shares of Common Stock, no par value, outstanding as of May 6, 2024: 14,707,392.

 

 

 

   

 

 

TABLE OF CONTENTS

 

PART I – FINANCIAL INFORMATION  
   
Item 1. Financial Statements. 3
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. 19
Item 3. Quantitative and Qualitative Disclosures About Market Risk. 24
Item 4. Controls and Procedures. 24
   
PART II – OTHER INFORMATION  
   
Item 1. Legal Proceedings. 25
Item 1A. Risk Factors. 25
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 25
Item 3. Defaults Upon Senior Securities. 25
Item 5. Other Information. 25
Item 6. Exhibits. 25
  Signatures. 26

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 2 

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS.

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

March 31, 2024 and December 31, 2023

(In thousands)

         
   March 31, 2024   December 31, 
   (Unaudited)   2023 
Current assets          
Cash and cash equivalents  $12,025   $13,198 
Accounts receivable, net of allowance for credit losses and discounts & allowances of $1,640 and $1,270 at March 31, 2024 and December 31, 2023 respectively   15,064    13,875 
Inventories, net   8,130    9,104 
Prepaid expenses and other current assets   1,988    2,019 
Refundable income taxes   378     
Total current assets   37,585    38,196 
           
Property, plant and equipment, net   24,627    22,764 
Operating lease right-of-use asset   172    192 
Goodwill   11,704    11,704 
Intangible assets, net   6,763    6,898 
Other assets   1,900    1,900 
Total assets  $82,751   $81,654 
           
Current liabilities          
Current portion of note payable  $1,250   $1,250 
Accounts payable   10,024    9,976 
Accrued expenses   3,604    4,916 
Accrued income taxes       474 
Total current liabilities   14,878    16,616 
Note payable   1,235    1,483 
Operating lease liabilities   102    118 
Deferred income taxes, net   3,001    3,001 
Total liabilities   19,216    21,218 
           
Commitments and contingencies (Note 9)        
           
Stockholders’ equity          
Preferred stock, no par value; 2,500 shares authorized; no shares issued or outstanding at March 31, 2024 and December 31, 2023        
Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 14,691 outstanding at March 31, 2024 and December 31, 2023   6,509    6,509 
Paid-in capital   5,498    4,825 
Treasury stock, at cost   (16,695)   (16,695)
Retained earnings   68,223    65,797 
Total stockholders' equity   63,535    60,436 
           
Total liabilities and stockholders' equity  $82,751   $81,654 

 

See accompanying notes to consolidated financial statements

  

 

 

 3 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Operations

For the three ended March 31, 2024 and 2023

(Unaudited)

(In thousands, except per share data)

         
   2024   2023 
         
Net Sales  $44,634   $37,904 
           
Cost of goods sold   32,438    29,030 
Depreciation expense   661    648 
Total cost of goods sold   33,099    29,678 
           
Gross profit   11,535    8,226 
           
Selling expense   3,700    3,519 
General and administrative expense   4,136    3,135 
Amortization expense   135    135 
Total operating expenses   7,971    6,789 
           
Income from operations   3,564    1,437 
           
Other income (expense):          
Interest expense   (51)   (104)
Other income (expense), net   (5)   5 
Total other income (expense)   (56)   (99)
           
Income before provision for income taxes   3,508    1,338 
           
Provision for income taxes   1,082    508 
           
Net income  $2,426   $830 
           
Net earnings per common share:          
Basic  $0.17   $0.06 
Diluted  $0.16   $0.06 
           
Weighted average common shares outstanding:          
Basic   14,691    14,645 
Diluted   15,222    15,030 

 

See accompanying notes to consolidated financial statements

 

 

 

 4 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Stockholders’ Equity

(Unaudited)

(In thousands)

                             
   Common Stock             
   Issued   In treasury   Paid-In   Retained   Total 
   Shares   $   Shares   $   Capital   Earnings   Equity 
Balance, January 1, 2023   17,274   $6,509    (2,629)  $(16,993)  $3,624   $54,430   $47,570 
                                    
Stock-based compensation                   343        343 
                                    
Net income                       830    830 
                                    
Balance, March 31, 2023   17,274   $6,509    (2,629)  $(16,993)  $3,967   $55,260   $48,743 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Stockholders’ Equity

(Unaudited)

(In thousands)

                             
   Common Stock             
   Issued   In treasury   Paid-In   Retained   Total 
   Shares   $   Shares   $   Capital   Earnings   Equity 
Balance, January 1, 2024   17,274   $6,509    (2,583)  $(16,695)  $4,825   $65,797   $60,436 
                                    
Stock-based compensation                   673        673 
                                    
Net income                       2,426    2,426 
                                    
Balance, March 31, 2024   17,274   $6,509    (2,629)  $(16,695)  $5,498   $68,223   $63,535 

 

See accompanying notes to consolidated financial statements

 

 

 

 5 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)

         
   Three months ended March 31, 
   2024   2023 
Cash flows from operating activities:          
Net income  $2,426   $830 
Adjustments to reconcile net income to operating cash flow:          
Depreciation and amortization   796    783 
Stock-based compensation   673    343 
Non-cash interest expense   2    2 
(Increase) decrease in operating assets:          
Accounts receivable   (1,189)   (572)
Inventories   974    339 
Refundable income taxes   (378)   44 
Prepaid expenses and other current assets   31    377 
Increase (decrease) in operating liabilities:          
Accounts payable   (6)   1,046 
Accrued expenses   (1,309)   (581)
Accrued income taxes   (474)   416 
Net cash provided by operating activities   1,546    3,027 
           
Cash flows from investing activities:          
Purchases of property and equipment   (2,469)   (1,762)
Net cash used in investing activities   (2,469)   (1,762)
           
Cash flows from financing activities:          
Repayment of note payable   (250)   (500)
Net cash used in financing activities   (250)   (500)
           
Net (decrease) increase in cash and cash equivalents   (1,173)   765 
           
Cash and cash equivalents at the beginning of the period   13,198    4,444 
           
Cash and cash equivalents at the end of the period  $12,025   $5,209 
           
Supplemental cash flow information:          
Cash paid for income taxes, net of (refunds)  $1,934   $47 
Cash paid for interest  $50   $130 
           
Non-cash investing activities          
Accrued purchase of property and equipment  $192   $122 
Right-of-use assets obtained in exchange for lease obligations  $   $19 

 

See accompanying notes to consolidated financial statements

 

 

 

 6 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data)

 

 

Note 1 – Basis of Presentation

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) for interim financial information, and do not include certain information and footnote disclosures required for complete, audited financial statements. In the opinion of management, these statements include all adjustments necessary for a fair presentation of the results of all interim periods reported herein. The consolidated financial statements and related notes should be read in conjunction with the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Results of operations for any interim period are not necessarily indicative of future or annual results.

 

Principles of consolidation

 

The consolidated financial statements include the accounts of Lifeway Foods, Inc. and all its wholly owned subsidiaries (collectively “Lifeway” or the “Company”). All significant intercompany accounts and transactions have been eliminated.

 

Note 2 – Summary of Significant Accounting Policies

 

Our significant accounting policies, which are summarized in detail in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, have not materially changed. The following is a description of certain of our significant accounting policies.

 

Use of estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made in preparing the consolidated financial statements include the reserve for promotional allowances, the valuation of goodwill and intangible assets, stock-based and incentive compensation, and deferred income taxes.

 

Cash and cash equivalents

 

Lifeway considers cash and all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents are stated at cost, which approximates or equals fair value due to their short-term nature.

 

Lifeway from time to time may have bank deposits in excess of insurance limits of the Federal Deposit Insurance Corporation. The Company places its cash and cash equivalents with high credit quality financial institutions. Lifeway has not experienced any losses in such accounts and believes the financial risks associated with these financial instruments are minimal.

 

 

 

 7 

 

 

Advertising and promotional costs

 

Advertising costs are expensed as incurred and reported in Selling expense in the Company’s consolidated statement of operations. Total advertising expense was $1,372 and $1,463 for the three months ended March 31, 2024 and 2023, respectively.

 

Segments

 

The Company is managed as a single reportable segment. The Chief Executive Officer, who is the Company’s Chief Operating Decision Maker (“CODM”), reviews financial information on an aggregate basis for purposes of allocating resources and assessing financial performance, as well as for making strategic operational decisions and managing the organization. Substantially all of Lifeway’s consolidated revenues relate to the sale of cultured dairy products that it produces using the same processes and materials and are sold to consumers through a common network of distributors and retailers in the United States.  

 

Recent accounting pronouncements

 

Issued but not yet effective

 

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07: Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The new guidance requires entities to report incremental information about significant segment expenses included in a segment’s profit or loss measure as well as the name and title of the chief operating decision maker. The guidance also requires interim disclosures related to reportable segment profit or loss and assets that had previously only been disclosed annually. The new standard is effective for our annual period ending December 31, 2024 and our interim periods during the fiscal year ending December 31, 2025. The guidance does not affect recognition or measurement in the Company’s consolidated financial statements.

 

In December 2023, the FASB issued ASU No. 2023-09: Income Taxes (Topic 740): Improvements to Income Tax Disclosures that requires entities to disclose additional information about federal, state, and foreign income taxes primarily related to the income tax rate reconciliation and income taxes paid. The new standard also eliminates certain existing disclosure requirements related to uncertain tax positions and unrecognized deferred tax liabilities. The guidance is effective for our fiscal year ending December 31, 2024. The guidance does not affect recognition or measurement in the Company’s consolidated financial statements.

 

Note 3 – Inventories, net

 

Inventories consisted of the following:

        
   March 31,
2024
   December 31,
2023
 
Ingredients  $2,411   $2,929 
Packaging   2,640    3,014 
Finished goods   3,079    3,161 
Total inventories, net  $8,130   $9,104 

 

 

 

 8 

 

 

Note 4 – Property, Plant and Equipment, net

 

Property, plant and equipment consisted of the following:

        
   March 31,
2024
   December 31,
2023
 
Land  $1,565   $1,565 
Buildings and improvements   21,855    21,661 
Machinery and equipment   33,890    33,573 
Vehicles   705    705 
Office equipment   1,072    1,072 
Construction in process   4,107    2,154 
    63,194    60,730 
Less accumulated depreciation   (38,567)   (37,966)
Total property, plant and equipment, net  $24,627   $22,764 

 

Note 5 – Goodwill and Intangible Assets

 

Goodwill

 

Goodwill consisted of the following:

    
   Total 
Balance at December 31, 2023     
Goodwill  $12,948 
Accumulated impairment losses   (1,244)
   $11,704 

 

Balance at March 31, 2024     
Goodwill  $12,948 
Accumulated impairment losses   (1,244)
   $11,704 

 

 

 

 

 

 9 

 

 

Intangible Assets

 

Other intangible assets, net consisted of the following:

                        
   March 31, 2024   December 31, 2023 
   Gross       Net   Gross       Net 
   Carrying   Accumulated   Carrying   Carrying   Accumulated   Carrying 
   Amount   Amortization   Amount   Amount   Amortization   Amount 
                         
Recipes  $44   $(44)  $   $44   $(44)  $ 
Customer lists and other customer related intangibles   4,529    (4,529)       4,529    (4,529)    
Customer relationships   3,385    (1,412)   1,973    3,385    (1,372)   2,013 
Brand names   7,948    (3,158)   4,790    7,948    (3,063)   4,885 
Formula   438    (438)       438    (438)    
Total intangible assets, net  $16,344   $(9,581)  $6,763   $16,344   $(9,446)  $6,898 

 

Estimated amortization expense on intangible assets for the next five years is as follows:

    
Year  Amortization 
Nine months ended December 31, 2024  $405 
2024  $540 
2025  $540 
2026  $540 
2027  $540 

 

The weighted-average remaining amortization expense period for the customer relationship and brand name intangible assets is 12.3 and 12.6 years, respectively, as of March 31, 2024. The weighted-average remaining amortization expense period for total intangible assets is 12.5 years as of March 31, 2024.

  

Note 6 – Accrued Expenses

 

Accrued expenses consisted of the following:

        
   March 31,
2024
  

December 31,

2023

 
Payroll and incentive compensation  $2,621   $3,853 
Real estate taxes   343    442 
Utilities   193    241 
Current portion of operating lease liabilities   71    74 
Other   376    306 
Total accrued expenses  $3,604   $4,916 

 

 

 

 10 

 

 

Note 7 – Debt

 

Note payable consisted of the following:

        
  

March 31,

2024

  

December 31,

2023

 
Term loan due August 18, 2026. Interest (7.39% at March 31, 2024) payable monthly.  $2,500   $2,750 
Unamortized deferred financing costs   (15)   (17)
Total note payable   2,485    2,733 
Less current portion   (1,250)   (1,250)
Total long-term portion  $1,235   $1,483 

 

The scheduled maturities of the term loan, excluding deferred financing costs, at March 31, 2024 are as follows: 

    
Nine months ended December 31, 2024  $1,000 
2025   1,000 
2026   500 
Total term loan  $2,500 

 

Credit Agreement

 

The Company is party to an Amended and Restated Loan and Security Agreement (as amended and modified from time to time, the “Credit Agreement”) with its existing lender and certain of its subsidiaries. The Credit Agreement provides for, among other things, a $5 million term loan to be repaid in quarterly installments of principal and interest over a term of five years, a revolving line of credit up to a maximum of $5 million (the “Revolving Credit Facility”) and an incremental facility not to exceed $5 million. The termination date of the term loan is August 18, 2026, unless earlier terminated. The termination date of the revolving credit facility is June 30, 2025, unless earlier terminated.

 

All outstanding amounts under the Credit Agreement bear interest at the Secured Overnight Financing Rate (“SOFR”), plus 2.07%. Interest is payable monthly in arrears. Lifeway is also required to pay a quarterly unused revolving line of credit fee of 0.20% and, in conjunction with the issuance of any letters of credit, a letter of credit fee of 0.20%.

 

The Credit Agreement includes customary representations, warranties, and covenants, including financial covenants requiring the Company to maintain a fixed charge coverage ratio of no less than 1.25 to 1.00, and a minimum working capital financial covenant, as defined, of no less than $11.25 million, in each of the fiscal quarters ending through the expiration date. The Credit Agreement continues to provide for events of default, including failure to repay principal and interest when due and failure to perform or violation of the provisions or covenants of the agreement, as a result of which amounts due under the Credit Agreement may be accelerated. The loans and all other amounts due and owed under the Credit Agreement and related documents are secured by substantially all of the Company’s assets.

 

Lifeway was in compliance with the fixed charge coverage ratio and minimum working capital covenants at March 31, 2024.

 

 

 

 11 

 

 

Revolving Credit Facility

 

As of March 31, 2024, the Company had $0 outstanding under the Revolving Credit Facility. The Company had $5,000 available for future borrowings under the Revolving Credit Facility as of March 31, 2024.

 

Note 8 – Leases

 

The Company leases certain machinery and equipment with fixed base rent payments and variable costs based on usage. Remaining lease terms for these leases range from less than one year to six years. The Company includes lease extension options, if applicable and reasonably certain to be exercised, in the calculation of the right-of-use asset and lease liabilities. Lifeway includes only fixed payments for lease components in the measurement of the right-of-use asset and lease liability. Variable lease payments are those that vary because of changes in facts or circumstances occurring after the commencement date, other than the passage of time. There are no residual value guarantees. Lifeway does not currently have leases which meet the finance lease classification as defined under ASC 842.

 

Lifeway treats contracts as a lease when the contract conveys the right to use a physically distinct asset for a period of time in exchange for consideration, it directs the use of the asset and obtains substantially all the economic benefits of the asset.

 

Right-of-use assets and lease liabilities are measured and recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. Lifeway has elected the practical expedient to combine lease and non-lease components into a single component for all of its leases. When the Company is unable to determine an implicit interest rate, it uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments for those leases. Lifeway includes options to extend or terminate the lease in the measurement of the right-of-use asset and lease liability when it is reasonably certain that it will exercise such options. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.

 

The Company does not record leases with an initial term of 12 months or less on the balance sheet. Expense for these short-term leases is recorded on a straight-line basis over the lease term. Total lease expense was $35 and $31 (including short term leases) for the three months ended March 31, 2024 and 2023, respectively.

 

Future maturities of lease liabilities were as follows:

     
Year  Operating Leases 
Nine months ended December 31, 2024  $64 
2025   55 
2026   31 
2027   21 
2028   17 
Thereafter   10 
Total lease payments   198 
Less: Interest   (26)
Present value of lease liabilities  $172 

 

The weighted-average remaining lease term for its operating leases was 3.5 years as of March 31, 2024. The weighted average discount rate of its operating leases was 9.49% as of March 31, 2024. Cash paid for amounts included in the measurement of lease liabilities was $24 and $25 for the three months ended March 31, 2024 and 2023, respectively.

 

 

 

 12 

 

 

Note 9 – Commitments and contingencies

 

Litigation

 

Lifeway is involved in various legal proceedings, claims, disputes, regulatory matters, audits, and proceedings arising in the ordinary course of, or incidental, to the Company’s business, including commercial disputes, product liabilities, intellectual property matters and employment-related matters.

 

Lifeway records provisions in the consolidated financial statements for pending legal matters when it believes it is probable that a loss will be incurred and the amount of such loss can be reasonably estimated. The Company evaluates, on a periodic basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and estimable, it does not establish an accrued liability. Currently, none of its accruals for outstanding legal matters are material individually or in the aggregate to its financial position and it is management’s opinion that the ultimate resolution of these outstanding legal matters will not have a material adverse effect on its business, financial condition, results of operations, or cash flows. However, if the Company is ultimately required to make payments in connection with an adverse outcome, it is possible that such contingency could have a material adverse effect on the Company’s business, financial condition, results of operations or cash flows.

  

Note 10 – Income taxes

 

Income taxes were recognized at effective rates of 30.8% and 37.9% for the three months ended March 31, 2024 and 2023, respectively.

 

The Company calculates the provision for income taxes during interim reporting periods by applying an estimate of the annual effective tax rate for the full year, excluding unusual or infrequently occurring discrete items, and applies that rate to income (loss) before provision for income taxes for the period.

 

The Company’s effective tax rate may change from period to period based on recurring and non-recurring factors including the relative mix of pre-tax earnings (or losses), the jurisdictional mix of earnings, enacted tax legislation, state income taxes, the impact of non-deductible items, changes in valuation allowances, settlement of tax audits, and the expiration of the statute of limitations in relation to unrecognized tax benefits. The Company records discrete income tax items such as enacted tax rate changes and completed tax audits in the period in which they occur. The Company consistently reflects non-deductible officer compensation expense, non-deductible compensation expense related to equity incentive awards and separate state tax rates from period to period. Although similar items were reflected in 2024, the percentage effect is different due to the difference in pre-tax income in 2024 compared to 2023.

 

Unrecognized tax benefits were $0 at March 31, 2024 and 2023, respectively. The Company does not expect material changes to its unrecognized tax benefits during the next twelve months.

 

 

 

 

 

 13 

 

 

Note 11 – Stock-based and Other Compensation

 

Omnibus Incentive Plan

 

In December 2015, Lifeway stockholders approved the 2015 Omnibus Incentive Plan, which authorized the issuance of an aggregate of 3.5 million shares to satisfy awards of stock options, stock appreciation rights, unrestricted stock, restricted stock, restricted stock units, performance shares and performance units to qualifying employees. Under the 2015 Omnibus Incentive Plan, the Board of Directors or its Compensation Committee approves stock awards to executive officers and certain senior executives, generally in the form of restricted stock or performance shares. The number of performance shares that participants may earn depends on the extent to which the corresponding performance goals have been achieved. Stock awards generally vest over a three-year performance or service period. At March 31, 2024, no shares remain available for award under the 2015 Omnibus Incentive Plan as it was terminated on August 31, 2022. However, any outstanding awards under the 2015 Omnibus Incentive Plan are unaffected by the termination of the 2015 Omnibus Incentive Plan or by the approval of the 2022 Omnibus Incentive Plan (the “2022 Plan”) as described below.

 

On August 31, 2022, Lifeway stockholders approved the 2022 Plan. Under the 2022 Plan, the Compensation Committee of the Board of Directors may grant awards of various types of compensation, including, nonqualified stock options, incentive stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units, cash-based awards and other stock-based awards. The maximum number of shares authorized to be awarded under the 2022 Plan is 3.25 million shares of common stock, which includes shares that remained available under the now terminated 2015 Omnibus Incentive Plan.

 

Awards granted under the 2022 Plan are generally subject to a minimum vesting period of at least one year. Awards may be subject to cliff-vesting or graded-vesting conditions, with graded vesting starting no earlier than one year after the grant date. The Plan Administrator may provide for shorter vesting periods in an award agreement for no more than five percent of the maximum number of shares authorized for issuance under the 2022 Plan. As of March 31, 2024, 2.64 million shares remain available to award under the 2022 Plan.

 

Stock Options

 

The following table summarizes stock option activity during the three months ended March 31, 2024:

                               
    Options     Weighted
average
exercise price
    Weighted
average
remaining contractual life
    Aggregate
intrinsic value
 
    (In thousands)                          
Outstanding at December 31, 2023     41     $ 10.42       2.21     $ 121  
Granted                        
Exercised                        
Forfeited                        
Outstanding at March 31, 2024     41     $ 10.42       1.97     $ 276  
Exercisable at March 31, 2024     41     $ 10.42       1.97     $ 276  

 

 

 

 14 

 

 

Restricted Stock Units

 

A Restricted Stock Unit (“RSU”) represents the right to receive one share of common stock in the future. RSUs have no exercise price. The grant date fair value of the awards is determined by the Company’s closing stock price on the grant date. Lifeway expenses RSUs over the vesting period. The following table summarizes RSU activity during the three months ended March 31, 2024.

         
   Restricted Stock Units   Weighted Average Grant Date Fair Value 
   (In thousands)     
Outstanding at December 31, 2023   207   $6.89 
Granted   33    13.73 
Shares issued upon vesting        
Forfeited        
Outstanding at March 31, 2024   240   $7.82 
Vested and deferred at March 31, 2024   67   $5.98 

 

For the three months ended March 31, 2024 and 2023 total pre-tax stock-based compensation expense recognized in the consolidated statements of operations was $233 and $104, respectively. For the three months ended March 31, 2024 and 2023 tax-related benefits of $65 and $29, respectively, were also recognized. Future compensation expense related to restricted stock units was $918 as of March 31, 2024 and will be recognized on a weighted average basis over the next 1.3 years.

 

Long-Term Incentive Plan Compensation

 

Lifeway has established long-term incentive-based compensation programs for certain senior executives and key employees pursuant to the terms of its incentive plans.

 

2020 CEO Incentive Award 

 

During the fourth quarter 2020, Lifeway awarded a long-term equity-based incentive of $750 to its Chief Executive Officer (the “2020 CEO Award”) depending on Lifeway’s 2020 performance levels compared to the respective targets. The equity-based incentive compensation is payable in restricted stock that vests one-third in April 2022, one-third in April 2023, and one-third in April 2024. The issuance of vested equity awards is subject to approval under the Stock Purchase Agreement dated October 1, 1999. For the three months ended March 31, 2024 and 2023, $18 and $43 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively. As of March 31, 2024, the total remaining unearned compensation of $6 will be recognized in 2024, subject to vesting.

 

2021 Equity Award

 

The 2021 long-term equity incentive plan compensation is based on Lifeway’s achievement of adjusted EBITDA performance versus the respective target established by the Board of Directors for 2021. Under the 2021 plan, collectively the participants earned equity-based incentive compensation of $1,069 based on Lifeway’s achievement of the respective financial target. The equity-based incentive compensation is payable in restricted stock that vests one-third in April 2022, one-third in April 2023, and one-third in April 2024. For the three months ended March 31, 2024 and 2023, $33 and $84 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively. As of March 31, 2024, the total remaining unearned compensation of $7 will be recognized in 2024, subject to vesting.

 

 

 

 15 

 

 

2022 Equity Award

 

Under the 2022 long-term incentive plan, participants can earn a specified number of target level Performance Share Units (“PSUs”) contingent upon the achievement of strategic milestones during the three-year Measurement Period, which is fiscal year 2022 to 2024. The strategic milestones are 1) 3-year cumulative net revenue, and 2) 3-year cumulative adjusted EBITDA. The target number of PSU awards are weighted 50% on net revenue and 50% on adjusted EBITDA. Collectively, the participants can earn 125,066 PSUs at the target level. Participants may earn more or less than the target number of shares based on actual results, however the minimum and maximum number of shares that can be earned are bound by minimum and maximum thresholds of net revenue and adjusted EBITDA. The PSU awards will be earned and will vest, if at all, after the end of the three-year measurement period based on achievement of the milestones. The PSU awards do not vest during the three-year measurement period. The PSUs have a grant date fair value of $6.25 dollars per share. For the three months ended March 31, 2024 and 2023, $156 and $112 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively.

 

The 2022 long-term incentive plan also granted restricted stock unit awards that contain only a service condition and vest on the passage of time in three equal installments on each of the first three anniversaries of the August 31, 2022 grant date. The stock-based compensation expense for these awards is included in the Restricted Stock Units section above.

 

2023 Equity Award

 

Under the 2023 long-term incentive plan, participants can earn a specified number of target level Performance Share Units (“PSUs”) contingent upon the achievement of strategic milestones during the three-year Measurement Period, which is fiscal year 2023 to 2025. The strategic milestones are 1) 3-year cumulative net revenue, and 2) 3-year cumulative adjusted EBITDA. The target number of PSU awards are weighted 50% on net revenue and 50% on adjusted EBITDA. Collectively, the participants can earn 115,622 PSUs at the target level. Participants may earn more or less than the target number of shares based on actual results, however the minimum and maximum number of shares that can be earned are bound by minimum and maximum thresholds of net revenue and adjusted EBITDA. The PSU awards will be earned and will vest, if at all, after the end of the three-year measurement period based on achievement of the milestones. The PSU awards do not vest during the three-year measurement period. The PSUs have a grant date fair value of $6.88 dollars per share. For the three months ended March 31, 2024 and 2023, $130 and $0 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively.

 

The 2023 long-term incentive plan also granted restricted stock unit awards that contain only a service condition and vest on the passage of time in three equal installments on each of the first three anniversaries of the June 16, 2023 grant date. The stock-based compensation expense for these awards is included in the Restricted Stock Units section above.

 

2024 Equity Award

 

Under the 2024 long-term incentive plan, participants can earn a specified number of target level Performance Share Units (“PSUs”) contingent upon the achievement of strategic milestones during the three-year Measurement Period, which is fiscal year 2024 to 2026. The strategic milestones are 1) 3-year cumulative net revenue, and 2) 3-year cumulative adjusted EBITDA. The target number of PSU awards are weighted 50% on net revenue and 50% on adjusted EBITDA. Collectively, the participants can earn 64,986 PSUs at the target level. Participants may earn more or less than the target number of shares based on actual results, however the minimum and maximum number of shares that can be earned are bound by minimum and maximum thresholds of net revenue and adjusted EBITDA. The PSU awards will be earned and will vest, if at all, after the end of the three-year measurement period based on achievement of the milestones. The PSU awards do not vest during the three-year measurement period. The PSUs have a grant date fair value of $13.73 dollars per share. For the three months ended March 31, 2024 and 2023, $102 and $0 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively.

 

 

 

 16 

 

 

The 2024 long-term incentive plan also granted restricted stock unit awards that contain only a service condition and vest on the passage of time in three equal installments on each of the first three anniversaries of the January 10, 2024 grant date. The stock-based compensation expense for these awards is included in the Restricted Stock Units section above.

 

Non-Employee Director Plan

 

On August 31, 2022, Lifeway stockholders approved the 2022 Non-Employee Director Equity and Deferred Compensation Plan (the “2022 Director Plan”), which authorizes the grant of restricted stock units (“RSUs”), which will vest on such schedule as the Company, in its sole discretion, shall determine. Each non-employee director of the Company is eligible to be a participant in the 2022 Director Plan until they no longer serve as a non-employee director. As of the date of each annual shareholder meeting, the Company may grant each director a number of RSUs for such year and set the vesting schedule for the RSUs granted. Whether and how many RSUs the Company will grant to directors in any year is subject to the sole discretion of the Company and shall in any event be subject to the 2022 Director Plan’s overall share limits. The maximum aggregate number of shares of common stock that may be issued under the 2022 Director Plan is 500 thousand shares. As of March 31, 2024, 430 thousand shares remain available to award under the 2022 Director Plan. The aggregate fair market value of shares underlying RSU compensation that may be issued as RSU compensation to a director in any year shall not exceed $170. In addition to the grant of RSUs, the 2022 Director Plan also provides for the deferral by electing participants of all or part of their cash compensation (in 10% increments) into a deferred cash account, and they may defer all or part of their cash and/or RSU compensation (in 10% increments) into a deferred RSU account. Deferred benefits are paid in a lump sum upon the applicable director’s departure from the Board of Directors.

 

Retirement Benefits

 

Lifeway has a defined contribution plan which is available to substantially all full-time employees. Under the terms of the plan, the Company matches employee contributions under a prescribed formula. For the three months ended March 31, 2024 and 2023, total contribution expense recognized in the consolidated statements of operations was $193 and $150, respectively.

 

Note 12 - Earnings Per Share

 

The following table summarizes the effects of the share-based compensation awards on the weighted average number of shares outstanding used in calculating diluted earnings per share:

        
   Three Months Ended 
   March 31, 
   2024   2023 
   (In Thousands) 
Weighted average common shares outstanding   14,691    14,645 
Assumed exercise/vesting of equity awards   531    385 
Weighted average diluted common shares outstanding   15,222    15,030 

 

 

 

 17 

 

 

Note 13 – Disaggregation of Revenue and Significant Customers

 

Lifeway’s primary product is drinkable kefir. The Company manufactures (directly or through a co-manufacturer) and markets products under the Lifeway, Fresh Made, and GlenOaks Farms brand names, as well as under private labels on behalf of certain customers.

  

The Company’s product categories are:

 

  · Drinkable kefir, a cultured dairy product sold in a variety of organic and non-organic sizes, flavors, and types.
  · European-style soft cheeses, including farmer cheese, white cheese, and Sweet Kiss.
  · Cream and other, which primarily consists of cream, a byproduct of raw milk processing.
  · Drinkable yogurt, sold in a variety of sizes and flavors.
  · ProBugs, a line of kefir products designed for children.
  · Other dairy, which primarily consists of Fresh Made butter and sour cream.

 

Net sales of products by category were as follows for the three months ended March 31:

                               
    2024     2023  
In thousands   $     %     $     %  
                         
Drinkable Kefir other than ProBugs     36,533       82%       29,800       79%  
Cheese     3,515       8%       3,345       9%  
Cream and other     1,816       4%       1,920       5%  
Drinkable Yogurt     1,536       3%       1,616       4%  
ProBugs Kefir     866       2%       808       2%  
Other dairy     368       1%       415       1%  
Net Sales     44,634       100%       37,904       100%  

 

Significant Customers

 

Sales are predominately to companies in the retail food industry located within the United States. Two major customers accounted for approximately 25% and 24% of net sales for the three months ended March 31, 2024 and 2023, respectively.

 

Geographic Information

 

Net sales outside the of the United States represented less than 1% of total consolidated net sales for the three months ended March 31, 2024 and 2023. Net sales are determined based on the destination where the products are shipped by Lifeway.

 

All the Company’s long-lived assets are in the United States.

 

 

 

 18 

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) in this Form 10-Q is provided as a supplement to, and should be read in conjunction with, our audited consolidated financial statements, the accompanying notes, and the MD&A included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”). Unless otherwise specified, any description of “our”, “we”, and “us” in this MD&A refer to Lifeway Foods, Inc. and our subsidiaries.

 

Cautionary Statement Regarding Forward-Looking Statements

 

In addition to historical information, this quarterly report contains “forward-looking” statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of words such as “anticipate,” “from time to time,” “intend,” “plan,” “ongoing,” “realize,” “should,” “may,” “could," "believe," "future," "depend," "expect," "will," "result," "can," "remain," "assurance," "subject to," "require," "limit," "impose," "guarantee," "restrict," "continue," "become," "predict," "likely," "opportunities," "effect," "change," "predict," and "estimate,” and similar terms or terminology, or the negative of such terms or other comparable terminology. Examples of forward-looking statements include, among others, statements we make regarding:

 

  · Expectations of the effect on our financial condition of claims, litigation, environmental costs, contingent liabilities and governmental and regulatory investigations and proceedings, if any;
  · Strategy for acquisitions, customer retention, growth, product development, market position, financial results and reserves;
  · Estimates of the amounts of sales allowances and discounts to our customers and consumers;
  · Our belief that we will maintain compliance with our loan agreements and have sufficient liquidity to fund our business operations.

 

Forward looking statements are based on management’s beliefs, assumptions, estimates and observations of future events based on information available to our management at the time the statements are made and include any statements that do not relate to any historical or current fact. These statements are not guarantees of future performance and they involve certain risks, uncertainties and assumptions that are difficult to predict. Actual outcomes and results may differ materially from what is expressed, implied or forecast by our forward-looking statements due in part to the risks, uncertainties, and assumptions that include:

 

  · Changes in the pricing of commodities;
  · The actions and decisions of our competitors and customers, including those related to price competition;
  · Our ability to successfully implement our business strategy;
  · The effects of government regulation;
  · Disruptions to our supply chain, or our manufacturing and distribution capabilities, including those due to cybersecurity threats; and
  · Such other factors as discussed throughout Part I, Item 1 “Business”; Part I, Item 1A “Risk Factors”; and Part II, Item 7 “Management's Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 2023 , Part II, Item 1A of this Form 10-Q and that are described from time to time in our other periodic reports filed with the SEC.

 

These factors are not necessarily all of the important factors that could cause actual results to differ materially from those expressed in any of our forward-looking statements. Other unknown or unpredictable factors could also have material adverse effects on future results. The Company intends these forward-looking statements to speak only at the date made. Except as otherwise required to be disclosed in periodic reports required to be filed by public companies with the SEC pursuant to the SEC's rules, Lifeway has no duty to update these statements, and it undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

 

 

 19 

 

 

Business Overview

 

Lifeway was founded in 1986 by Michael Smolyansky, ten years after he and his family emigrated from Eastern Europe to the United States. Lifeway was the first to successfully introduce kefir to the U.S. consumer on a commercial scale, initially catering to ethnic consumers in the Chicago, Illinois metropolitan area. Lifeway has grown to become the largest producer and marketer of kefir in the U.S. and an important player in the broader market spaces of probiotic-based products and natural, “better for you” foods.

 

Our primary product is drinkable kefir, a cultured dairy product. Lifeway Kefir is tart and tangy, high in protein, calcium and vitamin D. The Company manufactures (directly or through a co-manufacturer) and markets products under the Lifeway, Fresh Made, and GlenOaks Farms brand names, as well as under private labels on behalf of certain customers.

 

The Company’s product categories are:

 

  · Drinkable Kefir, a cultured dairy product sold in a variety of organic and non-organic sizes, flavors, and types.
  · European-style soft cheeses, including farmer cheese, white cheese, and Sweet Kiss.
  · Cream and other, which primarily consists of cream, a byproduct of raw milk processing.
  · Drinkable Yogurt, sold in a variety of sizes and flavors.
  · ProBugs, a line of kefir products designed for children.
  · Other Dairy, which primarily consists of Fresh Made butter and sour cream.

 

Recent Developments

 

Current Macroeconomic Environment and Inflation Impact

 

Since 2022, we experienced inflationary and cost pressures due to volatility and disruption in the global economy which have increased our production and distribution costs. We have begun to see some moderation of inflationary pressures and have experienced pricing declines in certain of our input costs, such as milk, during 2023. We expect inflationary pressures to be moderate during 2024.

 

We have not experienced significant supply chain disruptions or labor supply shortages and have continued to satisfy customer and consumer demand for our products. Management continues to proactively manage the supply and transportation of materials used to make and package our products, staffing, and transportation of our products to customers. This proactive planning has allowed the Company to meet increased demand.

 

 

 

 

 

 20 

 

 

Results of Operations

 

Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023

 

The following table presents certain information concerning our financial results, including information presented as a percentage of consolidated net sales:

 

   Three Months Ended March 31, 
   2024   2023 
   $   %   $   % 
Net sales   44,634    100.0%    37,904    100.0% 
Cost of goods sold   32,438    72.7%    29,030    76.6% 
Depreciation expense   661    1.5%    648    1.7% 
Total cost of goods sold   33,099    74.2%    29,678    78.3% 
Gross profit   11,535    25.8%    8,226    21.7% 
Selling expenses   3,700    8.3%    3,519    9.3% 
General & administrative expense   4,136    9.3%    3,135    8.2% 
Amortization expense   135    0.3%    135    0.4% 
Total operating expenses   7,971    17.9%    6,789    17.9% 
Income from operations   3,564    7.9%    1,437    3.8% 
Other income (expense):                    
Interest expense   (51)   (0.1%)   (104)   (0.3%)
Other income (expense), net   (5)   0.0%    5    0.0% 
Total other income (expense)   (56)   (0.1%)   (99)   (0.3%)
Income before provision for income taxes   3,508    7.8%    1,338    3.5% 
Provision for income taxes   1,082    2.4%    508    1.3% 
Net income   2,426    5.4%    830    2.2% 

 

Net Sales

 

Net sales were at $44,634 for the three-month period ended March 31, 2024, an increase of $6,731 or 17.8% versus prior year. The net sales increase was primarily driven by higher volumes of our branded drinkable kefir.

 

Gross Profit

 

Gross profit as a percentage of net sales was 25.8% during the three-month period ended March 31, 2024. Gross profit percentage was 21.7% in the first quarter of the prior year. The increase versus the prior year was primarily due to the higher volumes of our branded products, and to a lesser extent a favorable impact to transportation costs.

 

Selling Expenses

 

Selling expenses increased by $181 to $3,700 during the three-month period ended March 31, 2024 from $3,519 during the same period in 2023. Selling expenses as a percentage of net sales decreased to 8.3% in the three-month period ended March 31, 2024 from 9.3% during the same period in 2023.

 

 

 

 21 

 

 

General and Administrative Expenses

 

General and administrative expenses increased $1,001 to $4,136 during the three-month period ended March 31, 2024 from $3,135 during the same period in 2023. The increase is primarily driven by incentive compensation and non-routine stockholder action expense.

 

Provision for Income Taxes

 

The provision for income taxes was $1,082 and $508 during the three months ended March 31, 2024 and 2023, respectively.

 

The effective income tax rate for the three months ended March 31, 2024 was 30.8% compared to 37.9% in the same period last year. The statutory Federal and state tax rates remained consistent from 2024 to 2023. The Company has items that are nondeductible or are discrete adjustments to tax expense. The Company consistently reflects non-deductible officer compensation expense, non-deductible compensation expense related to equity incentive awards and separate state tax rates from period to period. Although similar items were reflected in 2023, the percentage effect is different due to the difference in pre-tax income in 2024 compared to 2023.

 

The Company’s effective tax rate may change from period to period based on recurring and non-recurring factors including the relative mix of pre-tax earnings (or losses), the jurisdictional mix of earnings, enacted tax legislation, state income taxes, the impact of non-deductible items, changes in valuation allowances, settlement of tax audits, and the expiration of the statute of limitations in relation to unrecognized tax benefits. The Company records discrete income tax items such as enacted tax rate changes and completed tax audits in the period in which they occur.

 

Income taxes are discussed in Note 10 in the Notes to the Consolidated Financial Statements.

 

Liquidity and Capital Resources

 

Management assesses the Company's liquidity in terms of its ability to generate cash to fund its operating, investing, and financing activities. The Company remains in a strong financial position, and while it has been impacted by the macroeconomic challenges with commodity inflation and other input cost increases, the Company believes that its cash flow from operations, revolving credit and term loan facility, and cash and cash equivalents will continue to provide sufficient liquidity for its working capital needs, capital resource requirements, and growth initiatives and to ensure the continuation of the Company as a going concern.

 

If additional borrowings are needed, $5,000 was available under the Revolving Credit Facility as of March 31, 2024 (see Note 7, Debt). We are in compliance with the terms of the Credit Agreement and expect to meet foreseeable financial requirements. The success of our business and financing strategies will continue to provide us with the financial flexibility to take advantage of various opportunities as they arise. To date, we have been successful in generating cash and obtaining financing as needed. However, if a serious economic or credit market crisis ensues, it could have a negative effect on our liquidity, results of operations and financial condition.

 

The Company’s most significant ongoing short-term cash requirements relate primarily to funding operations (including expenditures for raw materials, labor, manufacturing and distribution, trade and promotions, advertising and marketing, and income tax liabilities) as well as expenditures for property, plant and equipment.

 

Long-term cash requirements primarily relate to funding long-term debt repayments (see Note 7, Debt) and deferred income taxes (see Note 10, Income Taxes, in our Annual Report on Form 10-K).

 

 

 

 22 

 

 

Cash Flow

 

The following table is derived from our Consolidated Statement of Cash Flows:

 

   Three months Ended
March 31,
 
Net Cash Flows Provided By (Used In):  2024   2023 
Operating activities  $1,546   $3,027 
Investing activities  $(2,469)  $(1,762)
Financing activities  $(250)  $(500)

 

Operating Activities

 

Net cash provided by operating activities was $1,546 during the three-month period ended March 31, 2024 compared to $3,027 in the same period in 2023. The decrease was primarily due to the change in working capital, partially offset by higher cash earnings driven by increased product volumes and declines in certain input costs.

 

Investing Activities

 

Net cash used in investing activities was $2,469 during the three-month period ended March 31, 2024 compared to $1,762 in the same period in 2023. The increase in cash used reflects our planned capital spending increase during 2024 compared to 2023. Our capital spending is focused in three core areas: growth, cost reduction, and facility improvements. Growth capital spending supports capacity expansion and new product innovation and enhancements. Cost reduction and facility improvements support manufacturing efficiency, safety, and productivity.

 

Financing Activities

 

Net cash used in financing activities was $250 and $500 during the three-month period ended March 31, 2024 and 2023, respectively. The cash used represents the quarterly principal payments under the term loan.

 

Debt Obligations

 

The Company is party to an Amended and Restated Loan and Security Agreement (as amended and modified from time to time, the “Credit Agreement”) with its existing lender and certain of its subsidiaries. The Credit Agreement provides for, among other things, a $5 million term loan to be repaid in quarterly installments of principal and interest over a term of five years, a revolving line of credit up to a maximum of $5 million (the “Revolving Credit Facility”) and an incremental facility not to exceed $5 million. The termination date of the term loan is August 18, 2026, unless earlier terminated. The termination date of the revolving credit facility is June 30, 2025, unless earlier terminated.

 

As of March 31, 2024, the Company had $0 outstanding under the Revolving Credit Facility and $2,485 outstanding under the note payable, net of $15 of unamortized deferred financing fees. The Company had $5,000 available for future borrowings under the Revolving Credit Facility as of March 31, 2024.

 

All outstanding amounts under the loans bear interest at the Secured Overnight Financing Rate (“SOFR”), plus 2.07%. The Company’s interest rate on debt outstanding under the note payable as of March 31, 2024 was 7.39%. Interest is payable monthly in arrears. Lifeway is also required to pay a quarterly unused line fee of 0.20% on the Revolving Credit Facility, and in conjunction with the issuance of any letters of credit, a letter of credit fee of 0.20%.

 

 

 

 23 

 

 

The Company is in compliance with all applicable financial debt covenants as of March 31, 2024. See Note 7 to our Consolidated Financial Statements for additional information regarding our indebtedness and related agreements.

 

Recent Accounting Pronouncements

 

Information regarding recent accounting pronouncements is provided in Note 2 – Summary of Significant Accounting Policies.

 

Critical Accounting Policies and Estimates

 

A description of the Company's critical accounting policies and estimates is contained in its Annual Report on Form 10-K for the year ended December 31, 2023. There were no material changes to the Company’s critical accounting policies and estimates in the three months ended March 31, 2024.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures 

 

The Company has established disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”)) that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (“SEC”), and such information is accumulated and communicated to management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to allow timely decisions regarding required disclosure. Management, together with our CEO and CFO, evaluated the effectiveness of the Company’s disclosure controls and procedures as of March 31, 2024. Based on this evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective as of March 31, 2024.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that occurred during the quarter ended March 31, 2024 that has materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

 

 

 

 

 

 24 

 

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

Information regarding legal proceedings is available in Note 9, Commitment and Contingencies.

 

ITEM 1A. RISK FACTORS.

 

There have been no material changes from the risk factors disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

None.

  

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 5. OTHER INFORMATION.

 

During the quarter ended March 31, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

 

ITEM 6. EXHIBITS.

 

No.   Description   Form   Period Ending   Exhibit   Filing Date
                     
31.1   Rule 13a-14(a)/15d-14(a) Certification of Julie Smolyansky   Filed Herewith            
                     
31.2   Rule 13a-14(a)/15d-14(a) Certification of Eric Hanson   Filed Herewith            
                     
32.1   Section 1350 Certification of Julie Smolyansky*   Furnished Herewith            
                     
32.2   Section 1350 Certification of Eric Hanson*   Furnished Herewith            
                 
99.1   Press release dated May 14, 2024 reporting Lifeway’s financial results for the three months ended March 31, 2024*   Furnished Herewith            

 

101.INS   Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted in IXBRL, and included in exhibit 101).

 

* The exhibits deemed furnished with this Form 10-Q and are not deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act., whether made before or after the date of the filing of this Form 10-Q and irrespective of any general incorporation language contained in such filing.

 

 

 

 25 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  LIFEWAY FOODS, INC.
   
   
     
Date: May 14, 2024 By:   /s/ Julie Smolyansky
    Julie Smolyansky
    Chief Executive Officer, President, and Director
    (Principal Executive Officer)
     
     
     
Date: May 14, 2024 By:   /s/ Eric Hanson
    Eric Hanson
    Chief Financial & Accounting Officer
    (Principal Financial and Accounting Officer)

 

 

 

 

 

 

 

 

 

 26 

 

EX-31.1 2 lifeway_ex3101.htm SECTION 302 CERTIFICATION OF CEO

EXHIBIT 31.1

 

SECTION 302 CERTIFICATION OF C.E.O.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Julie Smolyansky, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Lifeway Foods, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 14, 2024 By: /s/ Julie Smolyansky
  Julie Smolyansky
  Chief Executive Officer, President and Director
  (Principal Executive Officer)

 

EX-31.2 3 lifeway_ex3102.htm SECTION 302 CERTIFICATION OF CFO

EXHIBIT 31.2

 

SECTION 302 CERTIFICATION OF C.F.O.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Eric Hanson, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Lifeway Foods, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 14, 2024 By: /s/ Eric Hanson
  Eric Hanson
  Chief Financial Officer
  (Principal Financial and Accounting Officer)

 

EX-32.1 4 lifeway_ex3201.htm SECTION 906 CERTIFICATION OF CEO

EXHIBIT 32.1

 

SECTION 906 CERTIFICATION OF C.E.O.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT

TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Lifeway Foods, Inc. (the “Company”) for the period ended March 31, 2024 as filed with the SEC (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to her knowledge:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 14, 2024 By: /s/ Julie Smolyansky
  Julie Smolyansky
  Chief Executive Officer, President and Director
  (Principal Executive Officer)

 

EX-32.2 5 lifeway_ex3202.htm SECTION 906 CERTIFICATION OF CFO

EXHIBIT 32.2

 

SECTION 906 CERTIFICATION OF C.F.O.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT

TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Lifeway Foods, Inc. (the “Company”) for the period ended March 31, 2024 as filed with the SEC (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 14, 2024 By: /s/ Eric Hanson
  Eric Hanson
  Chief Financial Officer
  (Principal Financial and Accounting Officer)

 

EX-99.1 6 lifeway_ex9901.htm PRESS RELEASE

EXHIBIT 99.1

 

 

 

Lifeway Foods® Announces Record Results for the First Quarter Ended March 31, 2024

 

Net sales of $44.6 million; up 17.8% year-over-year driven by volume growth of Lifeway Kefir

 

18th consecutive quarter of year-over-year growth

 

Delivers 410 basis points of gross profit margin expansion

 

Morton Grove, IL — May 14, 2024 — Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today reported financial results for the first quarter ended March 31, 2024.

 

“Following our tremendous results in 2023, I am thrilled to report yet another record-breaking quarter on the topline to kick off 2024,” commented Julie Smolyansky, President and Chief Executive Officer of Lifeway Foods. “Driven by volume growth in our flagship Lifeway drinkable kefir, we delivered our highest ever quarterly net sales of $44.6 million in the first quarter, up nearly 18% year-over-year, as our strategic sales and marketing investments continue to accelerate our sales velocities, grow awareness and win new consumers seeking better-for-you, premium products at a great value. This marked our 18th consecutive quarter of growth and 4th consecutive quarter reporting record net sales, which demonstrates the loyalty of our core customer base. Through our strong operational execution, accompanied by favorable transportation cost tailwinds, we also continued to improve on our key profitability metrics in the quarter, highlighted by our gross margin expansion and net income growth. We are pleased with this strong start to the year, and are consistently evaluating additional brand marketing and incremental distribution opportunities in an effort to build on this high bar of success throughout 2024.”

 

First Quarter 2024 Results

 

Net sales were $44.6 million for the first quarter ended March 31, 2024, an increase of $6.7 million or 17.8% from the same period in 2023. The net sales increase was primarily driven by higher volumes of our branded drinkable kefir.

 

Gross profit as a percentage of net sales increased to 25.8% for the first quarter ended March 31, 2024 from 21.7% during the same period in 2023. The 410-basis point increase versus the prior year was primarily due to the higher volumes of Lifeway branded products, and to a lesser extent a favorable impact of transportation costs.

 

Selling, general and administrative expenses as a percentage of net sales were 17.6% for the first quarter ended March 31, 2024 and 2023, respectively.

 

The Company reported net income of $2.4 million or $0.17 per basic and $0.16 per diluted common share for the first quarter ended March 31, 2024 compared to net income of $0.8 million or $0.06 per basic and diluted common share during the same period in 2023.

 

 

 

 

 1 

 

 

Conference Call and Webcast

A pre-recorded conference call and webcast with Julie Smolyansky discussing these results with additional comments and details is available through the “Investor Relations” section of the Company’s website at https://lifewaykefir.com/webinars-reports/ and will also be available for replay.

 

About Lifeway Foods, Inc.


Lifeway Foods, Inc., which has been recognized as one of Forbes' Best Small Companies, is America's leading supplier of the probiotic, fermented beverage known as kefir. In addition to its line of drinkable kefir, the company also produces a variety of cheeses and a ProBugs line for kids. Lifeway's tart and tangy fermented dairy products are now sold across the United States, Mexico, Ireland and France. Learn how Lifeway is good for more than just you at lifewayfoods.com.

 

Forward-Looking Statements

 

This release (and oral statements made regarding the subjects of this release) contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product development, market position, business strategy and objectives. These statements use words, and variations of words, such as "continue," "build," "future," "increase," "drive," "believe," "look," "ahead," "confident," "deliver," "outlook," "expect," and "predict." Other examples of forward-looking statements may include, but are not limited to, (i) statements of Company plans and objectives, including the introduction of new products, or estimates or predictions of actions by customers or suppliers, (ii) statements of future economic performance, and (III) statements of assumptions underlying other statements and statements about Lifeway or its business. You are cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events and thus are inherently subject to uncertainty. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from Lifeway's expectations and projections. These risks, uncertainties, and other factors include: price competition; the decisions of customers or consumers; the actions of competitors; changes in the pricing of commodities; the effects of government regulation; possible delays in the introduction of new products; and customer acceptance of products and services. A further list and description of these risks, uncertainties, and other factors can be found in Lifeway's Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and the Company's subsequent filings with the SEC. Copies of these filings are available online at https://www.sec.gov, http://lifewaykefir.com/investor-relations/, or on request from Lifeway. Information in this release is as of the dates and time periods indicated herein, and Lifeway does not undertake to update any of the information contained in these materials, except as required by law. Accordingly, YOU SHOULD NOT RELY ON THE ACCURACY OF ANY OF THE STATEMENTS OR OTHER INFORMATION CONTAINED IN ANY ARCHIVED PRESS RELEASE.

 

Media:
Derek Miller
Vice President of Communications, Lifeway Foods
Email: derekm@lifeway.net

 

General inquiries:
Lifeway Foods, Inc.
Phone: 847-967-1010
Email: info@lifeway.net

 

 

 

 

 

 2 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

March 31, 2024 and 2023

(In thousands)

 

             
    March 31, 2024     December 31,  
    (Unaudited)     2023  
Current assets                
Cash and cash equivalents   $ 12,025     $ 13,198  
Accounts receivable, net of allowance for credit losses and discounts & allowances of $1,640 and $1,270 at March 31, 2024 and December 31, 2023 respectively     15,064       13,875  
Inventories, net     8,130       9,104  
Prepaid expenses and other current assets     1,988       2,019  
Refundable income taxes     378        
Total current assets     37,585       38,196  
                 
Property, plant and equipment, net     24,627       22,764  
Operating lease right-of-use asset     172       192  
Goodwill     11,704       11,704  
Intangible assets, net     6,763       6,898  
Other assets     1,900       1,900  
Total assets   $ 82,751     $ 81,654  
                 
Current liabilities                
Current portion of note payable   $ 1,250     $ 1,250  
Accounts payable     10,024       9,976  
Accrued expenses     3,604       4,916  
Accrued income taxes           474  
Total current liabilities     14,878       16,616  
Note payable     1,235       1,483  
Operating lease liabilities     102       118  
Deferred income taxes, net     3,001       3,001  
Total liabilities     19,216       21,218  
                 
Commitments and contingencies (Note 9)                
                 
Stockholders’ equity                
Preferred stock, no par value; 2,500 shares authorized; no shares issued or outstanding at March 31, 2024 and December 31, 2023            
Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 14,691 outstanding at March 31, 2024 and December 31, 2023     6,509       6,509  
Paid-in capital     5,498       4,825  
Treasury stock, at cost     (16,695 )     (16,695 )
Retained earnings     68,223       65,797  
Total stockholders' equity     63,535       60,436  
                 
Total liabilities and stockholders' equity   $ 82,751     $ 81,654  

 

 

 

 

 3 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Operations

For the three months ended March 31, 2024 and 2023

(In thousands, except per share data)

 

             
    2024     2023  
             
Net Sales   $ 44,634     $ 37,904  
                 
Cost of goods sold     32,438       29,030  
Depreciation expense     661       648  
Total cost of goods sold     33,099       29,678  
                 
Gross profit     11,535       8,226  
                 
Selling expense     3,700       3,519  
General and administrative expense     4,136       3,135  
Amortization expense     135       135  
Total operating expenses     7,971       6,789  
                 
Income from operations     3,564       1,437  
                 
Other income (expense):                
Interest expense     (51 )     (104 )
Other income (expense), net     (5     5  
Total other income (expense)     (56 )     (99 )
                 
Income before provision for income taxes     3,508       1,338  
                 
Provision for income taxes     1,082       508  
                 
Net income   $ 2,426     $ 830  
                 
Net earnings per common share:                
Basic   $ 0.17     $ 0.06  
Diluted   $ 0.16     $ 0.06  
                 
Weighted average common shares outstanding:                
Basic     14,691       14,645  
Diluted     15,222       15,030  

 

 

 

 

 4 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)

 

             
    Three months ended March 31,  
    2024     2023  
Cash flows from operating activities:                
Net income   $ 2,426     $ 830  
Adjustments to reconcile net income to operating cash flow:                
Depreciation and amortization     796       783  
Stock-based compensation     673       343  
Non-cash interest expense     2       2  
(Increase) decrease in operating assets:                
Accounts receivable     (1,189 )     (572 )
Inventories     974       339  
Refundable income taxes     (378 )     44  
Prepaid expenses and other current assets     31       377  
Increase (decrease) in operating liabilities:                
Accounts payable     (6 )     1,046  
Accrued expenses     (1,309 )     (581 )
Accrued income taxes     (474 )     416  
Net cash provided by operating activities     1,546       3,027  
                 
Cash flows from investing activities:                
Purchases of property and equipment     (2,469 )     (1,762 )
Net cash used in investing activities     (2,469 )     (1,762 )
                 
Cash flows from financing activities:                
Repayment of note payable     (250 )     (500 )
Net cash used in financing activities     (250 )     (500 )
                 
Net (decrease) increase in cash and cash equivalents     (1,173 )     765  
                 
Cash and cash equivalents at the beginning of the period     13,198       4,444  
                 
Cash and cash equivalents at the end of the period   $ 12,025     $ 5,209  
                 
Supplemental cash flow information:                
Cash paid for income taxes, net of (refunds)   $ 1,934     $ 47  
Cash paid for interest   $ 50     $ 130  
                 
Non-cash investing activities                
Accrued purchase of property and equipment   $ 192     $ 122  
Right-of-use assets obtained in exchange for lease obligations   $     $ 19  

 

 

 

 

 5 

 

EX-101.SCH 7 lway-20240331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 995512 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 995513 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995514 - Disclosure - Inventories, net link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Property, Plant and Equipment, net link:presentationLink link:calculationLink link:definitionLink 995516 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 995517 - Disclosure - Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 995518 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 995519 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 995520 - Disclosure - Commitments and contingencies link:presentationLink link:calculationLink link:definitionLink 995521 - Disclosure - Income taxes link:presentationLink link:calculationLink link:definitionLink 995522 - Disclosure - Stock-based and Other Compensation link:presentationLink link:calculationLink link:definitionLink 995523 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 995524 - Disclosure - Disaggregation of Revenue and Significant Customers link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 995526 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995527 - Disclosure - Inventories, net (Tables) link:presentationLink link:calculationLink link:definitionLink 995528 - Disclosure - Property, Plant and Equipment, net (Tables) link:presentationLink link:calculationLink link:definitionLink 995529 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 995530 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 995531 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 995532 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 995533 - Disclosure - Stock-based and Other Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995534 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Disaggregation of Revenue and Significant Customers (Tables) link:presentationLink link:calculationLink link:definitionLink 995536 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995537 - Disclosure - Inventories, net (Details) link:presentationLink link:calculationLink link:definitionLink 995538 - Disclosure - Property, Plant and Equipment, net (Details) link:presentationLink link:calculationLink link:definitionLink 995539 - Disclosure - Goodwill and Intangible Assets (Details - Goodwill) link:presentationLink link:calculationLink link:definitionLink 995540 - Disclosure - Goodwill and Intangible Assets (Details - Finite lived) link:presentationLink link:calculationLink link:definitionLink 995541 - Disclosure - Goodwill and Intangible Assets (Details - Amortization expense on intangible assets) link:presentationLink link:calculationLink link:definitionLink 995542 - Disclosure - Goodwill and Intangible Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995543 - Disclosure - Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 995544 - Disclosure - Debt (Details) link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Debt (Details - Maturities) link:presentationLink link:calculationLink link:definitionLink 995546 - Disclosure - Debt (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995547 - Disclosure - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 995548 - Disclosure - Leases (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995549 - Disclosure - Income taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995550 - Disclosure - Stock-based and Other Compensation (Details - Option Activity) link:presentationLink link:calculationLink link:definitionLink 995551 - Disclosure - Stock-based and Other Compensation (Details - Restricted Stock Units) link:presentationLink link:calculationLink link:definitionLink 995552 - Disclosure - Stock-based and Other Compensation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995553 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 995554 - Disclosure - Disaggregation of Revenue and Significant Customers (Details) link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Disaggregation of Revenue and Significant Customers (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 lway-20240331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 lway-20240331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 lway-20240331_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Treasury Stock, Common [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Long-Lived Tangible Asset [Axis] Land [Member] Building and Building Improvements [Member] Machinery and Equipment [Member] Vehicles [Member] Office Equipment [Member] Construction in Progress [Member] Finite-Lived Intangible Assets by Major Class [Axis] Recipes [Member] Customer Lists and Other Customer Related Intangibles [Member] Customer Relationships [Member] Brand Names [Member] Formula [Member] Debt Instrument [Axis] Credit Agreement Term Loan [Member] Credit Facility [Axis] Revolving Credit Facility [Member] Incremental Facility [Member] Credit Agreement [Member] Plan Name [Axis] 2015 Omnibus Incentive Plan [Member] 2012 Omnibus Incentive Plan [Member] Award Type [Axis] Restricted Stock Units (RSUs) [Member] 2020 CEO Incentive Award [Member] 2021 Equity Award [Member] 2022 Equity Award [Member] 2023 Equity Award [Member] 2024 Equity Award [Member] 2022 Director Plan [Member] Defined Contribution Plan [Member] Equity Option [Member] Product and Service [Axis] Drinkable Kefir other than ProBugs [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Cheese [Member] Cream And Other [Member] Drinkable Yogurt [Member] ProBugs Kefir [Member] Other Dairy [Member] Net Sales [Member] Customer [Axis] Two Customers [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] Current assets Cash and cash equivalents Accounts receivable, net of allowance for credit losses and discounts & allowances of $1,640 and $1,270 at March 31, 2024 and December 31, 2023 respectively Inventories, net Prepaid expenses and other current assets Refundable income taxes Total current assets Property, plant and equipment, net Operating lease right-of-use asset Goodwill Intangible assets, net Other assets Total assets Current liabilities Current portion of note payable Accounts payable Accrued expenses Accrued income taxes Total current liabilities Note payable Operating lease liabilities Deferred income taxes, net Total liabilities Commitments and contingencies (Note 9) Stockholders’ equity Preferred stock, no par value; 2,500 shares authorized; no shares issued or outstanding at March 31, 2024 and December 31, 2023 Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 14,691 outstanding at March 31, 2024 and December 31, 2023 Paid-in capital Treasury stock, at cost Retained earnings Total stockholders' equity Total liabilities and stockholders' equity Allowance for credit losses and discounts Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Net Sales Cost of goods sold Depreciation expense Total cost of goods sold Gross profit Selling expense General and administrative expense Amortization expense Total operating expenses Income from operations Other income (expense): Interest expense Other income (expense), net Total other income (expense) Income before provision for income taxes Provision for income taxes Net income Net earnings per common share: Basic Diluted Weighted average common shares outstanding: Basic Diluted Statement [Table] Statement [Line Items] Beginning balance, value Beginning balance, shares Stock-based compensation Net income Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net income to operating cash flow: Depreciation and amortization Stock-based compensation Non-cash interest expense (Increase) decrease in operating assets: Accounts receivable Inventories Refundable income taxes Prepaid expenses and other current assets Increase (decrease) in operating liabilities: Accounts payable Accrued expenses Accrued income taxes Net cash provided by operating activities Cash flows from investing activities: Purchases of property and equipment Net cash used in investing activities Cash flows from financing activities: Repayment of note payable Net cash used in financing activities Net (decrease) increase in cash and cash equivalents Cash and cash equivalents at the beginning of the period Cash and cash equivalents at the end of the period Supplemental cash flow information: Cash paid for income taxes, net of (refunds) Cash paid for interest Non-cash investing activities Accrued purchase of property and equipment Right-of-use assets obtained in exchange for lease obligations Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance [Table Text Block] Company Selected Measure Name Named Executive Officers, Footnote [Text Block] Peer Group Issuers, Footnote [Text Block] Changed Peer Group, Footnote [Text Block] PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote [Text Block] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Equity Valuation Assumption Difference, Footnote [Text Block] Compensation Actually Paid vs. Total Shareholder Return [Text Block] Compensation Actually Paid vs. Net Income [Text Block] Compensation Actually Paid vs. Company Selected Measure [Text Block] Total Shareholder Return Vs Peer Group [Text Block] Compensation Actually Paid vs. Other Measure [Text Block] Tabular List [Table Text Block] Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Attributable to Parent Company Selected Measure Amount Other Performance Measure Amount Adjustment to Compensation Amount PEO Name Measure Name Non-GAAP Measure Description [Text Block] Additional 402(v) Disclosure [Text Block] Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis [Text Block] Stock Price or TSR Estimation Method [Text Block] Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined [Text Block] Forgone Recovery, Individual Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability [Text Block] Outstanding Recovery, Individual Name Outstanding Recovery Compensation Amount Restatement Does Not Require Recovery [Text Block] Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure [Text Block] Award Timing Method [Text Block] Award Timing Predetermined [Flag] Award Timing MNPI Considered [Flag] Award Timing, How MNPI Considered [Text Block] MNPI Disclosure Timed for Compensation Value [Flag] Awards Close in Time to MNPI Disclosures [Table Text Block] Awards Close in Time to MNPI Disclosures, Individual Name Award Underlying Securities Amount Award Exercise Price Award Grant Date Fair Value Underlying Security Market Price Change, Percent Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Arrangement Duration Aggregate Available Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted [Flag] Insider Trading Policies and Procedures Not Adopted [Text Block] Accounting Policies [Abstract] Basis of Presentation Summary of Significant Accounting Policies Inventory Disclosure [Abstract] Inventories, net Property, Plant and Equipment [Abstract] Property, Plant and Equipment, net Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Payables and Accruals [Abstract] Accrued Expenses Debt Disclosure [Abstract] Debt Leases Leases Commitments and Contingencies Disclosure [Abstract] Commitments and contingencies Income Tax Disclosure [Abstract] Income taxes Share-Based Payment Arrangement [Abstract] Stock-based and Other Compensation Earnings Per Share [Abstract] Earnings Per Share Segment Reporting [Abstract] Disaggregation of Revenue and Significant Customers Principles of consolidation Use of estimates Cash and cash equivalents Advertising and promotional costs Segments Recent accounting pronouncements Schedule of inventories Schedule of property, plant and equipment Schedule of goodwill Schedule of finite-lived intangible assets Schedule of estimated amortization expense on intangible assets Schedule of accrued expenses Schedule of debt Schedule of maturities of long-term debt Schedule of future maturities of lease liabilities Schedule of stock option activity Schedule of RSUs Activity Schedule of weighted average number of shares outstanding Schedule of sales of products by category Advertising expense Ingredients Packaging Finished goods Total inventories, net Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, gross Less accumulated depreciation Total property, plant and equipment, net Goodwill before impairment Goodwill, impaired, accumulated impairment loss Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Gross Carrying Amount Accumulated Amortization Net Carrying Amount Nine months ended December 31, 2024 2024 2025 2026 2027 Weighted average remaining contractual term Payroll and incentive compensation Real estate taxes Utilities Current portion of operating lease liabilities Other Total accrued expenses Term loan due August 18, 2026. Interest (7.39% at March 31, 2024) payable monthly. Unamortized deferred financing costs Total note payable Less current portion Total long-term portion Nine months ended December 31, 2024 2025 2026 Total term loan Schedule of Short-Term Debt [Table] Short-Term Debt [Line Items] Termination loans Outstanding amount Termination date Description of debt instrument, interest rate terms Unused revolving line of credit fee Letter of credit fee percentage Future borrowings Nine months ended December 31, 2024 2025 2026 2027 2028 Thereafter Total lease payments Less: Interest Present value of lease liabilities Total lease expense Weighted average remaining lease term Weighted average discount rate Operating lease liabilities Effective income tax rate reconciliation, percent Unrecognized tax benefits Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Options outstanding, beginning balance Weighted average exercise price, options outstanding, beginning balance Weighted average remaining contractual life, outstanding Aggregate intrinsic value, options outstanding beginning Options granted Weighted average exercise price, options granted Options exercised Weighted average exercise price, options exercised Options forfeited Weighted average exercise price, options forfeited Options outstanding, ending balance Weighted average exercise price, options outstanding, ending balance Aggregate intrinsic value, options outstanding ending Exercisable Weighted average exercise price, exercisable Weighted average remaining contractual life, exercisable Aggregate intrinsic value, options exercisable Restricted stock units outstanding, beginning Weighted average grant date fair value outstanding, beginning Restricted stock units, granted Weighted average grant date fair value, granted Restricted stock units, shares issued upon vesting Weighted average grant date fair value, shares issued upon vesting Restricted stock units, forfeited Weighted average grant date fair value, forfeited Restricted stock units outstanding, ending Weighted average grant date fair value outstanding, ending Restricted stock units, vested and deferred Weighted average grant date fair value, vested and deferred Number of shares authorized for issuance Share based remain available to award Share-based compensation Tax related benefits Compensation expense related to restricted stock units Weighted average basis term Long-term equity-based incentive Contribution expense Weighted average common shares outstanding Assumed exercise/vesting of equity awards Weighted average diluted common shares outstanding Schedule of Revenue by Major Customers, by Reporting Segments [Table] Revenue, Major Customer [Line Items] Net sales Net sales percentage Concentration risk, percentage Long-term equity-based incentive Assets, Current Assets Liabilities, Current Liabilities Treasury Stock, Value Equity, Attributable to Parent Liabilities and Equity Cost of Goods and Services Sold Gross Profit Operating Expenses Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Shares, Outstanding Share-Based Payment Arrangement, Noncash Expense Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Income Taxes Receivable Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Income Taxes Payable Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Notes Payable Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Inventory Disclosure [Text Block] Lessee, Operating Leases [Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Goodwill, Impaired, Accumulated Impairment Loss Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Gross Notes Payable Long-Term Debt, Maturity, Remainder of Fiscal Year Long-Term Debt, Maturity, Year One Long-Term Debt, Maturity, Year Two Long-Term Debt Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Lessee, Operating Lease, Liability, to be Paid, Year One Lessee, Operating Lease, Liability, to be Paid, Year Two Lessee, Operating Lease, Liability, to be Paid, Year Three Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Operating Lease, Cost Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number EX-101.PRE 11 lway-20240331_pre.xml XBRL PRESENTATION FILE GRAPHIC 12 image_001.gif GRAPHIC begin 644 image_001.gif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end XML 14 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover - shares
3 Months Ended
Mar. 31, 2024
May 06, 2024
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --12-31  
Entity File Number 000-17363  
Entity Registrant Name LIFEWAY FOODS, INC.  
Entity Central Index Key 0000814586  
Entity Tax Identification Number 36-3442829  
Entity Incorporation, State or Country Code IL  
Entity Address, Address Line One 6431 West Oakton  
Entity Address, City or Town Morton Grove  
Entity Address, State or Province IL  
Entity Address, Postal Zip Code 60053  
City Area Code 847  
Local Phone Number 967-1010  
Title of 12(b) Security Common Stock, No Par Value  
Trading Symbol LWAY  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   14,707,392
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 12,025 $ 13,198
Accounts receivable, net of allowance for credit losses and discounts & allowances of $1,640 and $1,270 at March 31, 2024 and December 31, 2023 respectively 15,064 13,875
Inventories, net 8,130 9,104
Prepaid expenses and other current assets 1,988 2,019
Refundable income taxes 378 0
Total current assets 37,585 38,196
Property, plant and equipment, net 24,627 22,764
Operating lease right-of-use asset 172 192
Goodwill 11,704 11,704
Intangible assets, net 6,763 6,898
Other assets 1,900 1,900
Total assets 82,751 81,654
Current liabilities    
Current portion of note payable 1,250 1,250
Accounts payable 10,024 9,976
Accrued expenses 3,604 4,916
Accrued income taxes 0 474
Total current liabilities 14,878 16,616
Note payable 1,235 1,483
Operating lease liabilities 102 118
Deferred income taxes, net 3,001 3,001
Total liabilities 19,216 21,218
Commitments and contingencies (Note 9)
Stockholders’ equity    
Preferred stock, no par value; 2,500 shares authorized; no shares issued or outstanding at March 31, 2024 and December 31, 2023 0 0
Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 14,691 outstanding at March 31, 2024 and December 31, 2023 6,509 6,509
Paid-in capital 5,498 4,825
Treasury stock, at cost (16,695) (16,695)
Retained earnings 68,223 65,797
Total stockholders' equity 63,535 60,436
Total liabilities and stockholders' equity $ 82,751 $ 81,654
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Balance Sheets (Parenthetical) - USD ($)
shares in Thousands, $ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Allowance for credit losses and discounts $ 1,640 $ 1,270
Preferred stock, par value $ 0 $ 0
Preferred stock, shares authorized 2,500 2,500
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0 $ 0
Common stock, shares authorized 40,000 40,000
Common stock, shares issued 17,274 17,274
Common stock, shares outstanding 14,691 14,691
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Net Sales $ 44,634 $ 37,904
Cost of goods sold 32,438 29,030
Depreciation expense 661 648
Total cost of goods sold 33,099 29,678
Gross profit 11,535 8,226
Selling expense 3,700 3,519
General and administrative expense 4,136 3,135
Amortization expense 135 135
Total operating expenses 7,971 6,789
Income from operations 3,564 1,437
Other income (expense):    
Interest expense (51) (104)
Other income (expense), net (5) 5
Total other income (expense) (56) (99)
Income before provision for income taxes 3,508 1,338
Provision for income taxes 1,082 508
Net income $ 2,426 $ 830
Net earnings per common share:    
Basic $ 0.17 $ 0.06
Diluted $ 0.16 $ 0.06
Weighted average common shares outstanding:    
Basic 14,691 14,645
Diluted 15,222 15,030
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2022 $ 6,509 $ (16,993) $ 3,624 $ 54,430 $ 47,570
Beginning balance, shares at Dec. 31, 2022 17,274 (2,629)      
Stock-based compensation 343 343
Net income 830 830
Ending balance, value at Mar. 31, 2023 $ 6,509 $ (16,993) 3,967 55,260 48,743
Ending balance, shares at Mar. 31, 2023 17,274 (2,629)      
Beginning balance, value at Dec. 31, 2023 $ 6,509 $ (16,695) 4,825 65,797 60,436
Beginning balance, shares at Dec. 31, 2023 17,274 (2,583)      
Stock-based compensation 673 673
Net income 2,426 2,426
Ending balance, value at Mar. 31, 2024 $ 6,509 $ (16,695) $ 5,498 $ 68,223 $ 63,535
Ending balance, shares at Mar. 31, 2024 17,274 (2,629)      
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income $ 2,426 $ 830
Adjustments to reconcile net income to operating cash flow:    
Depreciation and amortization 796 783
Stock-based compensation 673 343
Non-cash interest expense 2 2
(Increase) decrease in operating assets:    
Accounts receivable (1,189) (572)
Inventories 974 339
Refundable income taxes (378) 44
Prepaid expenses and other current assets 31 377
Increase (decrease) in operating liabilities:    
Accounts payable (6) 1,046
Accrued expenses (1,309) (581)
Accrued income taxes (474) 416
Net cash provided by operating activities 1,546 3,027
Cash flows from investing activities:    
Purchases of property and equipment (2,469) (1,762)
Net cash used in investing activities (2,469) (1,762)
Cash flows from financing activities:    
Repayment of note payable (250) (500)
Net cash used in financing activities (250) (500)
Net (decrease) increase in cash and cash equivalents (1,173) 765
Cash and cash equivalents at the beginning of the period 13,198 4,444
Cash and cash equivalents at the end of the period 12,025 5,209
Supplemental cash flow information:    
Cash paid for income taxes, net of (refunds) 1,934 47
Cash paid for interest 50 130
Non-cash investing activities    
Accrued purchase of property and equipment 192 122
Right-of-use assets obtained in exchange for lease obligations $ 0 $ 19
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure [Table]    
Net Income (Loss) Attributable to Parent $ 2,426 $ 830
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2024
Insider Trading Arrangements [Line Items]  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Basis of Presentation
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation

Note 1 – Basis of Presentation

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) for interim financial information, and do not include certain information and footnote disclosures required for complete, audited financial statements. In the opinion of management, these statements include all adjustments necessary for a fair presentation of the results of all interim periods reported herein. The consolidated financial statements and related notes should be read in conjunction with the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Results of operations for any interim period are not necessarily indicative of future or annual results.

 

Principles of consolidation

 

The consolidated financial statements include the accounts of Lifeway Foods, Inc. and all its wholly owned subsidiaries (collectively “Lifeway” or the “Company”). All significant intercompany accounts and transactions have been eliminated.

 

XML 23 R10.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2 – Summary of Significant Accounting Policies

 

Our significant accounting policies, which are summarized in detail in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, have not materially changed. The following is a description of certain of our significant accounting policies.

 

Use of estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made in preparing the consolidated financial statements include the reserve for promotional allowances, the valuation of goodwill and intangible assets, stock-based and incentive compensation, and deferred income taxes.

 

Cash and cash equivalents

 

Lifeway considers cash and all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents are stated at cost, which approximates or equals fair value due to their short-term nature.

 

Lifeway from time to time may have bank deposits in excess of insurance limits of the Federal Deposit Insurance Corporation. The Company places its cash and cash equivalents with high credit quality financial institutions. Lifeway has not experienced any losses in such accounts and believes the financial risks associated with these financial instruments are minimal.

 

Advertising and promotional costs

 

Advertising costs are expensed as incurred and reported in Selling expense in the Company’s consolidated statement of operations. Total advertising expense was $1,372 and $1,463 for the three months ended March 31, 2024 and 2023, respectively.

 

Segments

 

The Company is managed as a single reportable segment. The Chief Executive Officer, who is the Company’s Chief Operating Decision Maker (“CODM”), reviews financial information on an aggregate basis for purposes of allocating resources and assessing financial performance, as well as for making strategic operational decisions and managing the organization. Substantially all of Lifeway’s consolidated revenues relate to the sale of cultured dairy products that it produces using the same processes and materials and are sold to consumers through a common network of distributors and retailers in the United States.  

 

Recent accounting pronouncements

 

Issued but not yet effective

 

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07: Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The new guidance requires entities to report incremental information about significant segment expenses included in a segment’s profit or loss measure as well as the name and title of the chief operating decision maker. The guidance also requires interim disclosures related to reportable segment profit or loss and assets that had previously only been disclosed annually. The new standard is effective for our annual period ending December 31, 2024 and our interim periods during the fiscal year ending December 31, 2025. The guidance does not affect recognition or measurement in the Company’s consolidated financial statements.

 

In December 2023, the FASB issued ASU No. 2023-09: Income Taxes (Topic 740): Improvements to Income Tax Disclosures that requires entities to disclose additional information about federal, state, and foreign income taxes primarily related to the income tax rate reconciliation and income taxes paid. The new standard also eliminates certain existing disclosure requirements related to uncertain tax positions and unrecognized deferred tax liabilities. The guidance is effective for our fiscal year ending December 31, 2024. The guidance does not affect recognition or measurement in the Company’s consolidated financial statements.

 

XML 24 R11.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Inventories, net
3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Inventories, net

Note 3 – Inventories, net

 

Inventories consisted of the following:

        
   March 31,
2024
   December 31,
2023
 
Ingredients  $2,411   $2,929 
Packaging   2,640    3,014 
Finished goods   3,079    3,161 
Total inventories, net  $8,130   $9,104 

 

XML 25 R12.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Property, Plant and Equipment, net
3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment, net

Note 4 – Property, Plant and Equipment, net

 

Property, plant and equipment consisted of the following:

        
   March 31,
2024
   December 31,
2023
 
Land  $1,565   $1,565 
Buildings and improvements   21,855    21,661 
Machinery and equipment   33,890    33,573 
Vehicles   705    705 
Office equipment   1,072    1,072 
Construction in process   4,107    2,154 
    63,194    60,730 
Less accumulated depreciation   (38,567)   (37,966)
Total property, plant and equipment, net  $24,627   $22,764 

 

XML 26 R13.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Goodwill and Intangible Assets
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets

Note 5 – Goodwill and Intangible Assets

 

Goodwill

 

Goodwill consisted of the following:

    
   Total 
Balance at December 31, 2023     
Goodwill  $12,948 
Accumulated impairment losses   (1,244)
   $11,704 

 

Balance at March 31, 2024     
Goodwill  $12,948 
Accumulated impairment losses   (1,244)
   $11,704 

 

Intangible Assets

 

Other intangible assets, net consisted of the following:

                        
   March 31, 2024   December 31, 2023 
   Gross       Net   Gross       Net 
   Carrying   Accumulated   Carrying   Carrying   Accumulated   Carrying 
   Amount   Amortization   Amount   Amount   Amortization   Amount 
                         
Recipes  $44   $(44)  $   $44   $(44)  $ 
Customer lists and other customer related intangibles   4,529    (4,529)       4,529    (4,529)    
Customer relationships   3,385    (1,412)   1,973    3,385    (1,372)   2,013 
Brand names   7,948    (3,158)   4,790    7,948    (3,063)   4,885 
Formula   438    (438)       438    (438)    
Total intangible assets, net  $16,344   $(9,581)  $6,763   $16,344   $(9,446)  $6,898 

 

Estimated amortization expense on intangible assets for the next five years is as follows:

    
Year  Amortization 
Nine months ended December 31, 2024  $405 
2024  $540 
2025  $540 
2026  $540 
2027  $540 

 

The weighted-average remaining amortization expense period for the customer relationship and brand name intangible assets is 12.3 and 12.6 years, respectively, as of March 31, 2024. The weighted-average remaining amortization expense period for total intangible assets is 12.5 years as of March 31, 2024.

  

XML 27 R14.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Accrued Expenses
3 Months Ended
Mar. 31, 2024
Payables and Accruals [Abstract]  
Accrued Expenses

Note 6 – Accrued Expenses

 

Accrued expenses consisted of the following:

        
   March 31,
2024
  

December 31,

2023

 
Payroll and incentive compensation  $2,621   $3,853 
Real estate taxes   343    442 
Utilities   193    241 
Current portion of operating lease liabilities   71    74 
Other   376    306 
Total accrued expenses  $3,604   $4,916 

 

XML 28 R15.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Debt

Note 7 – Debt

 

Note payable consisted of the following:

        
  

March 31,

2024

  

December 31,

2023

 
Term loan due August 18, 2026. Interest (7.39% at March 31, 2024) payable monthly.  $2,500   $2,750 
Unamortized deferred financing costs   (15)   (17)
Total note payable   2,485    2,733 
Less current portion   (1,250)   (1,250)
Total long-term portion  $1,235   $1,483 

 

The scheduled maturities of the term loan, excluding deferred financing costs, at March 31, 2024 are as follows: 

    
Nine months ended December 31, 2024  $1,000 
2025   1,000 
2026   500 
Total term loan  $2,500 

 

Credit Agreement

 

The Company is party to an Amended and Restated Loan and Security Agreement (as amended and modified from time to time, the “Credit Agreement”) with its existing lender and certain of its subsidiaries. The Credit Agreement provides for, among other things, a $5 million term loan to be repaid in quarterly installments of principal and interest over a term of five years, a revolving line of credit up to a maximum of $5 million (the “Revolving Credit Facility”) and an incremental facility not to exceed $5 million. The termination date of the term loan is August 18, 2026, unless earlier terminated. The termination date of the revolving credit facility is June 30, 2025, unless earlier terminated.

 

All outstanding amounts under the Credit Agreement bear interest at the Secured Overnight Financing Rate (“SOFR”), plus 2.07%. Interest is payable monthly in arrears. Lifeway is also required to pay a quarterly unused revolving line of credit fee of 0.20% and, in conjunction with the issuance of any letters of credit, a letter of credit fee of 0.20%.

 

The Credit Agreement includes customary representations, warranties, and covenants, including financial covenants requiring the Company to maintain a fixed charge coverage ratio of no less than 1.25 to 1.00, and a minimum working capital financial covenant, as defined, of no less than $11.25 million, in each of the fiscal quarters ending through the expiration date. The Credit Agreement continues to provide for events of default, including failure to repay principal and interest when due and failure to perform or violation of the provisions or covenants of the agreement, as a result of which amounts due under the Credit Agreement may be accelerated. The loans and all other amounts due and owed under the Credit Agreement and related documents are secured by substantially all of the Company’s assets.

 

Lifeway was in compliance with the fixed charge coverage ratio and minimum working capital covenants at March 31, 2024.

 

Revolving Credit Facility

 

As of March 31, 2024, the Company had $0 outstanding under the Revolving Credit Facility. The Company had $5,000 available for future borrowings under the Revolving Credit Facility as of March 31, 2024.

 

XML 29 R16.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Leases
3 Months Ended
Mar. 31, 2024
Leases  
Leases

Note 8 – Leases

 

The Company leases certain machinery and equipment with fixed base rent payments and variable costs based on usage. Remaining lease terms for these leases range from less than one year to six years. The Company includes lease extension options, if applicable and reasonably certain to be exercised, in the calculation of the right-of-use asset and lease liabilities. Lifeway includes only fixed payments for lease components in the measurement of the right-of-use asset and lease liability. Variable lease payments are those that vary because of changes in facts or circumstances occurring after the commencement date, other than the passage of time. There are no residual value guarantees. Lifeway does not currently have leases which meet the finance lease classification as defined under ASC 842.

 

Lifeway treats contracts as a lease when the contract conveys the right to use a physically distinct asset for a period of time in exchange for consideration, it directs the use of the asset and obtains substantially all the economic benefits of the asset.

 

Right-of-use assets and lease liabilities are measured and recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. Lifeway has elected the practical expedient to combine lease and non-lease components into a single component for all of its leases. When the Company is unable to determine an implicit interest rate, it uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments for those leases. Lifeway includes options to extend or terminate the lease in the measurement of the right-of-use asset and lease liability when it is reasonably certain that it will exercise such options. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.

 

The Company does not record leases with an initial term of 12 months or less on the balance sheet. Expense for these short-term leases is recorded on a straight-line basis over the lease term. Total lease expense was $35 and $31 (including short term leases) for the three months ended March 31, 2024 and 2023, respectively.

 

Future maturities of lease liabilities were as follows:

     
Year  Operating Leases 
Nine months ended December 31, 2024  $64 
2025   55 
2026   31 
2027   21 
2028   17 
Thereafter   10 
Total lease payments   198 
Less: Interest   (26)
Present value of lease liabilities  $172 

 

The weighted-average remaining lease term for its operating leases was 3.5 years as of March 31, 2024. The weighted average discount rate of its operating leases was 9.49% as of March 31, 2024. Cash paid for amounts included in the measurement of lease liabilities was $24 and $25 for the three months ended March 31, 2024 and 2023, respectively.

 

XML 30 R17.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and contingencies
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and contingencies

Note 9 – Commitments and contingencies

 

Litigation

 

Lifeway is involved in various legal proceedings, claims, disputes, regulatory matters, audits, and proceedings arising in the ordinary course of, or incidental, to the Company’s business, including commercial disputes, product liabilities, intellectual property matters and employment-related matters.

 

Lifeway records provisions in the consolidated financial statements for pending legal matters when it believes it is probable that a loss will be incurred and the amount of such loss can be reasonably estimated. The Company evaluates, on a periodic basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and estimable, it does not establish an accrued liability. Currently, none of its accruals for outstanding legal matters are material individually or in the aggregate to its financial position and it is management’s opinion that the ultimate resolution of these outstanding legal matters will not have a material adverse effect on its business, financial condition, results of operations, or cash flows. However, if the Company is ultimately required to make payments in connection with an adverse outcome, it is possible that such contingency could have a material adverse effect on the Company’s business, financial condition, results of operations or cash flows.

  

XML 31 R18.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Income taxes
3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Income taxes

Note 10 – Income taxes

 

Income taxes were recognized at effective rates of 30.8% and 37.9% for the three months ended March 31, 2024 and 2023, respectively.

 

The Company calculates the provision for income taxes during interim reporting periods by applying an estimate of the annual effective tax rate for the full year, excluding unusual or infrequently occurring discrete items, and applies that rate to income (loss) before provision for income taxes for the period.

 

The Company’s effective tax rate may change from period to period based on recurring and non-recurring factors including the relative mix of pre-tax earnings (or losses), the jurisdictional mix of earnings, enacted tax legislation, state income taxes, the impact of non-deductible items, changes in valuation allowances, settlement of tax audits, and the expiration of the statute of limitations in relation to unrecognized tax benefits. The Company records discrete income tax items such as enacted tax rate changes and completed tax audits in the period in which they occur. The Company consistently reflects non-deductible officer compensation expense, non-deductible compensation expense related to equity incentive awards and separate state tax rates from period to period. Although similar items were reflected in 2024, the percentage effect is different due to the difference in pre-tax income in 2024 compared to 2023.

 

Unrecognized tax benefits were $0 at March 31, 2024 and 2023, respectively. The Company does not expect material changes to its unrecognized tax benefits during the next twelve months.

 

XML 32 R19.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-based and Other Compensation
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-based and Other Compensation

Note 11 – Stock-based and Other Compensation

 

Omnibus Incentive Plan

 

In December 2015, Lifeway stockholders approved the 2015 Omnibus Incentive Plan, which authorized the issuance of an aggregate of 3.5 million shares to satisfy awards of stock options, stock appreciation rights, unrestricted stock, restricted stock, restricted stock units, performance shares and performance units to qualifying employees. Under the 2015 Omnibus Incentive Plan, the Board of Directors or its Compensation Committee approves stock awards to executive officers and certain senior executives, generally in the form of restricted stock or performance shares. The number of performance shares that participants may earn depends on the extent to which the corresponding performance goals have been achieved. Stock awards generally vest over a three-year performance or service period. At March 31, 2024, no shares remain available for award under the 2015 Omnibus Incentive Plan as it was terminated on August 31, 2022. However, any outstanding awards under the 2015 Omnibus Incentive Plan are unaffected by the termination of the 2015 Omnibus Incentive Plan or by the approval of the 2022 Omnibus Incentive Plan (the “2022 Plan”) as described below.

 

On August 31, 2022, Lifeway stockholders approved the 2022 Plan. Under the 2022 Plan, the Compensation Committee of the Board of Directors may grant awards of various types of compensation, including, nonqualified stock options, incentive stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units, cash-based awards and other stock-based awards. The maximum number of shares authorized to be awarded under the 2022 Plan is 3.25 million shares of common stock, which includes shares that remained available under the now terminated 2015 Omnibus Incentive Plan.

 

Awards granted under the 2022 Plan are generally subject to a minimum vesting period of at least one year. Awards may be subject to cliff-vesting or graded-vesting conditions, with graded vesting starting no earlier than one year after the grant date. The Plan Administrator may provide for shorter vesting periods in an award agreement for no more than five percent of the maximum number of shares authorized for issuance under the 2022 Plan. As of March 31, 2024, 2.64 million shares remain available to award under the 2022 Plan.

 

Stock Options

 

The following table summarizes stock option activity during the three months ended March 31, 2024:

                               
    Options     Weighted
average
exercise price
    Weighted
average
remaining contractual life
    Aggregate
intrinsic value
 
    (In thousands)                          
Outstanding at December 31, 2023     41     $ 10.42       2.21     $ 121  
Granted                        
Exercised                        
Forfeited                        
Outstanding at March 31, 2024     41     $ 10.42       1.97     $ 276  
Exercisable at March 31, 2024     41     $ 10.42       1.97     $ 276  

 

Restricted Stock Units

 

A Restricted Stock Unit (“RSU”) represents the right to receive one share of common stock in the future. RSUs have no exercise price. The grant date fair value of the awards is determined by the Company’s closing stock price on the grant date. Lifeway expenses RSUs over the vesting period. The following table summarizes RSU activity during the three months ended March 31, 2024.

         
   Restricted Stock Units   Weighted Average Grant Date Fair Value 
   (In thousands)     
Outstanding at December 31, 2023   207   $6.89 
Granted   33    13.73 
Shares issued upon vesting        
Forfeited        
Outstanding at March 31, 2024   240   $7.82 
Vested and deferred at March 31, 2024   67   $5.98 

 

For the three months ended March 31, 2024 and 2023 total pre-tax stock-based compensation expense recognized in the consolidated statements of operations was $233 and $104, respectively. For the three months ended March 31, 2024 and 2023 tax-related benefits of $65 and $29, respectively, were also recognized. Future compensation expense related to restricted stock units was $918 as of March 31, 2024 and will be recognized on a weighted average basis over the next 1.3 years.

 

Long-Term Incentive Plan Compensation

 

Lifeway has established long-term incentive-based compensation programs for certain senior executives and key employees pursuant to the terms of its incentive plans.

 

2020 CEO Incentive Award 

 

During the fourth quarter 2020, Lifeway awarded a long-term equity-based incentive of $750 to its Chief Executive Officer (the “2020 CEO Award”) depending on Lifeway’s 2020 performance levels compared to the respective targets. The equity-based incentive compensation is payable in restricted stock that vests one-third in April 2022, one-third in April 2023, and one-third in April 2024. The issuance of vested equity awards is subject to approval under the Stock Purchase Agreement dated October 1, 1999. For the three months ended March 31, 2024 and 2023, $18 and $43 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively. As of March 31, 2024, the total remaining unearned compensation of $6 will be recognized in 2024, subject to vesting.

 

2021 Equity Award

 

The 2021 long-term equity incentive plan compensation is based on Lifeway’s achievement of adjusted EBITDA performance versus the respective target established by the Board of Directors for 2021. Under the 2021 plan, collectively the participants earned equity-based incentive compensation of $1,069 based on Lifeway’s achievement of the respective financial target. The equity-based incentive compensation is payable in restricted stock that vests one-third in April 2022, one-third in April 2023, and one-third in April 2024. For the three months ended March 31, 2024 and 2023, $33 and $84 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively. As of March 31, 2024, the total remaining unearned compensation of $7 will be recognized in 2024, subject to vesting.

 

2022 Equity Award

 

Under the 2022 long-term incentive plan, participants can earn a specified number of target level Performance Share Units (“PSUs”) contingent upon the achievement of strategic milestones during the three-year Measurement Period, which is fiscal year 2022 to 2024. The strategic milestones are 1) 3-year cumulative net revenue, and 2) 3-year cumulative adjusted EBITDA. The target number of PSU awards are weighted 50% on net revenue and 50% on adjusted EBITDA. Collectively, the participants can earn 125,066 PSUs at the target level. Participants may earn more or less than the target number of shares based on actual results, however the minimum and maximum number of shares that can be earned are bound by minimum and maximum thresholds of net revenue and adjusted EBITDA. The PSU awards will be earned and will vest, if at all, after the end of the three-year measurement period based on achievement of the milestones. The PSU awards do not vest during the three-year measurement period. The PSUs have a grant date fair value of $6.25 dollars per share. For the three months ended March 31, 2024 and 2023, $156 and $112 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively.

 

The 2022 long-term incentive plan also granted restricted stock unit awards that contain only a service condition and vest on the passage of time in three equal installments on each of the first three anniversaries of the August 31, 2022 grant date. The stock-based compensation expense for these awards is included in the Restricted Stock Units section above.

 

2023 Equity Award

 

Under the 2023 long-term incentive plan, participants can earn a specified number of target level Performance Share Units (“PSUs”) contingent upon the achievement of strategic milestones during the three-year Measurement Period, which is fiscal year 2023 to 2025. The strategic milestones are 1) 3-year cumulative net revenue, and 2) 3-year cumulative adjusted EBITDA. The target number of PSU awards are weighted 50% on net revenue and 50% on adjusted EBITDA. Collectively, the participants can earn 115,622 PSUs at the target level. Participants may earn more or less than the target number of shares based on actual results, however the minimum and maximum number of shares that can be earned are bound by minimum and maximum thresholds of net revenue and adjusted EBITDA. The PSU awards will be earned and will vest, if at all, after the end of the three-year measurement period based on achievement of the milestones. The PSU awards do not vest during the three-year measurement period. The PSUs have a grant date fair value of $6.88 dollars per share. For the three months ended March 31, 2024 and 2023, $130 and $0 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively.

 

The 2023 long-term incentive plan also granted restricted stock unit awards that contain only a service condition and vest on the passage of time in three equal installments on each of the first three anniversaries of the June 16, 2023 grant date. The stock-based compensation expense for these awards is included in the Restricted Stock Units section above.

 

2024 Equity Award

 

Under the 2024 long-term incentive plan, participants can earn a specified number of target level Performance Share Units (“PSUs”) contingent upon the achievement of strategic milestones during the three-year Measurement Period, which is fiscal year 2024 to 2026. The strategic milestones are 1) 3-year cumulative net revenue, and 2) 3-year cumulative adjusted EBITDA. The target number of PSU awards are weighted 50% on net revenue and 50% on adjusted EBITDA. Collectively, the participants can earn 64,986 PSUs at the target level. Participants may earn more or less than the target number of shares based on actual results, however the minimum and maximum number of shares that can be earned are bound by minimum and maximum thresholds of net revenue and adjusted EBITDA. The PSU awards will be earned and will vest, if at all, after the end of the three-year measurement period based on achievement of the milestones. The PSU awards do not vest during the three-year measurement period. The PSUs have a grant date fair value of $13.73 dollars per share. For the three months ended March 31, 2024 and 2023, $102 and $0 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively.

 

The 2024 long-term incentive plan also granted restricted stock unit awards that contain only a service condition and vest on the passage of time in three equal installments on each of the first three anniversaries of the January 10, 2024 grant date. The stock-based compensation expense for these awards is included in the Restricted Stock Units section above.

 

Non-Employee Director Plan

 

On August 31, 2022, Lifeway stockholders approved the 2022 Non-Employee Director Equity and Deferred Compensation Plan (the “2022 Director Plan”), which authorizes the grant of restricted stock units (“RSUs”), which will vest on such schedule as the Company, in its sole discretion, shall determine. Each non-employee director of the Company is eligible to be a participant in the 2022 Director Plan until they no longer serve as a non-employee director. As of the date of each annual shareholder meeting, the Company may grant each director a number of RSUs for such year and set the vesting schedule for the RSUs granted. Whether and how many RSUs the Company will grant to directors in any year is subject to the sole discretion of the Company and shall in any event be subject to the 2022 Director Plan’s overall share limits. The maximum aggregate number of shares of common stock that may be issued under the 2022 Director Plan is 500 thousand shares. As of March 31, 2024, 430 thousand shares remain available to award under the 2022 Director Plan. The aggregate fair market value of shares underlying RSU compensation that may be issued as RSU compensation to a director in any year shall not exceed $170. In addition to the grant of RSUs, the 2022 Director Plan also provides for the deferral by electing participants of all or part of their cash compensation (in 10% increments) into a deferred cash account, and they may defer all or part of their cash and/or RSU compensation (in 10% increments) into a deferred RSU account. Deferred benefits are paid in a lump sum upon the applicable director’s departure from the Board of Directors.

 

Retirement Benefits

 

Lifeway has a defined contribution plan which is available to substantially all full-time employees. Under the terms of the plan, the Company matches employee contributions under a prescribed formula. For the three months ended March 31, 2024 and 2023, total contribution expense recognized in the consolidated statements of operations was $193 and $150, respectively.

 

XML 33 R20.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Earnings Per Share
3 Months Ended
Mar. 31, 2024
Net earnings per common share:  
Earnings Per Share

Note 12 - Earnings Per Share

 

The following table summarizes the effects of the share-based compensation awards on the weighted average number of shares outstanding used in calculating diluted earnings per share:

        
   Three Months Ended 
   March 31, 
   2024   2023 
   (In Thousands) 
Weighted average common shares outstanding   14,691    14,645 
Assumed exercise/vesting of equity awards   531    385 
Weighted average diluted common shares outstanding   15,222    15,030 

 

XML 34 R21.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Disaggregation of Revenue and Significant Customers
3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Disaggregation of Revenue and Significant Customers

Note 13 – Disaggregation of Revenue and Significant Customers

 

Lifeway’s primary product is drinkable kefir. The Company manufactures (directly or through a co-manufacturer) and markets products under the Lifeway, Fresh Made, and GlenOaks Farms brand names, as well as under private labels on behalf of certain customers.

  

The Company’s product categories are:

 

  · Drinkable kefir, a cultured dairy product sold in a variety of organic and non-organic sizes, flavors, and types.
  · European-style soft cheeses, including farmer cheese, white cheese, and Sweet Kiss.
  · Cream and other, which primarily consists of cream, a byproduct of raw milk processing.
  · Drinkable yogurt, sold in a variety of sizes and flavors.
  · ProBugs, a line of kefir products designed for children.
  · Other dairy, which primarily consists of Fresh Made butter and sour cream.

 

Net sales of products by category were as follows for the three months ended March 31:

                               
    2024     2023  
In thousands   $     %     $     %  
                         
Drinkable Kefir other than ProBugs     36,533       82%       29,800       79%  
Cheese     3,515       8%       3,345       9%  
Cream and other     1,816       4%       1,920       5%  
Drinkable Yogurt     1,536       3%       1,616       4%  
ProBugs Kefir     866       2%       808       2%  
Other dairy     368       1%       415       1%  
Net Sales     44,634       100%       37,904       100%  

 

Significant Customers

 

Sales are predominately to companies in the retail food industry located within the United States. Two major customers accounted for approximately 25% and 24% of net sales for the three months ended March 31, 2024 and 2023, respectively.

 

Geographic Information

 

Net sales outside the of the United States represented less than 1% of total consolidated net sales for the three months ended March 31, 2024 and 2023. Net sales are determined based on the destination where the products are shipped by Lifeway.

 

All the Company’s long-lived assets are in the United States.

 

XML 35 R22.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Basis of Presentation (Policies)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Principles of consolidation

Principles of consolidation

 

The consolidated financial statements include the accounts of Lifeway Foods, Inc. and all its wholly owned subsidiaries (collectively “Lifeway” or the “Company”). All significant intercompany accounts and transactions have been eliminated.

 

XML 36 R23.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Use of estimates

Use of estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made in preparing the consolidated financial statements include the reserve for promotional allowances, the valuation of goodwill and intangible assets, stock-based and incentive compensation, and deferred income taxes.

 

Cash and cash equivalents

Cash and cash equivalents

 

Lifeway considers cash and all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents are stated at cost, which approximates or equals fair value due to their short-term nature.

 

Lifeway from time to time may have bank deposits in excess of insurance limits of the Federal Deposit Insurance Corporation. The Company places its cash and cash equivalents with high credit quality financial institutions. Lifeway has not experienced any losses in such accounts and believes the financial risks associated with these financial instruments are minimal.

 

Advertising and promotional costs

Advertising and promotional costs

 

Advertising costs are expensed as incurred and reported in Selling expense in the Company’s consolidated statement of operations. Total advertising expense was $1,372 and $1,463 for the three months ended March 31, 2024 and 2023, respectively.

 

Segments

Segments

 

The Company is managed as a single reportable segment. The Chief Executive Officer, who is the Company’s Chief Operating Decision Maker (“CODM”), reviews financial information on an aggregate basis for purposes of allocating resources and assessing financial performance, as well as for making strategic operational decisions and managing the organization. Substantially all of Lifeway’s consolidated revenues relate to the sale of cultured dairy products that it produces using the same processes and materials and are sold to consumers through a common network of distributors and retailers in the United States.  

 

Recent accounting pronouncements

Recent accounting pronouncements

 

Issued but not yet effective

 

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07: Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The new guidance requires entities to report incremental information about significant segment expenses included in a segment’s profit or loss measure as well as the name and title of the chief operating decision maker. The guidance also requires interim disclosures related to reportable segment profit or loss and assets that had previously only been disclosed annually. The new standard is effective for our annual period ending December 31, 2024 and our interim periods during the fiscal year ending December 31, 2025. The guidance does not affect recognition or measurement in the Company’s consolidated financial statements.

 

In December 2023, the FASB issued ASU No. 2023-09: Income Taxes (Topic 740): Improvements to Income Tax Disclosures that requires entities to disclose additional information about federal, state, and foreign income taxes primarily related to the income tax rate reconciliation and income taxes paid. The new standard also eliminates certain existing disclosure requirements related to uncertain tax positions and unrecognized deferred tax liabilities. The guidance is effective for our fiscal year ending December 31, 2024. The guidance does not affect recognition or measurement in the Company’s consolidated financial statements.

 

XML 37 R24.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Inventories, net (Tables)
3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Schedule of inventories
        
   March 31,
2024
   December 31,
2023
 
Ingredients  $2,411   $2,929 
Packaging   2,640    3,014 
Finished goods   3,079    3,161 
Total inventories, net  $8,130   $9,104 
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Property, Plant and Equipment, net (Tables)
3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Schedule of property, plant and equipment
        
   March 31,
2024
   December 31,
2023
 
Land  $1,565   $1,565 
Buildings and improvements   21,855    21,661 
Machinery and equipment   33,890    33,573 
Vehicles   705    705 
Office equipment   1,072    1,072 
Construction in process   4,107    2,154 
    63,194    60,730 
Less accumulated depreciation   (38,567)   (37,966)
Total property, plant and equipment, net  $24,627   $22,764 
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Goodwill and Intangible Assets (Tables)
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of goodwill
    
   Total 
Balance at December 31, 2023     
Goodwill  $12,948 
Accumulated impairment losses   (1,244)
   $11,704 

 

Balance at March 31, 2024     
Goodwill  $12,948 
Accumulated impairment losses   (1,244)
   $11,704 
Schedule of finite-lived intangible assets
                        
   March 31, 2024   December 31, 2023 
   Gross       Net   Gross       Net 
   Carrying   Accumulated   Carrying   Carrying   Accumulated   Carrying 
   Amount   Amortization   Amount   Amount   Amortization   Amount 
                         
Recipes  $44   $(44)  $   $44   $(44)  $ 
Customer lists and other customer related intangibles   4,529    (4,529)       4,529    (4,529)    
Customer relationships   3,385    (1,412)   1,973    3,385    (1,372)   2,013 
Brand names   7,948    (3,158)   4,790    7,948    (3,063)   4,885 
Formula   438    (438)       438    (438)    
Total intangible assets, net  $16,344   $(9,581)  $6,763   $16,344   $(9,446)  $6,898 
Schedule of estimated amortization expense on intangible assets
    
Year  Amortization 
Nine months ended December 31, 2024  $405 
2024  $540 
2025  $540 
2026  $540 
2027  $540 
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Accrued Expenses (Tables)
3 Months Ended
Mar. 31, 2024
Payables and Accruals [Abstract]  
Schedule of accrued expenses
        
   March 31,
2024
  

December 31,

2023

 
Payroll and incentive compensation  $2,621   $3,853 
Real estate taxes   343    442 
Utilities   193    241 
Current portion of operating lease liabilities   71    74 
Other   376    306 
Total accrued expenses  $3,604   $4,916 
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt (Tables)
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Schedule of debt
        
  

March 31,

2024

  

December 31,

2023

 
Term loan due August 18, 2026. Interest (7.39% at March 31, 2024) payable monthly.  $2,500   $2,750 
Unamortized deferred financing costs   (15)   (17)
Total note payable   2,485    2,733 
Less current portion   (1,250)   (1,250)
Total long-term portion  $1,235   $1,483 
Schedule of maturities of long-term debt
    
Nine months ended December 31, 2024  $1,000 
2025   1,000 
2026   500 
Total term loan  $2,500 
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Leases (Tables)
3 Months Ended
Mar. 31, 2024
Leases  
Schedule of future maturities of lease liabilities
     
Year  Operating Leases 
Nine months ended December 31, 2024  $64 
2025   55 
2026   31 
2027   21 
2028   17 
Thereafter   10 
Total lease payments   198 
Less: Interest   (26)
Present value of lease liabilities  $172 
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-based and Other Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of stock option activity
                               
    Options     Weighted
average
exercise price
    Weighted
average
remaining contractual life
    Aggregate
intrinsic value
 
    (In thousands)                          
Outstanding at December 31, 2023     41     $ 10.42       2.21     $ 121  
Granted                        
Exercised                        
Forfeited                        
Outstanding at March 31, 2024     41     $ 10.42       1.97     $ 276  
Exercisable at March 31, 2024     41     $ 10.42       1.97     $ 276  
Schedule of RSUs Activity
         
   Restricted Stock Units   Weighted Average Grant Date Fair Value 
   (In thousands)     
Outstanding at December 31, 2023   207   $6.89 
Granted   33    13.73 
Shares issued upon vesting        
Forfeited        
Outstanding at March 31, 2024   240   $7.82 
Vested and deferred at March 31, 2024   67   $5.98 
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2024
Net earnings per common share:  
Schedule of weighted average number of shares outstanding
        
   Three Months Ended 
   March 31, 
   2024   2023 
   (In Thousands) 
Weighted average common shares outstanding   14,691    14,645 
Assumed exercise/vesting of equity awards   531    385 
Weighted average diluted common shares outstanding   15,222    15,030 
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Disaggregation of Revenue and Significant Customers (Tables)
3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Schedule of sales of products by category
                               
    2024     2023  
In thousands   $     %     $     %  
                         
Drinkable Kefir other than ProBugs     36,533       82%       29,800       79%  
Cheese     3,515       8%       3,345       9%  
Cream and other     1,816       4%       1,920       5%  
Drinkable Yogurt     1,536       3%       1,616       4%  
ProBugs Kefir     866       2%       808       2%  
Other dairy     368       1%       415       1%  
Net Sales     44,634       100%       37,904       100%  
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Accounting Policies [Abstract]    
Advertising expense $ 1,372 $ 1,463
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Inventories, net (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Ingredients $ 2,411 $ 2,929
Packaging 2,640 3,014
Finished goods 3,079 3,161
Total inventories, net $ 8,130 $ 9,104
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Property, Plant and Equipment, net (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 63,194 $ 60,730
Less accumulated depreciation (38,567) (37,966)
Total property, plant and equipment, net 24,627 22,764
Land [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 1,565 1,565
Building and Building Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 21,855 21,661
Machinery and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 33,890 33,573
Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 705 705
Office Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 1,072 1,072
Construction in Progress [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 4,107 $ 2,154
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Goodwill and Intangible Assets (Details - Goodwill) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]    
Goodwill before impairment $ 12,948 $ 12,948
Goodwill, impaired, accumulated impairment loss (1,244) (1,244)
Goodwill $ 11,704 $ 11,704
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Goodwill and Intangible Assets (Details - Finite lived) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 16,344 $ 16,344
Accumulated Amortization (9,581) (9,446)
Net Carrying Amount 6,763 6,898
Recipes [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 44 44
Accumulated Amortization (44) (44)
Net Carrying Amount 0 0
Customer Lists and Other Customer Related Intangibles [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 4,529 4,529
Accumulated Amortization (4,529) (4,529)
Net Carrying Amount 0 0
Customer Relationships [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 3,385 3,385
Accumulated Amortization (1,412) (1,372)
Net Carrying Amount 1,973 2,013
Brand Names [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 7,948 7,948
Accumulated Amortization (3,158) (3,063)
Net Carrying Amount 4,790 4,885
Formula [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 438 438
Accumulated Amortization (438) (438)
Net Carrying Amount $ 0 $ 0
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Goodwill and Intangible Assets (Details - Amortization expense on intangible assets)
$ in Thousands
Mar. 31, 2024
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
Nine months ended December 31, 2024 $ 405
2024 540
2025 540
2026 540
2027 $ 540
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Goodwill and Intangible Assets (Details Narrative)
3 Months Ended
Mar. 31, 2024
Finite-Lived Intangible Assets [Line Items]  
Weighted average remaining contractual term 12 years 6 months
Customer Relationships [Member]  
Finite-Lived Intangible Assets [Line Items]  
Weighted average remaining contractual term 12 years 3 months 18 days
Brand Names [Member]  
Finite-Lived Intangible Assets [Line Items]  
Weighted average remaining contractual term 12 years 7 months 6 days
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Accrued Expenses (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Payables and Accruals [Abstract]    
Payroll and incentive compensation $ 2,621 $ 3,853
Real estate taxes 343 442
Utilities 193 241
Current portion of operating lease liabilities 71 74
Other 376 306
Total accrued expenses $ 3,604 $ 4,916
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Debt Disclosure [Abstract]    
Term loan due August 18, 2026. Interest (7.39% at March 31, 2024) payable monthly. $ 2,500 $ 2,750
Unamortized deferred financing costs (15) (17)
Total note payable 2,485 2,733
Less current portion (1,250) (1,250)
Total long-term portion $ 1,235 $ 1,483
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt (Details - Maturities)
$ in Thousands
Mar. 31, 2024
USD ($)
Debt Disclosure [Abstract]  
Nine months ended December 31, 2024 $ 1,000
2025 1,000
2026 500
Total term loan $ 2,500
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt (Details Narrative)
3 Months Ended
Mar. 31, 2024
USD ($)
Short-Term Debt [Line Items]  
Outstanding amount $ 0
Unused revolving line of credit fee 0.20%
Letter of credit fee percentage 0.20%
Revolving Credit Facility [Member]  
Short-Term Debt [Line Items]  
Outstanding amount $ 5,000,000
Termination date Jun. 30, 2025
Future borrowings $ 5,000,000
Incremental Facility [Member]  
Short-Term Debt [Line Items]  
Outstanding amount 5,000,000
Credit Agreement Term Loan [Member]  
Short-Term Debt [Line Items]  
Termination loans $ 5,000,000
Termination date Aug. 18, 2026
Credit Agreement [Member]  
Short-Term Debt [Line Items]  
Description of debt instrument, interest rate terms Secured Overnight Financing Rate (“SOFR”), plus 2.07%. Interest is payable monthly in arrears.
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Leases (Details)
$ in Thousands
Mar. 31, 2024
USD ($)
Leases  
Nine months ended December 31, 2024 $ 64
2025 55
2026 31
2027 21
2028 17
Thereafter 10
Total lease payments 198
Less: Interest (26)
Present value of lease liabilities $ 172
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Leases (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Leases    
Total lease expense $ 35 $ 31
Weighted average remaining lease term 3 years 6 months  
Weighted average discount rate 9.49%  
Operating lease liabilities $ 24 $ 25
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Income taxes (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Tax Disclosure [Abstract]    
Effective income tax rate reconciliation, percent 30.80% 37.90%
Unrecognized tax benefits $ 0 $ 0
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-based and Other Compensation (Details - Option Activity) - Equity Option [Member] - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Options outstanding, beginning balance 41  
Weighted average exercise price, options outstanding, beginning balance $ 10.42  
Weighted average remaining contractual life, outstanding 1 year 11 months 19 days 2 years 2 months 15 days
Aggregate intrinsic value, options outstanding beginning $ 121  
Options granted 0  
Weighted average exercise price, options granted $ 0  
Options exercised 0  
Weighted average exercise price, options exercised $ 0  
Options forfeited 0  
Weighted average exercise price, options forfeited $ 0  
Options outstanding, ending balance 41 41
Weighted average exercise price, options outstanding, ending balance $ 10.42 $ 10.42
Aggregate intrinsic value, options outstanding ending $ 276 $ 121
Exercisable 41  
Weighted average exercise price, exercisable $ 10.42  
Weighted average remaining contractual life, exercisable 1 year 11 months 19 days  
Aggregate intrinsic value, options exercisable $ 276  
XML 61 R48.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-based and Other Compensation (Details - Restricted Stock Units) - Restricted Stock Units (RSUs) [Member]
shares in Thousands
3 Months Ended
Mar. 31, 2024
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Restricted stock units outstanding, beginning | shares 207
Weighted average grant date fair value outstanding, beginning | $ / shares $ 6.89
Restricted stock units, granted | shares 33
Weighted average grant date fair value, granted | $ / shares $ 13.73
Restricted stock units, shares issued upon vesting | shares 0
Weighted average grant date fair value, shares issued upon vesting | $ / shares $ 0
Restricted stock units, forfeited | shares 0
Weighted average grant date fair value, forfeited | $ / shares $ 0
Restricted stock units outstanding, ending | shares 240
Weighted average grant date fair value outstanding, ending | $ / shares $ 7.82
Restricted stock units, vested and deferred | shares 67
Weighted average grant date fair value, vested and deferred | $ / shares $ 5.98
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-based and Other Compensation (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2020
Aug. 31, 2022
Dec. 31, 2015
Restricted Stock Units (RSUs) [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Share-based compensation $ 233 $ 104      
Tax related benefits 65 29      
Compensation expense related to restricted stock units $ 918        
Weighted average basis term 1 year 3 months 18 days        
2020 CEO Incentive Award [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Share-based compensation $ 18 43      
Compensation expense related to restricted stock units 6        
Long-term equity-based incentive     $ 750    
2021 Equity Award [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Share-based compensation 33 84      
Compensation expense related to restricted stock units 7        
Long-term equity-based incentive 1,069        
2022 Equity Award [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Share-based compensation 156 112      
2023 Equity Award [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Share-based compensation 130 0      
2024 Equity Award [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Share-based compensation $ 102 0      
2015 Omnibus Incentive Plan [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Number of shares authorized for issuance         3,500,000
2012 Omnibus Incentive Plan [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Number of shares authorized for issuance       3,250,000  
Share based remain available to award 2,640,000        
2022 Director Plan [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Share based remain available to award 430,000        
Defined Contribution Plan [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Contribution expense $ 193 $ 150      
XML 63 R50.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Earnings Per Share (Details) - shares
shares in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Net earnings per common share:    
Weighted average common shares outstanding 14,691 14,645
Assumed exercise/vesting of equity awards 531 385
Weighted average diluted common shares outstanding 15,222 15,030
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Disaggregation of Revenue and Significant Customers (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue, Major Customer [Line Items]    
Net sales $ 44,634 $ 37,904
Drinkable Kefir other than ProBugs [Member]    
Revenue, Major Customer [Line Items]    
Net sales $ 36,533 $ 29,800
Drinkable Kefir other than ProBugs [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]    
Revenue, Major Customer [Line Items]    
Net sales percentage 82.00% 79.00%
Cheese [Member]    
Revenue, Major Customer [Line Items]    
Net sales $ 3,515 $ 3,345
Cheese [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]    
Revenue, Major Customer [Line Items]    
Net sales percentage 8.00% 9.00%
Cream And Other [Member]    
Revenue, Major Customer [Line Items]    
Net sales $ 1,816 $ 1,920
Cream And Other [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]    
Revenue, Major Customer [Line Items]    
Net sales percentage 4.00% 5.00%
Drinkable Yogurt [Member]    
Revenue, Major Customer [Line Items]    
Net sales $ 1,536 $ 1,616
Drinkable Yogurt [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]    
Revenue, Major Customer [Line Items]    
Net sales percentage 3.00% 4.00%
ProBugs Kefir [Member]    
Revenue, Major Customer [Line Items]    
Net sales $ 866 $ 808
ProBugs Kefir [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]    
Revenue, Major Customer [Line Items]    
Net sales percentage 2.00% 2.00%
Other Dairy [Member]    
Revenue, Major Customer [Line Items]    
Net sales $ 368 $ 415
Other Dairy [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]    
Revenue, Major Customer [Line Items]    
Net sales percentage 1.00% 1.00%
Net Sales [Member]    
Revenue, Major Customer [Line Items]    
Net sales $ 44,634 $ 37,904
Net Sales [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]    
Revenue, Major Customer [Line Items]    
Net sales percentage 100.00% 100.00%
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Disaggregation of Revenue and Significant Customers (Details Narrative)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue Benchmark [Member] | Two Customers [Member] | Customer Concentration Risk [Member]    
Revenue, Major Customer [Line Items]    
Concentration risk, percentage 25.00% 24.00%
EXCEL 66 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 67 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 68 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 70 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 118 231 1 false 40 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://lifeway.net/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://lifeway.net/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://lifeway.net/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://lifeway.net/role/StatementsOfOperations Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://lifeway.net/role/StatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://lifeway.net/role/StatementsOfCashFlows Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 7 false false R8.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 8 false false R9.htm 995512 - Disclosure - Basis of Presentation Sheet http://lifeway.net/role/BasisOfPresentation Basis of Presentation Notes 9 false false R10.htm 995513 - Disclosure - Summary of Significant Accounting Policies Sheet http://lifeway.net/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 995514 - Disclosure - Inventories, net Sheet http://lifeway.net/role/InventoriesNet Inventories, net Notes 11 false false R12.htm 995515 - Disclosure - Property, Plant and Equipment, net Sheet http://lifeway.net/role/PropertyPlantAndEquipmentNet Property, Plant and Equipment, net Notes 12 false false R13.htm 995516 - Disclosure - Goodwill and Intangible Assets Sheet http://lifeway.net/role/GoodwillAndIntangibleAssets Goodwill and Intangible Assets Notes 13 false false R14.htm 995517 - Disclosure - Accrued Expenses Sheet http://lifeway.net/role/AccruedExpenses Accrued Expenses Notes 14 false false R15.htm 995518 - Disclosure - Debt Sheet http://lifeway.net/role/Debt Debt Notes 15 false false R16.htm 995519 - Disclosure - Leases Sheet http://lifeway.net/role/Leases Leases Notes 16 false false R17.htm 995520 - Disclosure - Commitments and contingencies Sheet http://lifeway.net/role/CommitmentsAndContingencies Commitments and contingencies Notes 17 false false R18.htm 995521 - Disclosure - Income taxes Sheet http://lifeway.net/role/IncomeTaxes Income taxes Notes 18 false false R19.htm 995522 - Disclosure - Stock-based and Other Compensation Sheet http://lifeway.net/role/Stock-basedAndOtherCompensation Stock-based and Other Compensation Notes 19 false false R20.htm 995523 - Disclosure - Earnings Per Share Sheet http://lifeway.net/role/EarningsPerShare Earnings Per Share Notes 20 false false R21.htm 995524 - Disclosure - Disaggregation of Revenue and Significant Customers Sheet http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomers Disaggregation of Revenue and Significant Customers Notes 21 false false R22.htm 995525 - Disclosure - Basis of Presentation (Policies) Sheet http://lifeway.net/role/BasisOfPresentationPolicies Basis of Presentation (Policies) Policies http://lifeway.net/role/SummaryOfSignificantAccountingPolicies 22 false false R23.htm 995526 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://lifeway.net/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://lifeway.net/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 995527 - Disclosure - Inventories, net (Tables) Sheet http://lifeway.net/role/InventoriesNetTables Inventories, net (Tables) Tables http://lifeway.net/role/InventoriesNet 24 false false R25.htm 995528 - Disclosure - Property, Plant and Equipment, net (Tables) Sheet http://lifeway.net/role/PropertyPlantAndEquipmentNetTables Property, Plant and Equipment, net (Tables) Tables http://lifeway.net/role/PropertyPlantAndEquipmentNet 25 false false R26.htm 995529 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://lifeway.net/role/GoodwillAndIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://lifeway.net/role/GoodwillAndIntangibleAssets 26 false false R27.htm 995530 - Disclosure - Accrued Expenses (Tables) Sheet http://lifeway.net/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://lifeway.net/role/AccruedExpenses 27 false false R28.htm 995531 - Disclosure - Debt (Tables) Sheet http://lifeway.net/role/DebtTables Debt (Tables) Tables http://lifeway.net/role/Debt 28 false false R29.htm 995532 - Disclosure - Leases (Tables) Sheet http://lifeway.net/role/LeasesTables Leases (Tables) Tables http://lifeway.net/role/Leases 29 false false R30.htm 995533 - Disclosure - Stock-based and Other Compensation (Tables) Sheet http://lifeway.net/role/Stock-basedAndOtherCompensationTables Stock-based and Other Compensation (Tables) Tables http://lifeway.net/role/Stock-basedAndOtherCompensation 30 false false R31.htm 995534 - Disclosure - Earnings Per Share (Tables) Sheet http://lifeway.net/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://lifeway.net/role/EarningsPerShare 31 false false R32.htm 995535 - Disclosure - Disaggregation of Revenue and Significant Customers (Tables) Sheet http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersTables Disaggregation of Revenue and Significant Customers (Tables) Tables http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomers 32 false false R33.htm 995536 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://lifeway.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://lifeway.net/role/SummaryOfSignificantAccountingPoliciesPolicies 33 false false R34.htm 995537 - Disclosure - Inventories, net (Details) Sheet http://lifeway.net/role/InventoriesNetDetails Inventories, net (Details) Details http://lifeway.net/role/InventoriesNetTables 34 false false R35.htm 995538 - Disclosure - Property, Plant and Equipment, net (Details) Sheet http://lifeway.net/role/PropertyPlantAndEquipmentNetDetails Property, Plant and Equipment, net (Details) Details http://lifeway.net/role/PropertyPlantAndEquipmentNetTables 35 false false R36.htm 995539 - Disclosure - Goodwill and Intangible Assets (Details - Goodwill) Sheet http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-Goodwill Goodwill and Intangible Assets (Details - Goodwill) Details http://lifeway.net/role/GoodwillAndIntangibleAssetsTables 36 false false R37.htm 995540 - Disclosure - Goodwill and Intangible Assets (Details - Finite lived) Sheet http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-FiniteLived Goodwill and Intangible Assets (Details - Finite lived) Details http://lifeway.net/role/GoodwillAndIntangibleAssetsTables 37 false false R38.htm 995541 - Disclosure - Goodwill and Intangible Assets (Details - Amortization expense on intangible assets) Sheet http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-AmortizationExpenseOnIntangibleAssets Goodwill and Intangible Assets (Details - Amortization expense on intangible assets) Details http://lifeway.net/role/GoodwillAndIntangibleAssetsTables 38 false false R39.htm 995542 - Disclosure - Goodwill and Intangible Assets (Details Narrative) Sheet http://lifeway.net/role/GoodwillAndIntangibleAssetsDetailsNarrative Goodwill and Intangible Assets (Details Narrative) Details http://lifeway.net/role/GoodwillAndIntangibleAssetsTables 39 false false R40.htm 995543 - Disclosure - Accrued Expenses (Details) Sheet http://lifeway.net/role/AccruedExpensesDetails Accrued Expenses (Details) Details http://lifeway.net/role/AccruedExpensesTables 40 false false R41.htm 995544 - Disclosure - Debt (Details) Sheet http://lifeway.net/role/DebtDetails Debt (Details) Details http://lifeway.net/role/DebtTables 41 false false R42.htm 995545 - Disclosure - Debt (Details - Maturities) Sheet http://lifeway.net/role/DebtDetails-Maturities Debt (Details - Maturities) Details http://lifeway.net/role/DebtTables 42 false false R43.htm 995546 - Disclosure - Debt (Details Narrative) Sheet http://lifeway.net/role/DebtDetailsNarrative Debt (Details Narrative) Details http://lifeway.net/role/DebtTables 43 false false R44.htm 995547 - Disclosure - Leases (Details) Sheet http://lifeway.net/role/LeasesDetails Leases (Details) Details http://lifeway.net/role/LeasesTables 44 false false R45.htm 995548 - Disclosure - Leases (Details Narrative) Sheet http://lifeway.net/role/LeasesDetailsNarrative Leases (Details Narrative) Details http://lifeway.net/role/LeasesTables 45 false false R46.htm 995549 - Disclosure - Income taxes (Details Narrative) Sheet http://lifeway.net/role/IncomeTaxesDetailsNarrative Income taxes (Details Narrative) Details http://lifeway.net/role/IncomeTaxes 46 false false R47.htm 995550 - Disclosure - Stock-based and Other Compensation (Details - Option Activity) Sheet http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity Stock-based and Other Compensation (Details - Option Activity) Details http://lifeway.net/role/Stock-basedAndOtherCompensationTables 47 false false R48.htm 995551 - Disclosure - Stock-based and Other Compensation (Details - Restricted Stock Units) Sheet http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-RestrictedStockUnits Stock-based and Other Compensation (Details - Restricted Stock Units) Details http://lifeway.net/role/Stock-basedAndOtherCompensationTables 48 false false R49.htm 995552 - Disclosure - Stock-based and Other Compensation (Details Narrative) Sheet http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative Stock-based and Other Compensation (Details Narrative) Details http://lifeway.net/role/Stock-basedAndOtherCompensationTables 49 false false R50.htm 995553 - Disclosure - Earnings Per Share (Details) Sheet http://lifeway.net/role/EarningsPerShareDetails Earnings Per Share (Details) Details http://lifeway.net/role/EarningsPerShareTables 50 false false R51.htm 995554 - Disclosure - Disaggregation of Revenue and Significant Customers (Details) Sheet http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails Disaggregation of Revenue and Significant Customers (Details) Details http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersTables 51 false false R52.htm 995555 - Disclosure - Disaggregation of Revenue and Significant Customers (Details Narrative) Sheet http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetailsNarrative Disaggregation of Revenue and Significant Customers (Details Narrative) Details http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersTables 52 false false All Reports Book All Reports lifeway_i10q-033124.htm lway-20240331.xsd lway-20240331_cal.xml lway-20240331_def.xml lway-20240331_lab.xml lway-20240331_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 72 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "lifeway_i10q-033124.htm": { "nsprefix": "LWAY", "nsuri": "http://lifeway.net/20240331", "dts": { "inline": { "local": [ "lifeway_i10q-033124.htm" ] }, "schema": { "local": [ "lway-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "lway-20240331_cal.xml" ] }, "definitionLink": { "local": [ "lway-20240331_def.xml" ] }, "labelLink": { "local": [ "lway-20240331_lab.xml" ] }, "presentationLink": { "local": [ "lway-20240331_pre.xml" ] } }, "keyStandard": 223, "keyCustom": 8, "axisStandard": 11, "axisCustom": 0, "memberStandard": 16, "memberCustom": 24, "hidden": { "total": 19, "http://xbrl.sec.gov/dei/2023": 5, "http://fasb.org/us-gaap/2023": 14 }, "contextCount": 118, "entityCount": 1, "segmentCount": 40, "elementCount": 442, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 454, "http://xbrl.sec.gov/dei/2023": 29, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://lifeway.net/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R2": { "role": "http://lifeway.net/role/BalanceSheets", "longName": "00000002 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R3": { "role": "http://lifeway.net/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R4": { "role": "http://lifeway.net/role/StatementsOfOperations", "longName": "00000004 - Statement - Consolidated Statements of Operations (Unaudited)", "shortName": "Consolidated Statements of Operations (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "unique": true } }, "R5": { "role": "http://lifeway.net/role/StatementsOfStockholdersEquity", "longName": "00000005 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)", "shortName": "Consolidated Statements of Stockholders' Equity (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R6": { "role": "http://lifeway.net/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "unique": true } }, "R7": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true }, "uniqueAnchor": null }, "R8": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R9": { "role": "http://lifeway.net/role/BasisOfPresentation", "longName": "995512 - Disclosure - Basis of Presentation", "shortName": "Basis of Presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R10": { "role": "http://lifeway.net/role/SummaryOfSignificantAccountingPolicies", "longName": "995513 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R11": { "role": "http://lifeway.net/role/InventoriesNet", "longName": "995514 - Disclosure - Inventories, net", "shortName": "Inventories, net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R12": { "role": "http://lifeway.net/role/PropertyPlantAndEquipmentNet", "longName": "995515 - Disclosure - Property, Plant and Equipment, net", "shortName": "Property, Plant and Equipment, net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R13": { "role": "http://lifeway.net/role/GoodwillAndIntangibleAssets", "longName": "995516 - Disclosure - Goodwill and Intangible Assets", "shortName": "Goodwill and Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R14": { "role": "http://lifeway.net/role/AccruedExpenses", "longName": "995517 - Disclosure - Accrued Expenses", "shortName": "Accrued Expenses", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R15": { "role": "http://lifeway.net/role/Debt", "longName": "995518 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R16": { "role": "http://lifeway.net/role/Leases", "longName": "995519 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R17": { "role": "http://lifeway.net/role/CommitmentsAndContingencies", "longName": "995520 - Disclosure - Commitments and contingencies", "shortName": "Commitments and contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R18": { "role": "http://lifeway.net/role/IncomeTaxes", "longName": "995521 - Disclosure - Income taxes", "shortName": "Income taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R19": { "role": "http://lifeway.net/role/Stock-basedAndOtherCompensation", "longName": "995522 - Disclosure - Stock-based and Other Compensation", "shortName": "Stock-based and Other Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R20": { "role": "http://lifeway.net/role/EarningsPerShare", "longName": "995523 - Disclosure - Earnings Per Share", "shortName": "Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R21": { "role": "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomers", "longName": "995524 - Disclosure - Disaggregation of Revenue and Significant Customers", "shortName": "Disaggregation of Revenue and Significant Customers", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R22": { "role": "http://lifeway.net/role/BasisOfPresentationPolicies", "longName": "995525 - Disclosure - Basis of Presentation (Policies)", "shortName": "Basis of Presentation (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "22", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R23": { "role": "http://lifeway.net/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "995526 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "23", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R24": { "role": "http://lifeway.net/role/InventoriesNetTables", "longName": "995527 - Disclosure - Inventories, net (Tables)", "shortName": "Inventories, net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R25": { "role": "http://lifeway.net/role/PropertyPlantAndEquipmentNetTables", "longName": "995528 - Disclosure - Property, Plant and Equipment, net (Tables)", "shortName": "Property, Plant and Equipment, net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R26": { "role": "http://lifeway.net/role/GoodwillAndIntangibleAssetsTables", "longName": "995529 - Disclosure - Goodwill and Intangible Assets (Tables)", "shortName": "Goodwill and Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R27": { "role": "http://lifeway.net/role/AccruedExpensesTables", "longName": "995530 - Disclosure - Accrued Expenses (Tables)", "shortName": "Accrued Expenses (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R28": { "role": "http://lifeway.net/role/DebtTables", "longName": "995531 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R29": { "role": "http://lifeway.net/role/LeasesTables", "longName": "995532 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R30": { "role": "http://lifeway.net/role/Stock-basedAndOtherCompensationTables", "longName": "995533 - Disclosure - Stock-based and Other Compensation (Tables)", "shortName": "Stock-based and Other Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R31": { "role": "http://lifeway.net/role/EarningsPerShareTables", "longName": "995534 - Disclosure - Earnings Per Share (Tables)", "shortName": "Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R32": { "role": "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersTables", "longName": "995535 - Disclosure - Disaggregation of Revenue and Significant Customers (Tables)", "shortName": "Disaggregation of Revenue and Significant Customers (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R33": { "role": "http://lifeway.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "995536 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:AdvertisingExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "us-gaap:AdvertisingCostsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:AdvertisingExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "us-gaap:AdvertisingCostsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R34": { "role": "http://lifeway.net/role/InventoriesNetDetails", "longName": "995537 - Disclosure - Inventories, net (Details)", "shortName": "Inventories, net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R35": { "role": "http://lifeway.net/role/PropertyPlantAndEquipmentNetDetails", "longName": "995538 - Disclosure - Property, Plant and Equipment, net (Details)", "shortName": "Property, Plant and Equipment, net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R36": { "role": "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-Goodwill", "longName": "995539 - Disclosure - Goodwill and Intangible Assets (Details - Goodwill)", "shortName": "Goodwill and Intangible Assets (Details - Goodwill)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:GoodwillGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:GoodwillGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R37": { "role": "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-FiniteLived", "longName": "995540 - Disclosure - Goodwill and Intangible Assets (Details - Finite lived)", "shortName": "Goodwill and Intangible Assets (Details - Finite lived)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R38": { "role": "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-AmortizationExpenseOnIntangibleAssets", "longName": "995541 - Disclosure - Goodwill and Intangible Assets (Details - Amortization expense on intangible assets)", "shortName": "Goodwill and Intangible Assets (Details - Amortization expense on intangible assets)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R39": { "role": "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetailsNarrative", "longName": "995542 - Disclosure - Goodwill and Intangible Assets (Details Narrative)", "shortName": "Goodwill and Intangible Assets (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "LWAY:AmortizationOfLeaseExpenseOutstandingWeightedAverageRemainingContractualTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "LWAY:AmortizationOfLeaseExpenseOutstandingWeightedAverageRemainingContractualTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R40": { "role": "http://lifeway.net/role/AccruedExpensesDetails", "longName": "995543 - Disclosure - Accrued Expenses (Details)", "shortName": "Accrued Expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R41": { "role": "http://lifeway.net/role/DebtDetails", "longName": "995544 - Disclosure - Debt (Details)", "shortName": "Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LoansPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LoansPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R42": { "role": "http://lifeway.net/role/DebtDetails-Maturities", "longName": "995545 - Disclosure - Debt (Details - Maturities)", "shortName": "Debt (Details - Maturities)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R43": { "role": "http://lifeway.net/role/DebtDetailsNarrative", "longName": "995546 - Disclosure - Debt (Details Narrative)", "shortName": "Debt (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LineOfCredit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LineOfCredit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R44": { "role": "http://lifeway.net/role/LeasesDetails", "longName": "995547 - Disclosure - Leases (Details)", "shortName": "Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R45": { "role": "http://lifeway.net/role/LeasesDetailsNarrative", "longName": "995548 - Disclosure - Leases (Details Narrative)", "shortName": "Leases (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:OperatingLeaseExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:OperatingLeaseExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R46": { "role": "http://lifeway.net/role/IncomeTaxesDetailsNarrative", "longName": "995549 - Disclosure - Income taxes (Details Narrative)", "shortName": "Income taxes (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R47": { "role": "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity", "longName": "995550 - Disclosure - Stock-based and Other Compensation (Details - Option Activity)", "shortName": "Stock-based and Other Compensation (Details - Option Activity)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "AsOf2023-12-31_us-gaap_StockOptionMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_us-gaap_StockOptionMember", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "unique": true } }, "R48": { "role": "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-RestrictedStockUnits", "longName": "995551 - Disclosure - Stock-based and Other Compensation (Details - Restricted Stock Units)", "shortName": "Stock-based and Other Compensation (Details - Restricted Stock Units)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "AsOf2023-12-31_us-gaap_RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_us-gaap_RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R49": { "role": "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative", "longName": "995552 - Disclosure - Stock-based and Other Compensation (Details Narrative)", "shortName": "Stock-based and Other Compensation (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "From2024-01-012024-03-31_us-gaap_RestrictedStockUnitsRSUMember", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_us-gaap_RestrictedStockUnitsRSUMember", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } }, "R50": { "role": "http://lifeway.net/role/EarningsPerShareDetails", "longName": "995553 - Disclosure - Earnings Per Share (Details)", "shortName": "Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "unique": true } }, "R51": { "role": "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails", "longName": "995554 - Disclosure - Disaggregation of Revenue and Significant Customers (Details)", "shortName": "Disaggregation of Revenue and Significant Customers (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_custom_DrinkableKefirotherthanProBugsMember", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "unique": true } }, "R52": { "role": "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetailsNarrative", "longName": "995555 - Disclosure - Disaggregation of Revenue and Significant Customers (Details Narrative)", "shortName": "Disaggregation of Revenue and Significant Customers (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "From2024-01-012024-03-31_us-gaap_SalesRevenueNetMember_custom_TwoCustomersMember_us-gaap_CustomerConcentrationRiskMember", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_us-gaap_SalesRevenueNetMember_custom_TwoCustomersMember_us-gaap_CustomerConcentrationRiskMember", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lifeway_i10q-033124.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "presentation": [ "http://lifeway.net/role/AccruedExpenses" ], "lang": { "en-us": { "role": { "label": "Accrued Expenses", "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period." } } }, "auth_ref": [ "r12" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r11", "r483" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts receivable, net of allowance for credit losses and discounts & allowances of $1,640 and $1,270 at March 31, 2024 and December 31, 2023 respectively", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r215", "r216" ] }, "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://lifeway.net/role/AccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/AccruedExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Real estate taxes", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17", "r54", "r459" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued income taxes", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r65", "r106" ] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 }, "http://lifeway.net/role/AccruedExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://lifeway.net/role/AccruedExpensesDetails", "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued expenses", "totalLabel": "Total accrued expenses", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17" ] }, "LWAY_AccruedPurchaseOfPropertyAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://lifeway.net/20240331", "localname": "AccruedPurchaseOfPropertyAndEquipment", "crdr": "debit", "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accrued purchase of property and equipment" } } }, "auth_ref": [] }, "us-gaap_AccruedUtilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedUtilitiesCurrent", "crdr": "credit", "calculation": { "http://lifeway.net/role/AccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lifeway.net/role/AccruedExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Utilities", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for utilities, such as electrical power, heating oil, natural gas, and water. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://lifeway.net/role/PropertyPlantAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r46", "r129", "r382" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r543" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r68", "r483", "r659" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://lifeway.net/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r313", "r314", "r315", "r403", "r597", "r598", "r599", "r647", "r661" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r549" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r549" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r549" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r549" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://lifeway.net/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock-based compensation", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r52", "r53", "r279" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income to operating cash flow:" } } }, "auth_ref": [] }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingCostsPolicyTextBlock", "presentation": [ "http://lifeway.net/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Advertising and promotional costs", "documentation": "Disclosure of accounting policy for advertising cost." } } }, "auth_ref": [ "r113" ] }, "us-gaap_AdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingExpense", "crdr": "debit", "presentation": [ "http://lifeway.net/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Advertising expense", "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line." } } }, "auth_ref": [ "r317" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r513", "r525", "r535", "r560" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r516", "r528", "r538", "r563" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r549" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r556" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r520", "r529", "r539", "r556", "r564", "r568", "r576" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share-based compensation", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r308", "r316" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://lifeway.net/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Allowance for credit losses and discounts", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r134", "r217", "r221", "r222", "r223", "r655" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Amortization expense", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r3", "r41", "r45" ] }, "LWAY_AmortizationOfLeaseExpenseOutstandingWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://lifeway.net/20240331", "localname": "AmortizationOfLeaseExpenseOutstandingWeightedAverageRemainingContractualTerm", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual term" } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r521" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r104", "r133", "r151", "r187", "r202", "r207", "r218", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r335", "r337", "r348", "r375", "r425", "r483", "r494", "r616", "r617", "r652" ] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r125", "r136", "r151", "r218", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r335", "r337", "r348", "r483", "r616", "r617", "r652" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r521" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price" } } }, "auth_ref": [ "r571" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r572" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r567" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r567" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r567" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r567" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r567" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r567" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity", "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-RestrictedStockUnits", "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r570" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r569" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r568" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r568" ] }, "LWAY_BrandNamesMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "BrandNamesMember", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-FiniteLived", "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Brand Names [Member]" } } }, "auth_ref": [] }, "us-gaap_BuildingAndBuildingImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BuildingAndBuildingImprovementsMember", "presentation": [ "http://lifeway.net/role/PropertyPlantAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Building and Building Improvements [Member]", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing." } } }, "auth_ref": [] }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "presentation": [ "http://lifeway.net/role/BasisOfPresentation" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation", "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [ "r63", "r87", "r88" ] }, "LWAY_CEO2020AwardMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "CEO2020AwardMember", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2020 CEO Incentive Award [Member]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r25", "r127", "r457" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://lifeway.net/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r26" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents at the beginning of the period", "periodEndLabel": "Cash and cash equivalents at the end of the period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r25", "r84", "r148" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net (decrease) increase in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r84" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r547" ] }, "LWAY_CheeseMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "CheeseMember", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Cheese [Member]" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r548" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r548" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies (Note 9)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r21", "r62", "r377", "r412" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://lifeway.net/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r97", "r232", "r233", "r455", "r613" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://lifeway.net/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r485", "r486", "r487", "r489", "r490", "r491", "r492", "r597", "r598", "r647", "r658", "r661" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://lifeway.net/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r67" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://lifeway.net/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r67", "r413" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://lifeway.net/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r67" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://lifeway.net/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r6", "r67", "r413", "r431", "r661", "r662" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 14,691 outstanding at March 31, 2024 and December 31, 2023", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r67", "r379", "r483" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r553" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r552" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r554" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r551" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails", "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r29", "r31", "r58", "r59", "r214", "r454" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails", "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r29", "r31", "r58", "r59", "r214", "r399", "r454" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails", "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r29", "r31", "r58", "r59", "r214", "r454", "r586" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails", "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net sales percentage", "verboseLabel": "Concentration risk, percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r29", "r31", "r58", "r59", "r214" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails", "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r29", "r31", "r58", "r59", "r214", "r454" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://lifeway.net/role/BasisOfPresentationPolicies" ], "lang": { "en-us": { "role": { "label": "Principles of consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r57", "r463" ] }, "us-gaap_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConstructionInProgressMember", "presentation": [ "http://lifeway.net/role/PropertyPlantAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Construction in Progress [Member]", "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service." } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfOperations": { "parentTag": "us-gaap_CostOfGoodsAndServicesSold", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of goods sold", "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization." } } }, "auth_ref": [ "r588", "r589" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total cost of goods sold", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r79", "r367" ] }, "us-gaap_CostOfGoodsAndServicesSoldDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSoldDepreciation", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfOperations": { "parentTag": "us-gaap_CostOfGoodsAndServicesSold", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Depreciation expense", "documentation": "Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service." } } }, "auth_ref": [ "r592", "r612" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "LWAY_CreamAndOtherMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "CreamAndOtherMember", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Cream And Other [Member]" } } }, "auth_ref": [] }, "LWAY_CreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "CreditAgreementMember", "presentation": [ "http://lifeway.net/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Credit Agreement [Member]" } } }, "auth_ref": [] }, "LWAY_CreditAgreementTermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "CreditAgreementTermLoanMember", "presentation": [ "http://lifeway.net/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Credit Agreement Term Loan [Member]" } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://lifeway.net/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://lifeway.net/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "LWAY_CurrentPortionOfOperatingLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://lifeway.net/20240331", "localname": "CurrentPortionOfOperatingLeaseLiabilities", "crdr": "credit", "calculation": { "http://lifeway.net/role/AccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://lifeway.net/role/AccruedExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Current portion of operating lease liabilities" } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails", "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r30", "r214" ] }, "LWAY_CustomerListsAndOtherCustomerRelatedIntangiblesMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "CustomerListsAndOtherCustomerRelatedIntangiblesMember", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-FiniteLived" ], "lang": { "en-us": { "role": { "label": "Customer Lists and Other Customer Related Intangibles [Member]" } } }, "auth_ref": [] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerRelationshipsMember", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-FiniteLived", "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r56" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://lifeway.net/role/Debt" ], "lang": { "en-us": { "role": { "label": "Debt", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r98", "r150", "r243", "r249", "r250", "r251", "r252", "r253", "r254", "r259", "r266", "r267", "r268" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://lifeway.net/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r9", "r64", "r65", "r105", "r107", "r153", "r244", "r245", "r246", "r247", "r248", "r250", "r255", "r256", "r257", "r258", "r260", "r261", "r262", "r263", "r264", "r265", "r356", "r469", "r470", "r471", "r472", "r473", "r593" ] }, "us-gaap_DebtInstrumentInterestRateTerms": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateTerms", "presentation": [ "http://lifeway.net/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description of debt instrument, interest rate terms", "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets." } } }, "auth_ref": [ "r19" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://lifeway.net/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Termination date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r122", "r469", "r648" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://lifeway.net/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r20", "r153", "r244", "r245", "r246", "r247", "r248", "r250", "r255", "r256", "r257", "r258", "r260", "r261", "r262", "r263", "r264", "r265", "r356", "r469", "r470", "r471", "r472", "r473", "r593" ] }, "us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross", "crdr": "debit", "calculation": { "http://lifeway.net/role/DebtDetails": { "parentTag": "us-gaap_NotesPayable", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/DebtDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Unamortized deferred financing costs", "label": "Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Gross", "documentation": "Amount of issuance costs recognized in a share-lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing, before deduction of accumulated amortization or effects of subsequent adjustments." } } }, "auth_ref": [ "r47" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred income taxes, net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r320", "r321", "r376" ] }, "us-gaap_DeferredOtherTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredOtherTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tax related benefits", "documentation": "Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods." } } }, "auth_ref": [ "r55", "r102", "r595" ] }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanContributionsByEmployer", "crdr": "debit", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Contribution expense", "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets." } } }, "auth_ref": [ "r274", "r275", "r276", "r476", "r477", "r478", "r479" ] }, "LWAY_DefinedContributionPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "DefinedContributionPlanMember", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Defined Contribution Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r3", "r191" ] }, "LWAY_Director2022PlanMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "Director2022PlanMember", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2022 Director Plan [Member]" } } }, "auth_ref": [] }, "LWAY_DisclosureLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://lifeway.net/20240331", "localname": "DisclosureLeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensation" ], "lang": { "en-us": { "role": { "label": "Stock-based and Other Compensation", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r277", "r281", "r309", "r310", "r312", "r480" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r508" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r506", "r508", "r521" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r507" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r495" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r508" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r508" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r542" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r498" ] }, "LWAY_DrinkableKefirotherthanProBugsMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "DrinkableKefirotherthanProBugsMember", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Drinkable Kefir other than ProBugs [Member]" } } }, "auth_ref": [] }, "LWAY_DrinkableYogurtMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "DrinkableYogurtMember", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Drinkable Yogurt [Member]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net earnings per common share:", "verboseLabel": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r143", "r159", "r160", "r161", "r162", "r163", "r168", "r170", "r175", "r176", "r177", "r181", "r346", "r347", "r371", "r386", "r464" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r143", "r159", "r160", "r161", "r162", "r163", "r170", "r175", "r176", "r177", "r181", "r346", "r347", "r371", "r386", "r464" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://lifeway.net/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r167", "r178", "r179", "r180" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://lifeway.net/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Effective income tax rate reconciliation, percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r323" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://lifeway.net/role/AccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/AccruedExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Payroll and incentive compensation", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average basis term", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r311" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "crdr": "debit", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Compensation expense related to restricted stock units", "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r646" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r501" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r497" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r497" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r584" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r497" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r581" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r521" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r497" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r497" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r497" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r497" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r582" ] }, "us-gaap_EntityWideRevenueMajorCustomerLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EntityWideRevenueMajorCustomerLineItems", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails", "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue, Major Customer [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://lifeway.net/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r6", "r123", "r139", "r140", "r141", "r154", "r155", "r156", "r158", "r164", "r166", "r182", "r219", "r220", "r271", "r313", "r314", "r315", "r328", "r329", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r349", "r350", "r351", "r352", "r353", "r354", "r365", "r394", "r395", "r396", "r403", "r451" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r550" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r513", "r525", "r535", "r560" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r510", "r522", "r532", "r557" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r556" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-FiniteLived" ], "lang": { "en-us": { "role": { "label": "Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r131", "r230" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-AmortizationExpenseOnIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "2024", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r94" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "crdr": "debit", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-AmortizationExpenseOnIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Nine months ended December 31, 2024", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-AmortizationExpenseOnIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "2027", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r94" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-AmortizationExpenseOnIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "2026", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r94" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-AmortizationExpenseOnIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "2025", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r94" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-FiniteLived", "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r228", "r229", "r230", "r231", "r368", "r369" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-FiniteLived" ], "lang": { "en-us": { "role": { "label": "Gross Carrying Amount", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r93", "r369" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-FiniteLived", "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r368" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-FiniteLived", "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r42", "r44" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-FiniteLived" ], "lang": { "en-us": { "role": { "label": "Net Carrying Amount", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r93", "r368" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r517", "r529", "r539", "r564" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r517", "r529", "r539", "r564" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r517", "r529", "r539", "r564" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r517", "r529", "r539", "r564" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r517", "r529", "r539", "r564" ] }, "LWAY_FormulaMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "FormulaMember", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-FiniteLived" ], "lang": { "en-us": { "role": { "label": "Formula [Member]" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "General and administrative expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r80", "r435" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets", "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-Goodwill" ], "lang": { "en-us": { "role": { "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r130", "r225", "r370", "r468", "r483", "r602", "r609" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r92" ] }, "us-gaap_GoodwillGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillGross", "crdr": "debit", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-Goodwill" ], "lang": { "en-us": { "role": { "label": "Goodwill before impairment", "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r226", "r227", "r468" ] }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "crdr": "credit", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-Goodwill" ], "lang": { "en-us": { "role": { "negatedLabel": "Goodwill, impaired, accumulated impairment loss", "label": "Goodwill, Impaired, Accumulated Impairment Loss", "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r226", "r227", "r468" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://lifeway.net/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r78", "r151", "r187", "r201", "r206", "r209", "r218", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r348", "r466", "r616" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://lifeway.net/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Income before provision for income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r76", "r109", "r187", "r201", "r206", "r209", "r372", "r384", "r466" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://lifeway.net/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Income taxes", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r152", "r318", "r324", "r326", "r327", "r330", "r332", "r333", "r334", "r402" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Provision for income taxes", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r112", "r121", "r165", "r166", "r192", "r322", "r331", "r387" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid for income taxes, net of (refunds)", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r27" ] }, "us-gaap_IncomeTaxesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesReceivable", "crdr": "debit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Refundable income taxes", "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes." } } }, "auth_ref": [ "r61", "r590" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://lifeway.net/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued income taxes", "label": "Increase (Decrease) in Income Taxes Payable", "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedLiabilities", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued expenses", "label": "Increase (Decrease) in Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInIncomeTaxesReceivable", "crdr": "credit", "calculation": { "http://lifeway.net/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Refundable income taxes", "label": "Increase (Decrease) in Income Taxes Receivable", "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://lifeway.net/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "(Increase) decrease in operating assets:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract", "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in operating liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://lifeway.net/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants", "presentation": [ "http://lifeway.net/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Assumed exercise/vesting of equity awards", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method." } } }, "auth_ref": [ "r171", "r172", "r173", "r177" ] }, "LWAY_IncrementalFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "IncrementalFacilityMember", "presentation": [ "http://lifeway.net/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Incremental Facility [Member]" } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]" } } }, "auth_ref": [ "r520", "r529", "r539", "r556", "r564", "r568", "r576" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r574" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r509", "r580" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r509", "r580" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r509", "r580" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible assets, net", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r40", "r43" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r60", "r111", "r142", "r190", "r355", "r436", "r493", "r660" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid for interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r144", "r146", "r147" ] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://lifeway.net/role/InventoriesNet" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventories, net", "label": "Inventory Disclosure [Text Block]", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r224" ] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://lifeway.net/role/InventoriesNetDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lifeway.net/role/InventoriesNetDetails" ], "lang": { "en-us": { "role": { "label": "Finished goods", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r91", "r460" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 }, "http://lifeway.net/role/InventoriesNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://lifeway.net/role/BalanceSheets", "http://lifeway.net/role/InventoriesNetDetails" ], "lang": { "en-us": { "role": { "label": "Inventories, net", "totalLabel": "Total inventories, net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r135", "r458", "r483" ] }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterialsNetOfReserves", "crdr": "debit", "calculation": { "http://lifeway.net/role/InventoriesNetDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/InventoriesNetDetails" ], "lang": { "en-us": { "role": { "label": "Ingredients", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process." } } }, "auth_ref": [ "r91", "r461" ] }, "us-gaap_InventorySuppliesNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventorySuppliesNetOfReserves", "crdr": "debit", "calculation": { "http://lifeway.net/role/InventoriesNetDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/InventoriesNetDetails" ], "lang": { "en-us": { "role": { "label": "Packaging", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of products used directly or indirectly in the manufacturing or production process, which may or may not become part of the final product. May also include items used in the storage, presentation or transportation of physical goods." } } }, "auth_ref": [ "r38", "r462" ] }, "us-gaap_LandMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LandMember", "presentation": [ "http://lifeway.net/role/PropertyPlantAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Land [Member]", "documentation": "Part of earth's surface not covered by water." } } }, "auth_ref": [ "r619" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://lifeway.net/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of future maturities of lease liabilities", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r651" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://lifeway.net/role/LeasesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://lifeway.net/role/LeasesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r364" ] }, "LWAY_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://lifeway.net/20240331", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour", "crdr": "credit", "calculation": { "http://lifeway.net/role/LeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://lifeway.net/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Thereafter" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://lifeway.net/role/LeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/LeasesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r364" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://lifeway.net/role/LeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://lifeway.net/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "2028", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r364" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://lifeway.net/role/LeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://lifeway.net/role/LeasesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r364" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://lifeway.net/role/LeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lifeway.net/role/LeasesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r364" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://lifeway.net/role/LeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/LeasesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Nine months ended December 31, 2024", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year." } } }, "auth_ref": [ "r651" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://lifeway.net/role/LeasesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r364" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://lifeway.net/role/Leases" ], "lang": { "en-us": { "role": { "verboseLabel": "Leases", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r357" ] }, "LWAY_LetterOfCreditFeePercentage": { "xbrltype": "percentItemType", "nsuri": "http://lifeway.net/20240331", "localname": "LetterOfCreditFeePercentage", "presentation": [ "http://lifeway.net/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Letter of credit fee percentage" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r16", "r151", "r218", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r336", "r337", "r338", "r348", "r411", "r465", "r494", "r616", "r652", "r653" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders' equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r72", "r108", "r381", "r483", "r594", "r600", "r649" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r18", "r126", "r151", "r218", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r336", "r337", "r338", "r348", "r483", "r616", "r652", "r653" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "auth_ref": [] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://lifeway.net/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Outstanding amount", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r9", "r107", "r654" ] }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityCommitmentFeePercentage", "presentation": [ "http://lifeway.net/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unused revolving line of credit fee", "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "crdr": "credit", "presentation": [ "http://lifeway.net/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Future borrowings", "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)." } } }, "auth_ref": [ "r13" ] }, "us-gaap_LoansPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansPayableCurrent", "crdr": "credit", "calculation": { "http://lifeway.net/role/DebtDetails": { "parentTag": "us-gaap_NotesPayable", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/DebtDetails" ], "lang": { "en-us": { "role": { "label": "Term loan due August 18, 2026. Interest (7.39% at March 31, 2024) payable monthly.", "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r17" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://lifeway.net/role/DebtDetails-Maturities": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://lifeway.net/role/DebtDetails-Maturities" ], "lang": { "en-us": { "role": { "totalLabel": "Total term loan", "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r9", "r107", "r256", "r269", "r470", "r471", "r654" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://lifeway.net/role/DebtDetails-Maturities": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/DebtDetails-Maturities" ], "lang": { "en-us": { "role": { "verboseLabel": "2025", "label": "Long-Term Debt, Maturity, Year One", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r5", "r153", "r261" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://lifeway.net/role/DebtDetails-Maturities": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lifeway.net/role/DebtDetails-Maturities" ], "lang": { "en-us": { "role": { "verboseLabel": "2026", "label": "Long-Term Debt, Maturity, Year Two", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r5", "r153", "r261" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://lifeway.net/role/DebtDetails-Maturities": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/DebtDetails-Maturities" ], "lang": { "en-us": { "role": { "verboseLabel": "Nine months ended December 31, 2024", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year." } } }, "auth_ref": [ "r596" ] }, "us-gaap_LongTermNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermNotesPayable", "crdr": "credit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets", "http://lifeway.net/role/DebtDetails" ], "lang": { "en-us": { "role": { "label": "Note payable", "verboseLabel": "Total long-term portion", "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion." } } }, "auth_ref": [ "r20" ] }, "LWAY_LongtermEquitybasedIncentive": { "xbrltype": "monetaryItemType", "nsuri": "http://lifeway.net/20240331", "localname": "LongtermEquitybasedIncentive", "crdr": "debit", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Long-term equity-based incentive", "documentation": "Long-term equity-based incentive" } } }, "auth_ref": [] }, "us-gaap_MachineryAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MachineryAndEquipmentMember", "presentation": [ "http://lifeway.net/role/PropertyPlantAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Machinery and Equipment [Member]", "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment." } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r214", "r475", "r618", "r656", "r657" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]" } } }, "auth_ref": [ "r548" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name" } } }, "auth_ref": [ "r548" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r567" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r575" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetailsNarrative" ], "auth_ref": [ "r214", "r475", "r618", "r656", "r657" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r549" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r145" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r145" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://lifeway.net/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r84", "r85", "r86" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://lifeway.net/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://lifeway.net/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows", "http://lifeway.net/role/StatementsOfOperations", "http://lifeway.net/role/StatementsOfStockholdersEquity", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net income", "label": "Net income", "verboseLabel": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r77", "r86", "r110", "r124", "r137", "r138", "r141", "r151", "r157", "r159", "r160", "r161", "r162", "r165", "r166", "r174", "r187", "r201", "r206", "r209", "r218", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r347", "r348", "r385", "r433", "r449", "r450", "r466", "r493", "r616" ] }, "LWAY_NetSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "NetSalesMember", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Net Sales [Member]" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://lifeway.net/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recent accounting pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r548" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r546" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r545" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r575" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r575" ] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Non-cash investing activities" } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://lifeway.net/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income (expense)", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r81" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "auth_ref": [] }, "us-gaap_NotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayable", "crdr": "credit", "calculation": { "http://lifeway.net/role/DebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://lifeway.net/role/DebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total note payable", "label": "Notes Payable", "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r9", "r107", "r654" ] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets", "http://lifeway.net/role/DebtDetails" ], "lang": { "en-us": { "role": { "label": "Current portion of note payable", "negatedLabel": "Less current portion", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r15" ] }, "us-gaap_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OfficeEquipmentMember", "presentation": [ "http://lifeway.net/role/PropertyPlantAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Office Equipment [Member]", "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine." } } }, "auth_ref": [] }, "LWAY_Omnibus2015Member": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "Omnibus2015Member", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2015 Omnibus Incentive Plan [Member]" } } }, "auth_ref": [] }, "LWAY_Omnibus2022PlanMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "Omnibus2022PlanMember", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2012 Omnibus Incentive Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://lifeway.net/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Income from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r187", "r201", "r206", "r209", "r466" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "presentation": [ "http://lifeway.net/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating lease liabilities", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r360", "r482" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseExpense", "crdr": "debit", "presentation": [ "http://lifeway.net/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Total lease expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r650" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "presentation": [ "http://lifeway.net/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Present value of lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r359" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Operating lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r359" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Operating lease right-of-use asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r358" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://lifeway.net/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average discount rate", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r363", "r482" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://lifeway.net/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining lease term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r362", "r482" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://lifeway.net/role/AccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://lifeway.net/role/AccruedExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Other", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r17" ] }, "us-gaap_OtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssets", "crdr": "debit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other assets", "documentation": "Amount of assets classified as other." } } }, "auth_ref": [ "r103", "r132", "r374", "r494" ] }, "LWAY_OtherDairyMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "OtherDairyMember", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Other Dairy [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherNoncashExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashExpense", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Non-cash interest expense", "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other." } } }, "auth_ref": [ "r86" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://lifeway.net/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other income (expense), net", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r82" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure Amount" } } }, "auth_ref": [ "r548" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r508" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r515", "r527", "r537", "r562" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r518", "r530", "r540", "r565" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r518", "r530", "r540", "r565" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "auth_ref": [ "r544" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://lifeway.net/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r83" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r547" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r547" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r546" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name" } } }, "auth_ref": [ "r549" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r545" ] }, "LWAY_Plan2021Member": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "Plan2021Member", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2021 Equity Award [Member]" } } }, "auth_ref": [] }, "LWAY_Plan2022Member": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "Plan2022Member", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2022 Equity Award [Member]" } } }, "auth_ref": [] }, "LWAY_Plan2023Member": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "Plan2023Member", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2023 Equity Award [Member]" } } }, "auth_ref": [] }, "LWAY_Plan2024Member": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "Plan2024Member", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2024 Equity Award [Member]" } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r502" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r503" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://lifeway.net/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r66", "r270" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://lifeway.net/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r66", "r413" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://lifeway.net/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r66", "r270" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://lifeway.net/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r66", "r413", "r431", "r661", "r662" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred stock, no par value; 2,500 shares authorized; no shares issued or outstanding at March 31, 2024 and December 31, 2023", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r66", "r378", "r483" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r591" ] }, "LWAY_ProBugsKefirMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "ProBugsKefirMember", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails" ], "lang": { "en-us": { "role": { "label": "ProBugs Kefir [Member]" } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r211", "r367", "r388", "r389", "r390", "r391", "r392", "r393", "r456", "r474", "r484", "r587", "r614", "r615", "r618", "r656" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails" ], "auth_ref": [ "r211", "r367", "r388", "r389", "r390", "r391", "r392", "r393", "r456", "r474", "r484", "r587", "r614", "r615", "r618", "r656" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://lifeway.net/role/PropertyPlantAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r4" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://lifeway.net/role/PropertyPlantAndEquipmentNet" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, net", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r95", "r116", "r119", "r120" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "presentation": [ "http://lifeway.net/role/PropertyPlantAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r96", "r128", "r383" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://lifeway.net/role/PropertyPlantAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets", "http://lifeway.net/role/PropertyPlantAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment, net", "verboseLabel": "Total property, plant and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r4", "r373", "r383", "r483" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://lifeway.net/role/PropertyPlantAndEquipmentNetTables" ], "lang": { "en-us": { "role": { "label": "Schedule of property, plant and equipment", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r4" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://lifeway.net/role/PropertyPlantAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r96" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r544" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r544" ] }, "LWAY_RecipesMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "RecipesMember", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-FiniteLived" ], "lang": { "en-us": { "role": { "label": "Recipes [Member]" } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "auth_ref": [ "r510", "r522", "r532", "r557" ] }, "us-gaap_RepaymentsOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfNotesPayable", "crdr": "credit", "calculation": { "http://lifeway.net/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of note payable", "label": "Repayments of Notes Payable", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r24" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r511", "r523", "r533", "r558" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date" } } }, "auth_ref": [ "r512", "r524", "r534", "r559" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r519", "r531", "r541", "r566" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-RestrictedStockUnits", "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Retained earnings", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r69", "r99", "r380", "r397", "r398", "r401", "r414", "r483" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://lifeway.net/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r123", "r154", "r155", "r156", "r158", "r164", "r166", "r219", "r220", "r313", "r314", "r315", "r328", "r329", "r339", "r341", "r342", "r344", "r345", "r394", "r396", "r403", "r661" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://lifeway.net/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails", "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Sales", "verboseLabel": "Net sales", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r188", "r189", "r200", "r204", "r205", "r211", "r213", "r214", "r272", "r273", "r367" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://lifeway.net/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets obtained in exchange for lease obligations", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r361", "r482" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r575" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r575" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails", "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r214", "r585" ] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://lifeway.net/role/AccruedExpensesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of accrued expenses", "documentation": "Tabular disclosure of the components of accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://lifeway.net/role/DebtTables" ], "lang": { "en-us": { "role": { "label": "Schedule of debt", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetails", "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]", "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers." } } }, "auth_ref": [ "r89" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetails-FiniteLived", "http://lifeway.net/role/GoodwillAndIntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r42", "r44", "r368" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of finite-lived intangible assets", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r42", "r44" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of goodwill", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r468", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://lifeway.net/role/InventoriesNetTables" ], "lang": { "en-us": { "role": { "label": "Schedule of inventories", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r10", "r73", "r74", "r75" ] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://lifeway.net/role/DebtTables" ], "lang": { "en-us": { "role": { "label": "Schedule of maturities of long-term debt", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r5" ] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://lifeway.net/role/PropertyPlantAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r4" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersTables" ], "lang": { "en-us": { "role": { "label": "Schedule of sales of products by category", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r35", "r36", "r37", "r39" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity", "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-RestrictedStockUnits", "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r278", "r280", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307" ] }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of RSUs Activity", "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [ "r51" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of stock option activity", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r7", "r8", "r51" ] }, "us-gaap_ScheduleOfShortTermDebtTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShortTermDebtTable", "presentation": [ "http://lifeway.net/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Short-Term Debt [Table]", "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation." } } }, "auth_ref": [ "r14" ] }, "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "presentation": [ "http://lifeway.net/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of weighted average number of shares outstanding", "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit)." } } }, "auth_ref": [ "r28" ] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://lifeway.net/role/GoodwillAndIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of estimated amortization expense on intangible assets", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r44" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r496" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r500" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r499" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r504" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomers" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue and Significant Customers", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r183", "r184", "r185", "r186", "r187", "r193", "r203", "r207", "r208", "r209", "r210", "r211", "r212", "r214" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://lifeway.net/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Segments", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r194", "r195", "r196", "r197", "r198", "r199", "r213", "r467" ] }, "us-gaap_SellingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingExpense", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Selling expense", "documentation": "Expenses recognized in the period that are directly related to the selling and distribution of products or services." } } }, "auth_ref": [ "r80" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://lifeway.net/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock-based compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r2" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-RestrictedStockUnits" ], "lang": { "en-us": { "role": { "label": "Restricted stock units, forfeited", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r298" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-RestrictedStockUnits" ], "lang": { "en-us": { "role": { "label": "Weighted average grant date fair value, forfeited", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r298" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-RestrictedStockUnits" ], "lang": { "en-us": { "role": { "label": "Restricted stock units, granted", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r296" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-RestrictedStockUnits" ], "lang": { "en-us": { "role": { "label": "Weighted average grant date fair value, granted", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r296" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-RestrictedStockUnits" ], "lang": { "en-us": { "role": { "periodStartLabel": "Restricted stock units outstanding, beginning", "periodEndLabel": "Restricted stock units outstanding, ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r293", "r294" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-RestrictedStockUnits" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average grant date fair value outstanding, beginning", "label": "Weighted average grant date fair value outstanding, ending", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r293", "r294" ] }, "LWAY_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesIssuedUponVestingWeightedAverageFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://lifeway.net/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesIssuedUponVestingWeightedAverageFairValue", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-RestrictedStockUnits" ], "lang": { "en-us": { "role": { "label": "Weighted average grant date fair value, shares issued upon vesting" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-RestrictedStockUnits" ], "lang": { "en-us": { "role": { "label": "Restricted stock units, shares issued upon vesting", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r297" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-RestrictedStockUnits" ], "lang": { "en-us": { "role": { "label": "Weighted average grant date fair value, vested and deferred", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r297" ] }, "LWAY_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://lifeway.net/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-RestrictedStockUnits" ], "lang": { "en-us": { "role": { "label": "Restricted stock units, vested and deferred" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity", "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-RestrictedStockUnits", "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r278", "r280", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares authorized for issuance", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r481" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share based remain available to award", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r50" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity" ], "lang": { "en-us": { "role": { "label": "Exercisable", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r287" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, exercisable", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r287" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity" ], "lang": { "en-us": { "role": { "label": "Options forfeited", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r291" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity" ], "lang": { "en-us": { "role": { "label": "Options granted", "documentation": "Net number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r627" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregate intrinsic value, options outstanding beginning", "periodEndLabel": "Aggregate intrinsic value, options outstanding ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r50" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Options outstanding, beginning balance", "periodEndLabel": "Options outstanding, ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r285", "r286" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average exercise price, options outstanding, beginning balance", "periodEndLabel": "Weighted average exercise price, options outstanding, ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r285", "r286" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity", "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-RestrictedStockUnits", "http://lifeway.net/role/Stock-basedAndOtherCompensationDetailsNarrative", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, options exercised", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r290" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, options forfeited", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r291" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, options granted", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r289" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity" ], "lang": { "en-us": { "role": { "label": "Aggregate intrinsic value, options exercisable", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r50" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life, outstanding", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r100" ] }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life, exercisable", "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r101" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://lifeway.net/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance, shares", "periodEndLabel": "Ending balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtLineItems", "presentation": [ "http://lifeway.net/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://lifeway.net/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r87", "r149" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r505" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://lifeway.net/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r6", "r23", "r123", "r139", "r140", "r141", "r154", "r155", "r156", "r158", "r164", "r166", "r182", "r219", "r220", "r271", "r313", "r314", "r315", "r328", "r329", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r349", "r350", "r351", "r352", "r353", "r354", "r365", "r394", "r395", "r396", "r403", "r451" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://lifeway.net/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r154", "r155", "r156", "r182", "r367", "r400", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r413", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r426", "r427", "r428", "r429", "r430", "r432", "r434", "r435", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r451", "r488" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://lifeway.net/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r154", "r155", "r156", "r182", "r367", "r400", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r413", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r426", "r427", "r428", "r429", "r430", "r432", "r434", "r435", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r451", "r488" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r514", "r526", "r536", "r561" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity" ], "lang": { "en-us": { "role": { "label": "Options exercised", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r6", "r66", "r67", "r99", "r290" ] }, "us-gaap_StockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockOptionMember", "presentation": [ "http://lifeway.net/role/Stock-basedAndOtherCompensationDetails-OptionActivity" ], "lang": { "en-us": { "role": { "label": "Equity Option [Member]", "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)." } } }, "auth_ref": [ "r487" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets", "http://lifeway.net/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders' equity", "periodStartLabel": "Beginning balance, value", "periodEndLabel": "Ending balance, value", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r67", "r70", "r71", "r90", "r415", "r431", "r452", "r453", "r483", "r494", "r594", "r600", "r649", "r661" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 equity" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://lifeway.net/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental cash flow information:" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r555" ] }, "us-gaap_TerminationLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TerminationLoans", "crdr": "credit", "presentation": [ "http://lifeway.net/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Termination loans", "documentation": "Definite liabilities to third parties under a termination loan agreement, whether or not guaranteed in whole or in part by the government." } } }, "auth_ref": [ "r366" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r547" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r554" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Adoption Date" } } }, "auth_ref": [ "r577" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Arrangement Duration" } } }, "auth_ref": [ "r578" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Name" } } }, "auth_ref": [ "r576" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Title" } } }, "auth_ref": [ "r576" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Aggregate Available" } } }, "auth_ref": [ "r579" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Termination Date" } } }, "auth_ref": [ "r577" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonMember", "presentation": [ "http://lifeway.net/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r48" ] }, "us-gaap_TreasuryStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValue", "crdr": "debit", "calculation": { "http://lifeway.net/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://lifeway.net/role/BalanceSheets" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury stock, at cost", "label": "Treasury Stock, Value", "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury." } } }, "auth_ref": [ "r22", "r48", "r49" ] }, "LWAY_TwoCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://lifeway.net/20240331", "localname": "TwoCustomersMember", "presentation": [ "http://lifeway.net/role/DisaggregationOfRevenueAndSignificantCustomersDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Two Customers [Member]" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r573" ] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://lifeway.net/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized tax benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r319", "r325" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://lifeway.net/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r32", "r33", "r34", "r114", "r115", "r117", "r118" ] }, "us-gaap_VehiclesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VehiclesMember", "presentation": [ "http://lifeway.net/role/PropertyPlantAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Vehicles [Member]", "documentation": "Equipment used primarily for road transportation." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://lifeway.net/role/EarningsPerShareDetails", "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "verboseLabel": "Diluted", "label": "Weighted average diluted common shares outstanding", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r169", "r177" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average common shares outstanding:" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://lifeway.net/role/EarningsPerShareDetails", "http://lifeway.net/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "verboseLabel": "Basic", "label": "Weighted average common shares outstanding", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r168", "r177" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://lifeway.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r583" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29,30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "330", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "50", "Paragraph": "2A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-2A" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "720", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483384/720-30-45-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-26" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "405", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482379/912-405-45-4" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r457": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8" }, "r460": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r464": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r465": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r466": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r467": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r468": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r469": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r470": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r471": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r472": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r473": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r474": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r475": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r476": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r479": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18" }, "r480": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r483": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r484": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r485": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r487": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r491": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r492": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r493": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r494": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r495": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r496": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r497": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r498": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r499": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r501": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r502": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r503": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r504": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r505": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r506": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r507": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r508": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r509": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r510": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r511": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r512": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r513": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r514": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r515": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r516": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r517": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r518": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r519": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r520": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r521": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r522": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r523": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r524": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r525": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r526": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r527": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r528": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r529": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r530": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r531": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r532": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r533": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r534": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r535": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r536": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r537": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r538": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r539": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r540": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r541": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r542": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r544": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r545": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r546": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r547": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r548": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r549": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r550": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r551": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r552": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r553": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r554": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r555": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r556": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r557": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r558": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r559": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r560": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r561": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r562": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r563": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r564": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r565": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r566": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r567": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r568": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r569": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r570": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r571": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r572": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r573": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r574": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r575": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r576": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r577": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r578": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r579": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r580": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r581": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r582": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r583": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r584": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r585": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r586": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r587": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r588": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r589": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r590": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r591": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r592": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r593": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r594": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r595": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r596": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r597": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r598": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r599": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r600": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r601": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r602": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r603": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r604": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r605": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r606": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r607": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r608": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r609": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r610": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r611": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r612": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r613": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r614": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r615": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r616": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r617": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r618": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r619": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r620": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r621": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r622": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r623": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r624": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r625": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r626": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r627": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r628": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r629": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r630": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r631": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r632": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r633": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r634": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r635": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r636": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r637": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r638": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r639": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r640": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r641": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r642": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r643": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r644": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r645": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r646": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r647": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r648": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r649": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r650": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r651": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r652": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r653": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r654": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r655": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r656": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r657": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r658": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r659": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r660": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r661": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r662": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 73 0001683168-24-003353-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-24-003353-xbrl.zip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�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

14>/U#K^DPS>@C;+%+G$[,EX)4J?]J_4U-HW1SZ M%C,!ZIL+U /!K3U4!^;HZ-SH$#Y633->4 !QD"B@@/,G0 PC-02BJSHW#]#; MML$@NX!#DX1'@,DV2@V4XQ)*;-352$X!8:,?!I4Q@I)FP!OEMLF$J$%8=>0^ M*$Q.JP4:#V<&@-/ 3R@,WG*$/=!P+%4G@\6S ;J $ L/60"" :0":#+P53"C0KDU*9@2)B'2(%V&BS&!-V;+1!B$9'J\G M*@Z%14#5I'U1"DK$L;*9R'.)&_K0'/\\S7&/3"(O;ZD'9">L;T#DKJ&0FK>Y M6+(1S$O1X@1+.#'B+RCG!=PD&I[IA(1$)1MTVU0:Y7J2GW/$-S MG-I0XF'FY: !Q,@=?@/*R)!MB_PW&PO>:W0S<>\20H\XDT4VCH,J! +!<-H= MT$6D2]0'CK/2,>@)4MYU ^X*0A3.KG]#C]7=YS![2SKD2WC/XC7QY]T?5-WG M_0C2_R2+'4D)8D>N1T[PX_APBY>6,S'.D@UM'DY+1N1(#(JKBJ["1Z&5!D:. M4&4+>G/=&!"_#-BR"@*S*7$WN 7VN2:R?6E?UP=[FV $Q:S!%7,/(856KC.4 M!K()9()&N6NPH\<7E%+=SK@_('"3,QKH'IWM,M>H724:(!ZC0W-VX&G0>"=H M1 A\B=>9MR7>8\G1GW3C1<\8^*=0Z$DY=;?&=R5KEL&M7W<#DJSTD??XG%YW M32JQ:S)7W*0FB?OZ\:@$J=B-95",]IC\!"]$L'$S"X.79%.A[[C)X";D8#Q0 M^-5)^V@PX@::(< QAIBAASF>@I'1"N O?FI8CZYZ! 9\!G9N. MAICB1@<[L"L=[LKAZH#3HWW;(:N-!Q]5&R"NH'7RQ.A7!BPOHC6H1-%NM$%& MO,1 5UD?#XO0C(=?%E/GZ&HI?LSO@J>#OHR&KT8-8-=GC_!<3A#3S9I9(CUN MUA()4KAV/E*XWB"%:^TDUVVH5RH0K35YDS+9V M=)%OD]^I55!.G:E@2#!-NNX:VD#6K:=!-@.RE30_8/DM@*O4X1X_5.RXFBZQ MKMHV>0H0Z@T'L@7/Z=*!8QH]Y@JU4$%6<",\E<>T['$[5[?815C6@70,*,&DS3=(KT, Q))!?.DEB$9EP_3-['6 / M;0.45TU3=0,.UV6P=@^XFHW.>B /;],9E,484=*YG$?/)+U$@QM@< P>94(Y M"8#BT27<9TOBIW!+U/ 4Y#;4?;U-ZFGR@'G/-$P#-!/3#5$A=^1^6%BBH1K MT[;(O9SQ4]GAA;H,XE?6LJ[]T& V;@#U^('AN(H_UM"EEE1$].%B\+*S]M U MTC/5+B81N1$]N#'%F^M%<,XB6H"& IJ(DJ&&G^[#/OJ=\ L!'$3CA[X8"?%5 $FS:@'UE/9#EF M$$^W H^97P(H8OGU"*2]$0*(C6:E0WAI1SJ3*6^S_;0;_XQ,"3,&>11C@+JL'<4I;ZF+1IF_"+!XD\\Z<@"M;C] =NHV:+9:(Y E$]7 M((C_ WJ!44R(;J"%,U]E]C0CA5FPN.C9T.RHFF(R_0-X?F=[ZJ\YF:1]55)J M.&094%8N1661VB<[T]?45*"W7C$T_J5]/[O/2GN)96Q<_;HG"Q"[)4%?EQ*R]+;WL'_^\9Q,O>:,#H6!+45:)X4C)9GE$ T'80) MV,:&%T^W.NB.:0>OSZV4H.".!7"V6@,_USB8[@JWVB71+L+QKO#:EOQ KO;3_B.X.)4 MV]!J8:5+] LSP:)/BJ=:HG0$48IP4P)MAF@S:#.[=,: M!\D&E+!]K+%>:TR/9!5R'Y&LU4>R"KF/2-9Z$I+0E"-2@M8WG.5V6;JASD!G MO#/0051G(!)!(@5C_.G,R-/%E-LSK30(@O[JEH'"ET);Q(=$WR7+TR6#)0=- M;"!FHMS.C!:NB:2:H$\M^#NOF1-/^_";I_%DYJA.3F^3\)Z R??1S)>/W:T^QVVC(;\_W["Z=\)Q5[$ M>E&;G42(X2-$[#=BG7%&/QMHEPF_2MK@0U:5!IC>P3F+;X,.;T1IA;0A^-<: MHDGJA_S[3SCDQTVF3>U1E6AFN_&Y4*QEQ?^^Q$:M2Z6_IYX*;:D8L'I])V.L MF7STVQ-?4<)KF;S:N%T8C4M)5TFPC##:W.$^L;!)AA?)C_ !=@0[Z*3;N3$: M_ #[DL'N#B;Y /LF8OLBXNA^=)!YE%;*%]S#.!>5-!K8" NVY9YKTLTEA7T4 MSA:RI6)MTH-1+US29JJ%[>K81;[17@H[V5PQMR:;J5:V*S,"9KG:4T+U:!][ M@#=5[D'"<)QNL02JX4)L*BU&%'$-E4H^D6*;= OOZ.CY[7(RI7X#SUXIC3'( M/^7H^0B&/,?95R [8SC0C>%V68L6J^_P3HK%;&YGYT_%R&IIN_#'F85&"34NUT_3SI>/;6^0R$QIR^6RY6)[/=9A\ MKW\") OE[=JJ'P ,@6,3*Q)KJ=CYIIA17#;-6(]?_^RW#+9 M:FY=G ]14O>-ME+,EO-CFN\;[65G9K"LUB4#^@33F0G6#XV:D&2EJ^HJ-8=3 M11YZP!NS)""5LOGB&/]\-Q>V1#S.CRLZ;T;>X_;4FS/<& E8[QJPT'!3_(D1 M2/"GV'*Y=$RY=WGV/_K:2YMLP7-OH^C*'J$M_DD:?S6[4TT6+ODPG2:[1:K; M.Q_&? J K&2KM61^\P] OA5&+D&WG)^='^O4U(OZF1F!^I@_[\;!\*[,F:K^ M03HC4O&#EZ?#@K*E8O4#D"E0]M(B!:MV=_'.)RKGV9^%ZOWEGR6[3Z8_N$)? MSL=FTMS,2@(+QU@Q@>U"5^.0_5P>L\G&W_9EV9O(;><3^!R7OHW\>+;VFP C MB5_ZRULPU1AY%\UILUCY^XY]4Y_G]<>'CDJ=_U.3]A3!ELT]S M#:G9FV!(MOR:(/ S\9K2=5U$N_5R8^G$::[ZML>K1O@V-N=T^6QQO')OI.UN:GNE/+UYV2&EC0%I.P# _ M(#H+1&OC'0D^ +H0U23U3_QSCST)_,H9AJG^DX?1%GSC$39QLX<,R, MF - D]VP@_KH=+L-:*6^Y+B<'U;&EDGL 2B+A7TN7,V^-S.9T+!$7/&AT)790ZOV5S^9R>=13_J(*ZCFT M-T_HY8OEJ4(/311//5/'[9), Z>P(W&J- .KBSN6O7EI.,W6-!P;AS5:MM%\ MZH!YC..PFL%"W36=*$UX.!JM$='=&QZMV03TN^E,BE*3[OT7!7?H/O\JYVJ9 M,,I)A')6-++AKQ"5LCA&!,?0T12S#5!:$'"LU>(G"@!-HBEZ(]X# :!(OP%! MN)A#0ZP9&$U3Q'(05V4,4J8F@SWENP\L,%,0:X:X .T EO.)W1W1AJ/;5)MUT1J3;1QKCL0,^\=IB*AGP 'Q0T6U M@#O :K*"H*&9FF2?P>(N>8^\V-\",!&3M32 H)5!1A%\>:NE-G%H1]T@+98YA68)@1@I[0!5?KJJ]HR+G !T+#B4B6]!E' M0!H62.,O_%H?@0M:BDJ"3-8RXG?N\UG@AC+A KY%8VW5XK,WLX(X@UR6OY"[ M(,B*',5O0K&L.#J- NW+FB.$+ YXD@%C<( CLVV-ID>B;Q#7E>& G@.D0PJ% MZ@\DM3W^0;:K!AC-G1ZT!H>(01--'1W@9[1U, /X@1J@M+14VQHE;7P("UIS/V:G\%EA;Y^PD>VPF<#R6C"Y6X '1P' M):_+7!W+XASEW XY7,N)/"?-!R4#]8,C-DZ]"9W72.J$4M>4Q7KK3R_IRK( M!,4=#[PG]U1,&[YB..2ZF:IJES+ IH[2#8R0E9%;H?D0&+WZ/Q;0N3@["AFP MJ;OD.44: ^N91B8#4K7)*D'"E*T.?M!R %#XD-?# N?!]9G%_Z1YMASOD.LB MYU9ME8TQ"-1#+#[N'LP< _FQBZV9GF&IG$7BVX"^B?>1)M)@3!<,DKO^\$C= MD6'8P$$TC1$3>5'! @)2ZAH*%_SN6&Q\KYL;[DY/]LP;SH8S[EX;3%-9GPG] M!T].H&@!OPW7?:-NVS>T/AX=WJ6H?!PWPA9DAJRCS"'(\I/1>[P_4#L!?DYZ MTXNJ:=[D7S'XMZ\J..D7%2(5;]6[/JZLXZ\,\XF6%FBL,Z:@O!#_- 56PQ_P M2Y/S [Z3MFF\ *C YK15$G^6ZRL''[LN@'J+T!KIAW!:X M\I!DCR/)H4 +!", -F08?+88Y_)2-2OMLX;]A6:-XX(X#1R%I(J2GZ,[&1LN M,1,>\S7J;3! O GQ8A*X.W\9_5*P"NTS.._1QQ-A93A-X(I^A,6Q<"BY%:)Z M\EN IL,F(+)C^=OU5P2]^57UF8]-@ZJ5ONSYU?LRB'T'F0]&9AR=> N"C>0_ M?$E6AB&A *29\6(B.W -L?>6HR&_$WR-DXL@0Z.!LS!5GQ#$UCWR)V M2Y<:1&!A" 8<5T*8X2T'P/O9MP?(A 3H @.TB,F:\HL_3CW+)\%G<1"[@\:$ MXQH:.#'>-M6&PX484(,BYJV#N#"$I "T1J^YY1HG'&D\&1K0F(&ZB20 T[\@ M/KXPH"G4G]W M"G!4>* G#_BOQMDM78C"P"0WF3+J%O,?SN>R(UY!U(J(H.LZR$S4*9%C :IF M#@U8-9_;.OFRH7>RR:LE".T5/D)[;Q#:*WR$]M:=N-SA[,N8I@ZOW4,!< AF M6K*-[I0/";8*"- MYJG_MV'^Y^M;#U5/=DJ>9NNCI'3)K4%%VAU(GV_1OWFL^_V84KV)U"<8K^EH M]F6<A<4LJ5* M@OD3<[:,2K2%?+9:&2O!?:-6"9%7?Q'KC(V I7^AL.M8[ M(BE!C1"S'.-)(LY3DS&"\234IF*\GZ&J![;G)I>1J8RN<1VL9#9S9Y1H^(;V?P3BA M6&!O9"\4+(C+N0*;Y-ATPF@ NF *RLB[5NQQS M$%6N&"5)*M(I7"NQJ&O,WT06Y>0F83\->52[2-$9(1JDZ7'/)B$PIRVE8JJ*"8N6E.(73 M+81>2"%:8)%=S'7BN4=VAV>(RM)?9:FK:AIE67K)0K#I!J/(I$I4Z9.!J@-8 M-(T3 "6INF3!0\>B7S1P<-@T?R,\U<*T5LP8IR7]3"74RO![D;W@]'B-;%=^ M5;L._3*PO<\!"(;S6#)N'HL'2JIE$>7PN%M,\7!EC&Y0_@E[;3*L9_&6X&#$ M30,7(MF%;FTWX<@'#Z!-W6D#0DGY&G&72E9R=*SLS< 9-14!+%Z"V1N37CJ6 MM>4+0DOZ[@!XBCE:HNPN(44L\?ZILAZ1?I0=R?/JR'!5.5"D;,! 4D@RB?*: ML&0$%,%:.?C30$J4CB%TX.EH]%*7:$*[?!G_X^@R'^K' E%X7T2U&)!>YB:\ M24K!"J1?88)$R\%DB6#6UKQ)69MPV9HVJ?X_D@WJ9/1[K MHI13I%*4@&,HDPFC3'3B'&HLU>WB#BSF]= G8<-_0]H*<5-0TTWDB]O2J=IB M+S+1O:Q9AIM/PHL+X',YP(4='965#+%/0$+<0&Z[D/L;]ST1H]P,'TS>>G1T M7@+G9<.IEN50.A^\#[%98S:L9_D<.DL-#&S11X%_E@EN8 .0&E)^Z!*9@K35:,6Y0HNU;"LMV? M*[)9KQ@2I51O-E&7P.-?FH8.?PNOTV88K\>1%VWRL\O^V7LC9\]0U;R($;AE M7 6RI?)YD A.%]9&;[MT'4AM#H(2L+&)=N;[AR"@RAY8\2@IHDY(^M$!/(O) MUAN"-'709:VFJ?8BRF?^Q\)B 0X.'W\RO2 XF L.9']84<$+N='U#JPHG&0L M>4G&7@4ZM=#B7I)]0-5N _1'P?^X]QPL(RI?U@TOR=TMQ_3+"T?U]8A=2W&[ M#G0]FM0HX#UA-_?3I9W)B'D\DJK\[Z?G_$,NCQ_^!S_Z>GQS<";!5?VXK9_? M'-_4;X[O#J3Z^3Y^<.K^>__X>N_TXOKVZN!:JN]>W-Y(9_6KDX,;Z>KX^F1[ M,T@).&= TJ]I16O47>9'[Q+4CKV+\YNKB]-KNL?+JXN]@WV\NC0O:F4<_<"O M1@?VMJ]:3VPEHN1___[5WK<^(X$O_.7Z&B:J\F6X1@'IDAETD5#Y-XBH$L MD'E]H0P6P1<_4G[LP/[UIY;D%YB$''8P'%M3M4!L2=UJM;I;W3\-7$!F%"KR MN5#[@%D85:@I_!O?.W@D'#2MN. '^0V&&R#4*]5(I#;\@!>-.:,%K3E:7HZA MF@I'"SZAV#5BZ 21D GVB&+C!1O7PNQ81$L(1KN8[8R-$R^@)7O[2*J?P!LP]'HE 7\^5\MRCYZH&D& MA9!AAE'[PAL+F3==M>$ ->='K<16$+2B\"" 5Q!F!P2(IE-7=[DAS^ *=-<@ M2HG#C>A^!78A!#)!78NYBF=D &1 %&NBSU%.O.Y;8M_KGKH+[/G !UE[OM,/ M#=<&Y6B9SV0#AR)(".9#!CEE&J1_$&[9M-0M;+ORR0UDM8B""O("V?\?,3VS MH*X6I4'LLYKY3K^ ,%OZF*-+>) =!J\5C3,=-JP*%%H5U%-CJY?:"+G 76MZ M"!]$)&RO>WJDOC(V6HY,6$^')COTSUMT30VA 'ID\T@.7W6!+1X@BM! *7BS M7&FS0Z1 ])B%263F.$P)9O8&1<+$]@W!J\3(;4[U�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end XML 75 lifeway_i10q-033124_htm.xml IDEA: XBRL DOCUMENT 0000814586 2024-01-01 2024-03-31 0000814586 2024-05-06 0000814586 2024-03-31 0000814586 2023-12-31 0000814586 2023-01-01 2023-03-31 0000814586 us-gaap:CommonStockMember 2022-12-31 0000814586 us-gaap:TreasuryStockCommonMember 2022-12-31 0000814586 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000814586 us-gaap:RetainedEarningsMember 2022-12-31 0000814586 2022-12-31 0000814586 us-gaap:CommonStockMember 2023-12-31 0000814586 us-gaap:TreasuryStockCommonMember 2023-12-31 0000814586 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000814586 us-gaap:RetainedEarningsMember 2023-12-31 0000814586 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000814586 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0000814586 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000814586 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000814586 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000814586 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0000814586 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000814586 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000814586 us-gaap:CommonStockMember 2023-03-31 0000814586 us-gaap:TreasuryStockCommonMember 2023-03-31 0000814586 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000814586 us-gaap:RetainedEarningsMember 2023-03-31 0000814586 2023-03-31 0000814586 us-gaap:CommonStockMember 2024-03-31 0000814586 us-gaap:TreasuryStockCommonMember 2024-03-31 0000814586 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000814586 us-gaap:RetainedEarningsMember 2024-03-31 0000814586 us-gaap:LandMember 2024-03-31 0000814586 us-gaap:LandMember 2023-12-31 0000814586 us-gaap:BuildingAndBuildingImprovementsMember 2024-03-31 0000814586 us-gaap:BuildingAndBuildingImprovementsMember 2023-12-31 0000814586 us-gaap:MachineryAndEquipmentMember 2024-03-31 0000814586 us-gaap:MachineryAndEquipmentMember 2023-12-31 0000814586 us-gaap:VehiclesMember 2024-03-31 0000814586 us-gaap:VehiclesMember 2023-12-31 0000814586 us-gaap:OfficeEquipmentMember 2024-03-31 0000814586 us-gaap:OfficeEquipmentMember 2023-12-31 0000814586 us-gaap:ConstructionInProgressMember 2024-03-31 0000814586 us-gaap:ConstructionInProgressMember 2023-12-31 0000814586 LWAY:RecipesMember 2024-03-31 0000814586 LWAY:RecipesMember 2023-12-31 0000814586 LWAY:CustomerListsAndOtherCustomerRelatedIntangiblesMember 2024-03-31 0000814586 LWAY:CustomerListsAndOtherCustomerRelatedIntangiblesMember 2023-12-31 0000814586 us-gaap:CustomerRelationshipsMember 2024-03-31 0000814586 us-gaap:CustomerRelationshipsMember 2023-12-31 0000814586 LWAY:BrandNamesMember 2024-03-31 0000814586 LWAY:BrandNamesMember 2023-12-31 0000814586 LWAY:FormulaMember 2024-03-31 0000814586 LWAY:FormulaMember 2023-12-31 0000814586 us-gaap:CustomerRelationshipsMember 2024-01-01 2024-03-31 0000814586 LWAY:BrandNamesMember 2024-01-01 2024-03-31 0000814586 LWAY:CreditAgreementTermLoanMember 2024-03-31 0000814586 us-gaap:RevolvingCreditFacilityMember 2024-03-31 0000814586 LWAY:IncrementalFacilityMember 2024-03-31 0000814586 LWAY:CreditAgreementTermLoanMember 2024-01-01 2024-03-31 0000814586 us-gaap:RevolvingCreditFacilityMember 2024-01-01 2024-03-31 0000814586 LWAY:CreditAgreementMember 2024-01-01 2024-03-31 0000814586 LWAY:Omnibus2015Member 2015-12-31 0000814586 LWAY:Omnibus2022PlanMember 2022-08-31 0000814586 LWAY:Omnibus2022PlanMember 2024-03-31 0000814586 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0000814586 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0000814586 us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 0000814586 LWAY:CEO2020AwardMember 2020-10-01 2020-12-31 0000814586 LWAY:CEO2020AwardMember 2024-01-01 2024-03-31 0000814586 LWAY:CEO2020AwardMember 2023-01-01 2023-03-31 0000814586 LWAY:CEO2020AwardMember 2024-03-31 0000814586 LWAY:Plan2021Member 2024-01-01 2024-03-31 0000814586 LWAY:Plan2021Member 2023-01-01 2023-03-31 0000814586 LWAY:Plan2021Member 2024-03-31 0000814586 LWAY:Plan2022Member 2024-01-01 2024-03-31 0000814586 LWAY:Plan2022Member 2023-01-01 2023-03-31 0000814586 LWAY:Plan2023Member 2024-01-01 2024-03-31 0000814586 LWAY:Plan2023Member 2023-01-01 2023-03-31 0000814586 LWAY:Plan2024Member 2024-01-01 2024-03-31 0000814586 LWAY:Plan2024Member 2023-01-01 2023-03-31 0000814586 LWAY:Director2022PlanMember 2024-03-31 0000814586 LWAY:DefinedContributionPlanMember 2024-01-01 2024-03-31 0000814586 LWAY:DefinedContributionPlanMember 2023-01-01 2023-03-31 0000814586 us-gaap:StockOptionMember 2023-12-31 0000814586 us-gaap:StockOptionMember 2023-01-01 2023-12-31 0000814586 us-gaap:StockOptionMember 2024-01-01 2024-03-31 0000814586 us-gaap:StockOptionMember 2024-03-31 0000814586 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0000814586 LWAY:DrinkableKefirotherthanProBugsMember 2024-01-01 2024-03-31 0000814586 LWAY:DrinkableKefirotherthanProBugsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000814586 LWAY:DrinkableKefirotherthanProBugsMember 2023-01-01 2023-03-31 0000814586 LWAY:DrinkableKefirotherthanProBugsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000814586 LWAY:CheeseMember 2024-01-01 2024-03-31 0000814586 LWAY:CheeseMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000814586 LWAY:CheeseMember 2023-01-01 2023-03-31 0000814586 LWAY:CheeseMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000814586 LWAY:CreamAndOtherMember 2024-01-01 2024-03-31 0000814586 LWAY:CreamAndOtherMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000814586 LWAY:CreamAndOtherMember 2023-01-01 2023-03-31 0000814586 LWAY:CreamAndOtherMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000814586 LWAY:DrinkableYogurtMember 2024-01-01 2024-03-31 0000814586 LWAY:DrinkableYogurtMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000814586 LWAY:DrinkableYogurtMember 2023-01-01 2023-03-31 0000814586 LWAY:DrinkableYogurtMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000814586 LWAY:ProBugsKefirMember 2024-01-01 2024-03-31 0000814586 LWAY:ProBugsKefirMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000814586 LWAY:ProBugsKefirMember 2023-01-01 2023-03-31 0000814586 LWAY:ProBugsKefirMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000814586 LWAY:OtherDairyMember 2024-01-01 2024-03-31 0000814586 LWAY:OtherDairyMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000814586 LWAY:OtherDairyMember 2023-01-01 2023-03-31 0000814586 LWAY:OtherDairyMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000814586 LWAY:NetSalesMember 2024-01-01 2024-03-31 0000814586 LWAY:NetSalesMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000814586 LWAY:NetSalesMember 2023-01-01 2023-03-31 0000814586 LWAY:NetSalesMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0000814586 LWAY:TwoCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0000814586 LWAY:TwoCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 iso4217:USD shares iso4217:USD shares pure false --12-31 Q1 2024 0000814586 10-Q true 2024-03-31 false 000-17363 LIFEWAY FOODS, INC. IL 36-3442829 6431 West Oakton Morton Grove IL 60053 847 967-1010 Common Stock, No Par Value LWAY NASDAQ Yes Yes Non-accelerated Filer true false false 14707392 12025000 13198000 1640000 1270000 15064000 13875000 8130000 9104000 1988000 2019000 378000 0 37585000 38196000 24627000 22764000 172000 192000 11704000 11704000 6763000 6898000 1900000 1900000 82751000 81654000 1250000 1250000 10024000 9976000 3604000 4916000 0 474000 14878000 16616000 1235000 1483000 102000 118000 3001000 3001000 19216000 21218000 0 0 2500000 2500000 0 0 0 0 0 0 0 0 40000000 40000000 17274000 17274000 14691000 14691000 6509000 6509000 5498000 4825000 16695000 16695000 68223000 65797000 63535000 60436000 82751000 81654000 44634000 37904000 32438000 29030000 661000 648000 33099000 29678000 11535000 8226000 3700000 3519000 4136000 3135000 135000 135000 7971000 6789000 3564000 1437000 51000 104000 -5000 5000 -56000 -99000 3508000 1338000 1082000 508000 2426000 830000 0.17 0.06 0.16 0.06 14691000 14645000 15222000 15030000 17274000 6509000 -2629000 -16993000 3624000 54430000 47570000 343000 343000 830000 830000 17274000 6509000 -2629000 -16993000 3967000 55260000 48743000 17274000 6509000 -2583000 -16695000 4825000 65797000 60436000 673000 673000 2426000 2426000 17274000 6509000 -2629000 -16695000 5498000 68223000 63535000 2426000 830000 796000 783000 673000 343000 2000 2000 1189000 572000 -974000 -339000 378000 -44000 -31000 -377000 -6000 1046000 -1309000 -581000 -474000 416000 1546000 3027000 2469000 1762000 -2469000 -1762000 250000 500000 -250000 -500000 -1173000 765000 13198000 4444000 12025000 5209000 1934000 47000 50000 130000 192000 122000 0 19000 <p id="xdx_809_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zMaslfuvNtt6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1 – <span id="xdx_825_ziiMuMJrXta7">Basis of Presentation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) for interim financial information, and do not include certain information and footnote disclosures required for complete, audited financial statements. In the opinion of management, these statements include all adjustments necessary for a fair presentation of the results of all interim periods reported herein. The consolidated financial statements and related notes should be read in conjunction with the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Results of operations for any interim period are not necessarily indicative of future or annual results.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84B_eus-gaap--ConsolidationPolicyTextBlock_zZXerjEIQYZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Principles of consolidation</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include the accounts of Lifeway Foods, Inc. and all its wholly owned subsidiaries (collectively “Lifeway” or the “Company”). All significant intercompany accounts and transactions have been eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84B_eus-gaap--ConsolidationPolicyTextBlock_zZXerjEIQYZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Principles of consolidation</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include the accounts of Lifeway Foods, Inc. and all its wholly owned subsidiaries (collectively “Lifeway” or the “Company”). All significant intercompany accounts and transactions have been eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_802_eus-gaap--SignificantAccountingPoliciesTextBlock_zbRusitHwjik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 2 – <span id="xdx_828_z5NuriffvkJg">Summary of Significant Accounting Policies</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our significant accounting policies, which are summarized in detail in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, have not materially changed. The following is a description of certain of our significant accounting policies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--UseOfEstimates_zXaVerF6DsHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86D_ztTl49SV0W34">Use of estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made in preparing the consolidated financial statements include the reserve for promotional allowances, the valuation of goodwill and intangible assets, stock-based and incentive compensation, and deferred income taxes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zjhpIKk4dfpf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86E_z27NEXuN2ju5">Cash and cash equivalents</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lifeway considers cash and all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents are stated at cost, which approximates or equals fair value due to their short-term nature.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lifeway from time to time may have bank deposits in excess of insurance limits of the Federal Deposit Insurance Corporation. The Company places its cash and cash equivalents with high credit quality financial institutions. Lifeway has not experienced any losses in such accounts and believes the financial risks associated with these financial instruments are minimal.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_847_eus-gaap--AdvertisingCostsPolicyTextBlock_zKsbHH98C307" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_861_zDx8MNWKYfjc">Advertising and promotional costs</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advertising costs are expensed as incurred and reported in Selling expense in the Company’s consolidated statement of operations. Total advertising expense was $<span id="xdx_90E_eus-gaap--AdvertisingExpense_pn3n3_c20240101__20240331_zHM7YSKwNukh" title="Advertising expense">1,372</span> and $<span id="xdx_90F_eus-gaap--AdvertisingExpense_pn3n3_c20230101__20230331_zoSjDrfwxUs" title="Advertising expense">1,463</span> for the three months ended March 31, 2024 and 2023, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zO4safKkDHae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_866_zPDMChS9Z9U2">Segments</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is managed as a single reportable segment. The Chief Executive Officer, who is the Company’s Chief Operating Decision Maker (“CODM”), reviews financial information on an aggregate basis for purposes of allocating resources and assessing financial performance, as well as for making strategic operational decisions and managing the organization. Substantially all of Lifeway’s consolidated revenues relate to the sale of cultured dairy products that it produces using the same processes and materials and are sold to consumers through a common network of distributors and retailers in the United States.  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zUfkfsyzQEB4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_863_zII9Iw2rila8">Recent accounting pronouncements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Issued but not yet effective</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07: Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The new guidance requires entities to report incremental information about significant segment expenses included in a segment’s profit or loss measure as well as the name and title of the chief operating decision maker. The guidance also requires interim disclosures related to reportable segment profit or loss and assets that had previously only been disclosed annually. The new standard is effective for our annual period ending December 31, 2024 and our interim periods during the fiscal year ending December 31, 2025. The guidance does not affect recognition or measurement in the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2023, the FASB issued ASU No. 2023-09: Income Taxes (Topic 740): Improvements to Income Tax Disclosures that requires entities to disclose additional information about federal, state, and foreign income taxes primarily related to the income tax rate reconciliation and income taxes paid. The new standard also eliminates certain existing disclosure requirements related to uncertain tax positions and unrecognized deferred tax liabilities. The guidance is effective for our fiscal year ending December 31, 2024. The guidance does not affect recognition or measurement in the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p id="xdx_84D_eus-gaap--UseOfEstimates_zXaVerF6DsHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86D_ztTl49SV0W34">Use of estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made in preparing the consolidated financial statements include the reserve for promotional allowances, the valuation of goodwill and intangible assets, stock-based and incentive compensation, and deferred income taxes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zjhpIKk4dfpf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86E_z27NEXuN2ju5">Cash and cash equivalents</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lifeway considers cash and all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents are stated at cost, which approximates or equals fair value due to their short-term nature.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lifeway from time to time may have bank deposits in excess of insurance limits of the Federal Deposit Insurance Corporation. The Company places its cash and cash equivalents with high credit quality financial institutions. Lifeway has not experienced any losses in such accounts and believes the financial risks associated with these financial instruments are minimal.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_847_eus-gaap--AdvertisingCostsPolicyTextBlock_zKsbHH98C307" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_861_zDx8MNWKYfjc">Advertising and promotional costs</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advertising costs are expensed as incurred and reported in Selling expense in the Company’s consolidated statement of operations. Total advertising expense was $<span id="xdx_90E_eus-gaap--AdvertisingExpense_pn3n3_c20240101__20240331_zHM7YSKwNukh" title="Advertising expense">1,372</span> and $<span id="xdx_90F_eus-gaap--AdvertisingExpense_pn3n3_c20230101__20230331_zoSjDrfwxUs" title="Advertising expense">1,463</span> for the three months ended March 31, 2024 and 2023, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 1372000 1463000 <p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zO4safKkDHae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_866_zPDMChS9Z9U2">Segments</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is managed as a single reportable segment. The Chief Executive Officer, who is the Company’s Chief Operating Decision Maker (“CODM”), reviews financial information on an aggregate basis for purposes of allocating resources and assessing financial performance, as well as for making strategic operational decisions and managing the organization. Substantially all of Lifeway’s consolidated revenues relate to the sale of cultured dairy products that it produces using the same processes and materials and are sold to consumers through a common network of distributors and retailers in the United States.  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zUfkfsyzQEB4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_863_zII9Iw2rila8">Recent accounting pronouncements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Issued but not yet effective</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07: Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The new guidance requires entities to report incremental information about significant segment expenses included in a segment’s profit or loss measure as well as the name and title of the chief operating decision maker. The guidance also requires interim disclosures related to reportable segment profit or loss and assets that had previously only been disclosed annually. The new standard is effective for our annual period ending December 31, 2024 and our interim periods during the fiscal year ending December 31, 2025. The guidance does not affect recognition or measurement in the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2023, the FASB issued ASU No. 2023-09: Income Taxes (Topic 740): Improvements to Income Tax Disclosures that requires entities to disclose additional information about federal, state, and foreign income taxes primarily related to the income tax rate reconciliation and income taxes paid. The new standard also eliminates certain existing disclosure requirements related to uncertain tax positions and unrecognized deferred tax liabilities. The guidance is effective for our fiscal year ending December 31, 2024. The guidance does not affect recognition or measurement in the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p id="xdx_809_eus-gaap--InventoryDisclosureTextBlock_zVibR0aCP15i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 3 – <span id="xdx_82D_zemAf2YM31Qk">Inventories, net</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Inventories consisted of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zht8dmiqQ00f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventories, net (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B5_zJbuGRJpLos1" style="display: none"> Schedule of inventories</span></td><td> </td> <td colspan="2" id="xdx_497_20240331_z8uZxMMxf4e" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49D_20231231_znavwoMUX625" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_pn3n3_maINz2FW_zZZDt7Pb1bH2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%">Ingredients</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,411</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,929</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventorySuppliesNetOfReserves_iI_pn3n3_maINz2FW_zJTdtHh8ycta" style="vertical-align: bottom; background-color: White"> <td>Packaging</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,640</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,014</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_pn3n3_maINz2FW_zevjyA6xw4d8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,079</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,161</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--InventoryNet_iTI_pn3n3_mtINz2FW_zPFyFnvCkLki" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventories, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,130</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,104</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zht8dmiqQ00f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventories, net (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B5_zJbuGRJpLos1" style="display: none"> Schedule of inventories</span></td><td> </td> <td colspan="2" id="xdx_497_20240331_z8uZxMMxf4e" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49D_20231231_znavwoMUX625" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_pn3n3_maINz2FW_zZZDt7Pb1bH2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%">Ingredients</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,411</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,929</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventorySuppliesNetOfReserves_iI_pn3n3_maINz2FW_zJTdtHh8ycta" style="vertical-align: bottom; background-color: White"> <td>Packaging</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,640</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,014</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_pn3n3_maINz2FW_zevjyA6xw4d8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,079</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,161</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--InventoryNet_iTI_pn3n3_mtINz2FW_zPFyFnvCkLki" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventories, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,130</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,104</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2411000 2929000 2640000 3014000 3079000 3161000 8130000 9104000 <p id="xdx_803_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z70nr5QrmnDh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 4 – <span id="xdx_821_zFp1DHgxRXCd">Property, Plant and Equipment, net</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Property, plant and equipment consisted of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_pn3n3_zlrwWzMiX8lf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property, Plant and Equipment, net (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B9_zqBjfYLbyjn8" style="display: none"> Schedule of property, plant and equipment</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%">Land</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zaQ786tLVy89" style="width: 13%; text-align: right" title="Property and equipment, gross">1,565</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_pn3n3_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zEPDrSmhTifd" style="width: 13%; text-align: right" title="Property and equipment, gross">1,565</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Buildings and improvements</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingAndBuildingImprovementsMember_zMK8UttjAyVi" style="text-align: right" title="Property and equipment, gross">21,855</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_pn3n3_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingAndBuildingImprovementsMember_zjjDa4co4ZBc" style="text-align: right" title="Property and equipment, gross">21,661</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Machinery and equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zsTWfvfY2Ure" style="text-align: right" title="Property and equipment, gross">33,890</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_pn3n3_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zZWKIGNbfI48" style="text-align: right" title="Property and equipment, gross">33,573</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Vehicles</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zzPmNnN7XEt" style="text-align: right" title="Property and equipment, gross">705</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_pn3n3_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z992W0VxrYPd" style="text-align: right" title="Property and equipment, gross">705</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zUSFhdiEMQB6" style="text-align: right" title="Property and equipment, gross">1,072</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_pn3n3_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zWXkGh129la6" style="text-align: right" title="Property and equipment, gross">1,072</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Construction in process</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_zW4PK6QbHuN5" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">4,107</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_pn3n3_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_z7PXNNefE7Q3" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">2,154</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240331_zSugYfjRs1fg" style="text-align: right" title="Property and equipment, gross">63,194</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_pn3n3_c20231231_zQQKjN24oVUf" style="text-align: right" title="Property and equipment, gross">60,730</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20240331_zBBv86sYfXej" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation">(38,567</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20231231_zthbRgoXkZi3" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation">(37,966</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total property, plant and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240331_zBT9dLJ3PdXh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total property, plant and equipment, net">24,627</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_pn3n3_c20231231_zcYOX3XEw1k3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total property, plant and equipment, net">22,764</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_pn3n3_zlrwWzMiX8lf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property, Plant and Equipment, net (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B9_zqBjfYLbyjn8" style="display: none"> Schedule of property, plant and equipment</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%">Land</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zaQ786tLVy89" style="width: 13%; text-align: right" title="Property and equipment, gross">1,565</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_pn3n3_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zEPDrSmhTifd" style="width: 13%; text-align: right" title="Property and equipment, gross">1,565</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Buildings and improvements</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingAndBuildingImprovementsMember_zMK8UttjAyVi" style="text-align: right" title="Property and equipment, gross">21,855</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_pn3n3_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingAndBuildingImprovementsMember_zjjDa4co4ZBc" style="text-align: right" title="Property and equipment, gross">21,661</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Machinery and equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zsTWfvfY2Ure" style="text-align: right" title="Property and equipment, gross">33,890</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_pn3n3_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zZWKIGNbfI48" style="text-align: right" title="Property and equipment, gross">33,573</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Vehicles</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zzPmNnN7XEt" style="text-align: right" title="Property and equipment, gross">705</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_pn3n3_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z992W0VxrYPd" style="text-align: right" title="Property and equipment, gross">705</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zUSFhdiEMQB6" style="text-align: right" title="Property and equipment, gross">1,072</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_pn3n3_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zWXkGh129la6" style="text-align: right" title="Property and equipment, gross">1,072</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Construction in process</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_zW4PK6QbHuN5" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">4,107</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_pn3n3_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_z7PXNNefE7Q3" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">2,154</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20240331_zSugYfjRs1fg" style="text-align: right" title="Property and equipment, gross">63,194</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_pn3n3_c20231231_zQQKjN24oVUf" style="text-align: right" title="Property and equipment, gross">60,730</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20240331_zBBv86sYfXej" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation">(38,567</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20231231_zthbRgoXkZi3" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation">(37,966</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total property, plant and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240331_zBT9dLJ3PdXh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total property, plant and equipment, net">24,627</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_pn3n3_c20231231_zcYOX3XEw1k3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total property, plant and equipment, net">22,764</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1565000 1565000 21855000 21661000 33890000 33573000 705000 705000 1072000 1072000 4107000 2154000 63194000 60730000 38567000 37966000 24627000 22764000 <p id="xdx_80D_eus-gaap--GoodwillAndIntangibleAssetsDisclosureTextBlock_zw7C2lI5VBJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 5 – <span id="xdx_829_ztrkl13HIvJd">Goodwill and Intangible Assets</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Goodwill</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Goodwill consisted of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfGoodwillTextBlock_pn3n3_zxUAU4NFcKOe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details - Goodwill)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BD_zBPk3Mr6N6t5" style="display: none"> Schedule of goodwill</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-decoration: underline">Balance at December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 84%">Goodwill</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--GoodwillGross_iI_pn3n3_c20231231_zMpNpi2kLhNj" style="width: 13%; text-align: right" title="Goodwill before impairment">12,948</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accumulated impairment losses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--GoodwillImpairedAccumulatedImpairmentLoss_iNI_pn3n3_di_c20231231_zjhbNeAfGDFg" style="border-bottom: Black 1pt solid; text-align: right" title="Goodwill, impaired, accumulated impairment loss">(1,244</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Goodwill_pn3n3_c20231231_zzoH42S5nSX3" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill">11,704</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="margin: 0"> </p> <p style="margin: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-decoration: underline; width: 84%">Balance at March 31, 2024</td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 13%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Goodwill</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--GoodwillGross_iI_pn3n3_c20240331_zVAxYUc7P4I5" style="text-align: right" title="Goodwill before impairment">12,948</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accumulated impairment losses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--GoodwillImpairedAccumulatedImpairmentLoss_iNI_pn3n3_di_c20240331_z2AlP7P6YJRf" style="border-bottom: Black 1pt solid; text-align: right" title="Goodwill, impaired, accumulated impairment loss">(1,244</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--Goodwill_iI_pn3n3_c20240331_z1uGOV7ZwMZ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill">11,704</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zln1eCJfkobh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Intangible Assets</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other intangible assets, net consisted of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zPhcSR3QiBN8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details - Finite lived)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B1_zXsjjj60ZyIb" style="display: none"> Schedule of finite-lived intangible assets</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2024</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">Gross</td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Net</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Gross</td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Net</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">Carrying</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Accumulated</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Carrying</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Carrying</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Accumulated</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Carrying</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amortization</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amortization</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 34%">Recipes</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RecipesMember_z3Ll4WFbf06f" style="width: 8%; text-align: right" title="Gross Carrying Amount">44</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RecipesMember_zdWxpXR3wnG4" style="width: 8%; text-align: right" title="Accumulated Amortization">(44</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RecipesMember_zzz9Fm1HkUgh" style="width: 8%; text-align: right" title="Net Carrying Amount">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RecipesMember_z8ES5iAv7IZ" style="width: 8%; text-align: right" title="Gross Carrying Amount">44</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RecipesMember_zE6a8Z6UgmW6" style="width: 8%; text-align: right" title="Accumulated Amortization">(44</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RecipesMember_zgHrjCS7rkYb" style="width: 8%; text-align: right" title="Net Carrying Amount">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Customer lists and other customer related intangibles</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerListsAndOtherCustomerRelatedIntangiblesMember_zwHEHV2hj4b7" style="text-align: right" title="Gross Carrying Amount">4,529</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerListsAndOtherCustomerRelatedIntangiblesMember_zw88loD94Ow" style="text-align: right" title="Accumulated Amortization">(4,529</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerListsAndOtherCustomerRelatedIntangiblesMember_zLcchwkUyXYj" style="text-align: right" title="Net Carrying Amount">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerListsAndOtherCustomerRelatedIntangiblesMember_zIISTiCBqp5" style="text-align: right" title="Gross Carrying Amount">4,529</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerListsAndOtherCustomerRelatedIntangiblesMember_z3lM3nr8XI8f" style="text-align: right" title="Accumulated Amortization">(4,529</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerListsAndOtherCustomerRelatedIntangiblesMember_znSBWbBnCxr8" style="text-align: right" title="Net Carrying Amount">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Customer relationships</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zm6qkvqQ4cDj" style="text-align: right" title="Gross Carrying Amount">3,385</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zySXRCQynlH1" style="text-align: right" title="Accumulated Amortization">(1,412</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zhkiELdN8Pm5" style="text-align: right" title="Net Carrying Amount">1,973</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z9gYZ3IVJPEb" style="text-align: right" title="Gross Carrying Amount">3,385</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zODwvNNY0Pb2" style="text-align: right" title="Accumulated Amortization">(1,372</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zy0Aej976fze" style="text-align: right" title="Net Carrying Amount">2,013</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Brand names</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zK305qkfK20e" style="text-align: right" title="Gross Carrying Amount">7,948</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_z2WdwT1nUcj" style="text-align: right" title="Accumulated Amortization">(3,158</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zDUpQi3rOmhj" style="text-align: right" title="Net Carrying Amount">4,790</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_z8ro5ntyAFOk" style="text-align: right" title="Gross Carrying Amount">7,948</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zlDVdxJdlITh" style="text-align: right" title="Accumulated Amortization">(3,063</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_z5L6PZWZTqUh" style="text-align: right" title="Net Carrying Amount">4,885</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Formula</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaMember_zq94liM2xPZi" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount">438</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaMember_ze1bHtqyAs1c" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Amortization">(438</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaMember_z6G8yckROWJa" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaMember_zlkb4DlvOtMf" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount">438</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaMember_z9wj3tfTJEW3" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Amortization">(438</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaMember_zyP7fqmj04Eb" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20240331_z8UVVA6xHVKj" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount">16,344</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20240331_z11yod8S4ED6" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Amortization">(9,581</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_pn3n3_c20240331_zZrdJ09ktJmc" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount">6,763</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20231231_znxPlkXwBZhg" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount">16,344</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20231231_za0DHkNN87pj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Amortization">(9,446</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_pn3n3_c20231231_zERq1xH9wJR4" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount">6,898</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Estimated amortization expense on intangible assets for the next five years is as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_pn3n3_zj0PQKHqFrif" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details - Amortization expense on intangible assets)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B0_zAeYkbdyojX1" style="display: none"> Schedule of estimated amortization expense on intangible assets</span></td><td> </td> <td colspan="2" id="xdx_49E_20240331_zPRLOhfRb06k" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid">Year</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amortization</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 84%">Nine months ended December 31, 2024</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">405</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">540</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">540</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">540</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">540</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The weighted-average remaining amortization expense period for the customer relationship and brand name intangible assets is <span id="xdx_90E_ecustom--AmortizationOfLeaseExpenseOutstandingWeightedAverageRemainingContractualTerm_dtY_c20240101__20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zhhCKeeGRTXi" title="Weighted average remaining contractual term">12.3</span> and <span id="xdx_907_ecustom--AmortizationOfLeaseExpenseOutstandingWeightedAverageRemainingContractualTerm_dtY_c20240101__20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zELvCYw5j8y6" title="Weighted average remaining contractual term">12.6</span> years, respectively, as of March 31, 2024. The weighted-average remaining amortization expense period for total intangible assets is <span id="xdx_90A_ecustom--AmortizationOfLeaseExpenseOutstandingWeightedAverageRemainingContractualTerm_dtY_c20240101__20240331_zXHO2hDKIyrf" title="Weighted average remaining contractual term">12.5</span> years as of March 31, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>  </b></p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfGoodwillTextBlock_pn3n3_zxUAU4NFcKOe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details - Goodwill)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BD_zBPk3Mr6N6t5" style="display: none"> Schedule of goodwill</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-decoration: underline">Balance at December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 84%">Goodwill</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--GoodwillGross_iI_pn3n3_c20231231_zMpNpi2kLhNj" style="width: 13%; text-align: right" title="Goodwill before impairment">12,948</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accumulated impairment losses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--GoodwillImpairedAccumulatedImpairmentLoss_iNI_pn3n3_di_c20231231_zjhbNeAfGDFg" style="border-bottom: Black 1pt solid; text-align: right" title="Goodwill, impaired, accumulated impairment loss">(1,244</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Goodwill_pn3n3_c20231231_zzoH42S5nSX3" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill">11,704</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="margin: 0"> </p> <p style="margin: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-decoration: underline; width: 84%">Balance at March 31, 2024</td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 13%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Goodwill</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--GoodwillGross_iI_pn3n3_c20240331_zVAxYUc7P4I5" style="text-align: right" title="Goodwill before impairment">12,948</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accumulated impairment losses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--GoodwillImpairedAccumulatedImpairmentLoss_iNI_pn3n3_di_c20240331_z2AlP7P6YJRf" style="border-bottom: Black 1pt solid; text-align: right" title="Goodwill, impaired, accumulated impairment loss">(1,244</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--Goodwill_iI_pn3n3_c20240331_z1uGOV7ZwMZ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill">11,704</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 12948000 1244000 11704000 12948000 1244000 11704000 <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zPhcSR3QiBN8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details - Finite lived)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B1_zXsjjj60ZyIb" style="display: none"> Schedule of finite-lived intangible assets</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2024</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">Gross</td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Net</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Gross</td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Net</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">Carrying</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Accumulated</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Carrying</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Carrying</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Accumulated</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Carrying</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amortization</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amortization</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 34%">Recipes</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RecipesMember_z3Ll4WFbf06f" style="width: 8%; text-align: right" title="Gross Carrying Amount">44</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RecipesMember_zdWxpXR3wnG4" style="width: 8%; text-align: right" title="Accumulated Amortization">(44</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RecipesMember_zzz9Fm1HkUgh" style="width: 8%; text-align: right" title="Net Carrying Amount">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RecipesMember_z8ES5iAv7IZ" style="width: 8%; text-align: right" title="Gross Carrying Amount">44</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RecipesMember_zE6a8Z6UgmW6" style="width: 8%; text-align: right" title="Accumulated Amortization">(44</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RecipesMember_zgHrjCS7rkYb" style="width: 8%; text-align: right" title="Net Carrying Amount">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Customer lists and other customer related intangibles</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerListsAndOtherCustomerRelatedIntangiblesMember_zwHEHV2hj4b7" style="text-align: right" title="Gross Carrying Amount">4,529</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerListsAndOtherCustomerRelatedIntangiblesMember_zw88loD94Ow" style="text-align: right" title="Accumulated Amortization">(4,529</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerListsAndOtherCustomerRelatedIntangiblesMember_zLcchwkUyXYj" style="text-align: right" title="Net Carrying Amount">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerListsAndOtherCustomerRelatedIntangiblesMember_zIISTiCBqp5" style="text-align: right" title="Gross Carrying Amount">4,529</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerListsAndOtherCustomerRelatedIntangiblesMember_z3lM3nr8XI8f" style="text-align: right" title="Accumulated Amortization">(4,529</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CustomerListsAndOtherCustomerRelatedIntangiblesMember_znSBWbBnCxr8" style="text-align: right" title="Net Carrying Amount">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Customer relationships</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zm6qkvqQ4cDj" style="text-align: right" title="Gross Carrying Amount">3,385</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zySXRCQynlH1" style="text-align: right" title="Accumulated Amortization">(1,412</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zhkiELdN8Pm5" style="text-align: right" title="Net Carrying Amount">1,973</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z9gYZ3IVJPEb" style="text-align: right" title="Gross Carrying Amount">3,385</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zODwvNNY0Pb2" style="text-align: right" title="Accumulated Amortization">(1,372</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zy0Aej976fze" style="text-align: right" title="Net Carrying Amount">2,013</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Brand names</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zK305qkfK20e" style="text-align: right" title="Gross Carrying Amount">7,948</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_z2WdwT1nUcj" style="text-align: right" title="Accumulated Amortization">(3,158</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zDUpQi3rOmhj" style="text-align: right" title="Net Carrying Amount">4,790</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_z8ro5ntyAFOk" style="text-align: right" title="Gross Carrying Amount">7,948</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zlDVdxJdlITh" style="text-align: right" title="Accumulated Amortization">(3,063</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_z5L6PZWZTqUh" style="text-align: right" title="Net Carrying Amount">4,885</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Formula</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaMember_zq94liM2xPZi" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount">438</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaMember_ze1bHtqyAs1c" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Amortization">(438</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaMember_z6G8yckROWJa" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaMember_zlkb4DlvOtMf" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount">438</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaMember_z9wj3tfTJEW3" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Amortization">(438</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pn3n3_d0_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--FormulaMember_zyP7fqmj04Eb" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20240331_z8UVVA6xHVKj" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount">16,344</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20240331_z11yod8S4ED6" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Amortization">(9,581</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_pn3n3_c20240331_zZrdJ09ktJmc" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount">6,763</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_pn3n3_c20231231_znxPlkXwBZhg" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount">16,344</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_pn3n3_c20231231_za0DHkNN87pj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Amortization">(9,446</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_pn3n3_c20231231_zERq1xH9wJR4" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount">6,898</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 44000 -44000 0 44000 -44000 0 4529000 -4529000 0 4529000 -4529000 0 3385000 -1412000 1973000 3385000 -1372000 2013000 7948000 -3158000 4790000 7948000 -3063000 4885000 438000 -438000 0 438000 -438000 0 16344000 -9581000 6763000 16344000 -9446000 6898000 <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_pn3n3_zj0PQKHqFrif" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details - Amortization expense on intangible assets)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B0_zAeYkbdyojX1" style="display: none"> Schedule of estimated amortization expense on intangible assets</span></td><td> </td> <td colspan="2" id="xdx_49E_20240331_zPRLOhfRb06k" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid">Year</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amortization</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 84%">Nine months ended December 31, 2024</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">405</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">540</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">540</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">540</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">540</td><td style="text-align: left"> </td></tr> </table> 405000 540000 540000 540000 540000 P12Y3M18D P12Y7M6D P12Y6M <p id="xdx_802_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z6iavio14pf6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 6 – <span id="xdx_826_zggiVBbC7szj">Accrued Expenses</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accrued expenses consisted of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_pn3n3_zt54LctNdcMl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued Expenses (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B1_zmiIuhvgOwf4" style="display: none"> Schedule of accrued expenses</span></td><td> </td> <td colspan="2" id="xdx_494_20240331_zArGUPwzbK52" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49A_20231231_zmArB13Td2L8" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31,<br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2023</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_406_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pn3n3_maALCzoHM_zyo5mJa3Meik" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Payroll and incentive compensation</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,621</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">3,853</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_iI_pn3n3_maALCzoHM_zq8qGc5lj6ke" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Real estate taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">343</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">442</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccruedUtilitiesCurrent_iI_pn3n3_maALCzoHM_zK9xrBJM3Fhj" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Utilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">193</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">241</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--CurrentPortionOfOperatingLeaseLiabilities_iI_pn3n3_maALCzoHM_zGef9zbXylzg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Current portion of operating lease liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">71</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">74</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maALCzoHM_zZpvoCK3d414" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">376</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">306</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AccruedLiabilitiesCurrent_iTI_pn3n3_mtALCzoHM_zDlhTRVkCyY4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total accrued expenses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,604</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,916</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_pn3n3_zt54LctNdcMl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued Expenses (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B1_zmiIuhvgOwf4" style="display: none"> Schedule of accrued expenses</span></td><td> </td> <td colspan="2" id="xdx_494_20240331_zArGUPwzbK52" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49A_20231231_zmArB13Td2L8" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31,<br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2023</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_406_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pn3n3_maALCzoHM_zyo5mJa3Meik" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Payroll and incentive compensation</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,621</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">3,853</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_iI_pn3n3_maALCzoHM_zq8qGc5lj6ke" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Real estate taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">343</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">442</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccruedUtilitiesCurrent_iI_pn3n3_maALCzoHM_zK9xrBJM3Fhj" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Utilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">193</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">241</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--CurrentPortionOfOperatingLeaseLiabilities_iI_pn3n3_maALCzoHM_zGef9zbXylzg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Current portion of operating lease liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">71</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">74</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_maALCzoHM_zZpvoCK3d414" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">376</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">306</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AccruedLiabilitiesCurrent_iTI_pn3n3_mtALCzoHM_zDlhTRVkCyY4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total accrued expenses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,604</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,916</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2621000 3853000 343000 442000 193000 241000 71000 74000 376000 306000 3604000 4916000 <p id="xdx_80A_eus-gaap--DebtDisclosureTextBlock_zn9UWF3FCaea" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 7 – <span id="xdx_82E_z1ZutzebPfp2">Debt</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note payable consisted of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfDebtTableTextBlock_pn3n3_z82vDtmSsG8j" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Debt (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B8_zVosIayxSJmb" style="display: none"> Schedule of debt</span></td><td> </td> <td colspan="2" id="xdx_496_20240331_zVprUTca4UOh" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49C_20231231_zdQiGNSZNz72" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2024</b></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2023</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40B_eus-gaap--LoansPayableCurrent_iI_pn3n3_maNPz44x_zekOLIuFRWx6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Term loan due August 18, 2026. Interest (7.39% at March 31, 2024) payable monthly.</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,750</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross_iNI_pn3n3_di_msNPz44x_zJIBMEL9KP89" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Unamortized deferred financing costs</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(15</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(17</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--NotesPayable_iTI_pn3n3_mtNPz44x_zUEW7sVmgMu4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Total note payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,485</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,733</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--NotesPayableCurrent_iNI_pn3n3_di_zVZshCTxIMq9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,250</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,250</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--LongTermNotesPayable_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,235</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,483</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The scheduled maturities of the term loan, excluding deferred financing costs, at March 31, 2024 are as follows: </p> <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_pn3n3_zRp8WjSlOFRb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Debt (Details - Maturities)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BD_zGbF7CeQClo3" style="display: none"> Schedule of maturities of long-term debt</span></td><td> </td> <td colspan="2" id="xdx_492_20240331_zyMlaSEFrhCe" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_409_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_pn3n3_maLTDzIPT_zAK5HZZGOgo2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 84%">Nine months ended December 31, 2024</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pn3n3_maLTDzIPT_z5C95Uzce91i" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pn3n3_maLTDzIPT_ziEqA4ZThGHe" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">500</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LongTermDebt_iTI_pn3n3_mtLTDzIPT_ztAiFyKCj0c8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total term loan</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Credit Agreement</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is party to an Amended and Restated Loan and Security Agreement (as amended and modified from time to time, the “Credit Agreement”) with its existing lender and certain of its subsidiaries. The Credit Agreement provides for, among other things, a $<span id="xdx_909_eus-gaap--TerminationLoans_iI_dm_c20240331__us-gaap--DebtInstrumentAxis__custom--CreditAgreementTermLoanMember_zqEB36Sv3x71" title="Termination loans">5 million</span> term loan to be repaid in quarterly installments of principal and interest over a term of five years, a revolving line of credit up to a maximum of $<span id="xdx_90F_eus-gaap--LineOfCredit_iI_dm_c20240331__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zGlijMpYHJEi" title="Line of credit">5 million</span> (the “Revolving Credit Facility”) and an incremental facility not to exceed $<span id="xdx_906_eus-gaap--LineOfCredit_iI_dm_c20240331__us-gaap--CreditFacilityAxis__custom--IncrementalFacilityMember_zDssBL8N7Pkl" title="Line of credit">5 million</span>. The termination date of the term loan is <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--CreditAgreementTermLoanMember_zio9o5hBsODi" title="Termination date">August 18, 2026</span>, unless earlier terminated. The termination date of the revolving credit facility is <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240331__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zvqaOMrYo4C1" title="Termination date">June 30, 2025</span>, unless earlier terminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All outstanding amounts under the Credit Agreement bear interest at the <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateTerms_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--CreditAgreementMember_z6eoNkfyFY3a" title="Description of debt instrument, interest rate terms">Secured Overnight Financing Rate (“SOFR”), plus 2.07%. Interest is payable monthly in arrears.</span> Lifeway is also required to pay a quarterly unused revolving line of credit fee of <span id="xdx_90D_eus-gaap--LineOfCreditFacilityCommitmentFeePercentage_pip0_dp_c20240101__20240331_zYws4KQ9YPZk" title="Unused revolving line of credit fee">0.20</span>% and, in conjunction with the issuance of any letters of credit, a letter of credit fee of <span id="xdx_909_ecustom--LetterOfCreditFeePercentage_pip0_dp_c20240101__20240331_zwFzCq9tbF43" title="Letter of credit fee percentage">0.20</span>%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Credit Agreement includes customary representations, warranties, and covenants, including financial covenants requiring the Company to maintain a fixed charge coverage ratio of no less than 1.25 to 1.00, and a minimum working capital financial covenant, as defined, of no less than $11.25 million, in each of the fiscal quarters ending through the expiration date. The Credit Agreement continues to provide for events of default, including failure to repay principal and interest when due and failure to perform or violation of the provisions or covenants of the agreement, as a result of which amounts due under the Credit Agreement may be accelerated. The loans and all other amounts due and owed under the Credit Agreement and related documents are secured by substantially all of the Company’s assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lifeway was in compliance with the fixed charge coverage ratio and minimum working capital covenants at March 31, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Revolving Credit Facility</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2024, the Company had $<span id="xdx_904_eus-gaap--LineOfCredit_iI_pn3n3_c20240331_z1OLkNv0YBd7" title="Outstanding amount">0</span> outstanding under the Revolving Credit Facility. The Company had $<span id="xdx_90C_eus-gaap--LineOfCreditFacilityRemainingBorrowingCapacity_iI_pn3n3_c20240331__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zZaAuhnqylfa" title="Future borrowings">5,000</span> available for future borrowings under the Revolving Credit Facility as of March 31, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfDebtTableTextBlock_pn3n3_z82vDtmSsG8j" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Debt (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B8_zVosIayxSJmb" style="display: none"> Schedule of debt</span></td><td> </td> <td colspan="2" id="xdx_496_20240331_zVprUTca4UOh" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49C_20231231_zdQiGNSZNz72" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2024</b></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2023</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40B_eus-gaap--LoansPayableCurrent_iI_pn3n3_maNPz44x_zekOLIuFRWx6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Term loan due August 18, 2026. Interest (7.39% at March 31, 2024) payable monthly.</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,750</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross_iNI_pn3n3_di_msNPz44x_zJIBMEL9KP89" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Unamortized deferred financing costs</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(15</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(17</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--NotesPayable_iTI_pn3n3_mtNPz44x_zUEW7sVmgMu4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Total note payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,485</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,733</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--NotesPayableCurrent_iNI_pn3n3_di_zVZshCTxIMq9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,250</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,250</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--LongTermNotesPayable_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,235</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,483</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2500000 2750000 15000 17000 2485000 2733000 1250000 1250000 1235000 1483000 <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_pn3n3_zRp8WjSlOFRb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Debt (Details - Maturities)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BD_zGbF7CeQClo3" style="display: none"> Schedule of maturities of long-term debt</span></td><td> </td> <td colspan="2" id="xdx_492_20240331_zyMlaSEFrhCe" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_409_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_pn3n3_maLTDzIPT_zAK5HZZGOgo2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 84%">Nine months ended December 31, 2024</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pn3n3_maLTDzIPT_z5C95Uzce91i" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pn3n3_maLTDzIPT_ziEqA4ZThGHe" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">500</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LongTermDebt_iTI_pn3n3_mtLTDzIPT_ztAiFyKCj0c8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total term loan</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1000000 1000000 500000 2500000 5000000 5000000 5000000 2026-08-18 2025-06-30 Secured Overnight Financing Rate (“SOFR”), plus 2.07%. Interest is payable monthly in arrears. 0.0020 0.0020 0 5000000 <p id="xdx_80F_eus-gaap--LesseeOperatingLeasesTextBlock_zepbvOLzyvg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 8 – <span id="xdx_821_zqmhzk39fVb7">Leases</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company leases certain machinery and equipment with fixed base rent payments and variable costs based on usage. Remaining lease terms for these leases range from less than one year to six years. The Company includes lease extension options, if applicable and reasonably certain to be exercised, in the calculation of the right-of-use asset and lease liabilities. Lifeway includes only fixed payments for lease components in the measurement of the right-of-use asset and lease liability. Variable lease payments are those that vary because of changes in facts or circumstances occurring after the commencement date, other than the passage of time. There are no residual value guarantees. Lifeway does not currently have leases which meet the finance lease classification as defined under ASC 842.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lifeway treats contracts as a lease when the contract conveys the right to use a physically distinct asset for a period of time in exchange for consideration, it directs the use of the asset and obtains substantially all the economic benefits of the asset.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Right-of-use assets and lease liabilities are measured and recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. Lifeway has elected the practical expedient to combine lease and non-lease components into a single component for all of its leases. When the Company is unable to determine an implicit interest rate, it uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments for those leases. Lifeway includes options to extend or terminate the lease in the measurement of the right-of-use asset and lease liability when it is reasonably certain that it will exercise such options. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not record leases with an initial term of 12 months or less on the balance sheet. Expense for these short-term leases is recorded on a straight-line basis over the lease term. Total lease expense was $<span id="xdx_909_eus-gaap--OperatingLeaseExpense_pn3n3_c20240101__20240331_z2UtP8C6w6hh" title="Total lease expense">35</span> and $<span id="xdx_90A_eus-gaap--OperatingLeaseExpense_pn3n3_c20230101__20230331_zyCNTUjNx405" title="Total lease expense">31</span> (including short term leases) for the three months ended March 31, 2024 and 2023, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Future maturities of lease liabilities were as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_z9qvTktCJNlk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8B9_zSn8SmG1k72g" style="display: none">Schedule of future maturities of lease liabilities</span></td><td> </td> <td colspan="2" id="xdx_49A_20240331_zV9n1dPyvdVf" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid">Year</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Operating Leases</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pn3n3_maLOLLPzqc5_zWQX6VhggU6g" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 84%">Nine months ended December 31, 2024</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">64</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_maLOLLPzqc5_zdKfccGKwyc5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzqc5_zzdXTcW35Qj6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">31</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzqc5_zeJO9HYIxhNh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPzqc5_zZhB3q2zZDR4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_iI_pn3n3_d0_maLOLLPzqc5_zxdGWvO0MqGl" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">10</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtLOLLPzqc5_zkKrtSUyNLaf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Total lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">198</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_zBDbNEpkNicg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(26</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseLiability_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Present value of lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">172</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The weighted-average remaining lease term for its operating leases was <span id="xdx_907_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240331_zLTIvxXHYYy6" title="Weighted average remaining lease term">3.5</span> years as of March 31, 2024. The weighted average discount rate of its operating leases was <span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pip0_dp_c20240331_zaopkiopsAlj" title="Weighted average discount rate">9.49</span>% as of March 31, 2024. Cash paid for amounts included in the measurement of lease liabilities was $<span id="xdx_90F_eus-gaap--OperatingLeaseCost_pn3n3_c20240101__20240331_z4z87t3CHESf" title="Operating lease liabilities">24</span> and $<span id="xdx_909_eus-gaap--OperatingLeaseCost_pn3n3_c20230101__20230331_zXc7kmmKKIAg" title="Operating lease liabilities">25</span> for the three months ended March 31, 2024 and 2023, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 35000 31000 <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_z9qvTktCJNlk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8B9_zSn8SmG1k72g" style="display: none">Schedule of future maturities of lease liabilities</span></td><td> </td> <td colspan="2" id="xdx_49A_20240331_zV9n1dPyvdVf" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid">Year</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Operating Leases</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pn3n3_maLOLLPzqc5_zWQX6VhggU6g" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 84%">Nine months ended December 31, 2024</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">64</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_maLOLLPzqc5_zdKfccGKwyc5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzqc5_zzdXTcW35Qj6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">31</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzqc5_zeJO9HYIxhNh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_maLOLLPzqc5_zZhB3q2zZDR4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_iI_pn3n3_d0_maLOLLPzqc5_zxdGWvO0MqGl" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">10</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtLOLLPzqc5_zkKrtSUyNLaf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Total lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">198</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_zBDbNEpkNicg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(26</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseLiability_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Present value of lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">172</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 64000 55000 31000 21000 17000 10000 198000 26000 172000 P3Y6M 0.0949 24000 25000 <p id="xdx_804_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zeQqYdr6Czq" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 9 – <span id="xdx_828_zKVczIrFtwog">Commitments and contingencies</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Litigation</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lifeway is involved in various legal proceedings, claims, disputes, regulatory matters, audits, and proceedings arising in the ordinary course of, or incidental, to the Company’s business, including commercial disputes, product liabilities, intellectual property matters and employment-related matters.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lifeway records provisions in the consolidated financial statements for pending legal matters when it believes it is probable that a loss will be incurred and the amount of such loss can be reasonably estimated. The Company evaluates, on a periodic basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and estimable, it does not establish an accrued liability. Currently, none of its accruals for outstanding legal matters are material individually or in the aggregate to its financial position and it is management’s opinion that the ultimate resolution of these outstanding legal matters will not have a material adverse effect on its business, financial condition, results of operations, or cash flows. However, if the Company is ultimately required to make payments in connection with an adverse outcome, it is possible that such contingency could have a material adverse effect on the Company’s business, financial condition, results of operations or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_zoPZfdzChxOb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 10 – <span id="xdx_826_zYwqZ4z80ehb">Income taxes</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Income taxes were recognized at effective rates of <span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pip0_dp_c20240101__20240331_zETCnMEMIIjk" title="Effective income tax rate reconciliation, percent">30.8</span>% and <span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pip0_dp_c20230101__20230331_zMiw5rrrVvV9" title="Effective income tax rate reconciliation, percent">37.9</span>% for the three months ended March 31, 2024 and 2023, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company calculates the provision for income taxes during interim reporting periods by applying an estimate of the annual effective tax rate for the full year, excluding unusual or infrequently occurring discrete items, and applies that rate to income (loss) before provision for income taxes for the period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s effective tax rate may change from period to period based on recurring and non-recurring factors including the relative mix of pre-tax earnings (or losses), the jurisdictional mix of earnings, enacted tax legislation, state income taxes, the impact of non-deductible items, changes in valuation allowances, settlement of tax audits, and the expiration of the statute of limitations in relation to unrecognized tax benefits. The Company records discrete income tax items such as enacted tax rate changes and completed tax audits in the period in which they occur. The Company consistently reflects non-deductible officer compensation expense, non-deductible compensation expense related to equity incentive awards and separate state tax rates from period to period. Although similar items were reflected in 2024, the percentage effect is different due to the difference in pre-tax income in 2024 compared to 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unrecognized tax benefits were $<span id="xdx_90D_eus-gaap--UnrecognizedTaxBenefits_iI_pn3n3_c20240331_z751bHIDth71" title="Unrecognized tax benefits"><span id="xdx_903_eus-gaap--UnrecognizedTaxBenefits_iI_pn3n3_c20230331_z4tvVKPiwtt6" title="Unrecognized tax benefits">0</span></span> at March 31, 2024 and 2023, respectively. The Company does not expect material changes to its unrecognized tax benefits during the next twelve months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.308 0.379 0 0 <p id="xdx_807_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zeSldkm3zufe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 11 – <span id="xdx_820_zROAoILntpd3">Stock-based and Other Compensation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Omnibus Incentive Plan</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2015, Lifeway stockholders approved the 2015 Omnibus Incentive Plan, which authorized the issuance of an aggregate of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_dm_c20151231__us-gaap--PlanNameAxis__custom--Omnibus2015Member_zagXzeJ3SwOe" title="Number of shares authorized for issuance">3.5 million</span> shares to satisfy awards of stock options, stock appreciation rights, unrestricted stock, restricted stock, restricted stock units, performance shares and performance units to qualifying employees. Under the 2015 Omnibus Incentive Plan, the Board of Directors or its Compensation Committee approves stock awards to executive officers and certain senior executives, generally in the form of restricted stock or performance shares. The number of performance shares that participants may earn depends on the extent to which the corresponding performance goals have been achieved. Stock awards generally vest over a three-year performance or service period. At March 31, 2024, no shares remain available for award under the 2015 Omnibus Incentive Plan as it was terminated on August 31, 2022. However, any outstanding awards under the 2015 Omnibus Incentive Plan are unaffected by the termination of the 2015 Omnibus Incentive Plan or by the approval of the 2022 Omnibus Incentive Plan (the “2022 Plan”) as described below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 31, 2022, Lifeway stockholders approved the 2022 Plan. Under the 2022 Plan, the Compensation Committee of the Board of Directors may grant awards of various types of compensation, including, nonqualified stock options, incentive stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units, cash-based awards and other stock-based awards. The maximum number of shares authorized to be awarded under the 2022 Plan is <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_dm_c20220831__us-gaap--PlanNameAxis__custom--Omnibus2022PlanMember_z4J8r9GbxnK7" title="Number of shares authorized for issuance">3.25 million</span> shares of common stock, which includes shares that remained available under the now terminated 2015 Omnibus Incentive Plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Awards granted under the 2022 Plan are generally subject to a minimum vesting period of at least one year. Awards may be subject to cliff-vesting or graded-vesting conditions, with graded vesting starting no earlier than one year after the grant date. The Plan Administrator may provide for shorter vesting periods in an award agreement for no more than five percent of the maximum number of shares authorized for issuance under the 2022 Plan. As of March 31, 2024, <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_dm_c20240331__us-gaap--PlanNameAxis__custom--Omnibus2022PlanMember_zeQm3WWO6Tab" title="Number of shares avilable for issuance">2.64 million</span> shares remain available to award under the 2022 Plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Stock Options</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table summarizes stock option activity during the three months ended March 31, 2024:</p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_pn3n3_ziHaHBNOHNh2" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stock-based and Other Compensation (Details - Option Activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B4_zjuFA4KTdHrl" style="display: none">Schedule of stock option activity</span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted <br/> average <br/> exercise price</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted <br/> average <br/> remaining contractual life</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate <br/> intrinsic value</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(In thousands)</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at December 31, 2023</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfgDu675cQ7c" style="text-align: right; width: 12%" title="Options outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pip0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zsVmNtN1fcm6" style="text-align: right; width: 12%" title="Weighted average exercise price, options outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.42</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="text-align: right; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zbIfp9kvVvQ7" title="Weighted average remaining contractual life, outstanding">2.21</span></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zdztWIvz83jl" style="text-align: right; width: 12%" title="Aggregate intrinsic value, options outstanding beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">121</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pn3n3_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zUFoe2V8rLQa" style="text-align: right" title="Options granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pip0_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zBXGEf5VNi8b" style="text-align: right" title="Weighted average exercise price, options granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pn3n3_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z0J5ST5C7rvk" style="text-align: right" title="Options exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pip0_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z2GrFj5q41Sd" style="text-align: right" title="Weighted average exercise price, options exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pn3n3_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zzOKL1zY2HW" style="border-bottom: black 1pt solid; text-align: right" title="Options forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pip0_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zea0TvXvVCNf" style="text-align: right" title="Weighted average exercise price, options forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at March 31, 2024</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zMs0vnbRnon9" style="border-bottom: black 2.25pt double; text-align: right" title="Options outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pip0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zSWPuYONl6Pg" style="text-align: right" title="Weighted average exercise price, options outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.42</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDuDIU47MKtk" title="Weighted average remaining contractual life, outstanding">1.97</span></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPZzTU4vqp8" style="text-align: right" title="Aggregate intrinsic value, options outstanding ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">276</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at March 31, 2024</span></td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pn3n3_c20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPkkO4qJRMD5" style="text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pip0_c20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zVWypAz7Sc8c" style="text-align: right" title="Weighted average exercise price, exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.42</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zxAvX0XWil78" title="Weighted average remaining contractual life, exercisable">1.97</span></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pn3n3_c20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zsUOrVYywdoc" style="text-align: right" title="Aggregate intrinsic value, options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">276</span></td> <td> </td></tr> </table> <p id="xdx_8A5_zlKjrJrerXcj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Restricted Stock Units</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A Restricted Stock Unit (“RSU”) represents the right to receive one share of common stock in the future. RSUs have no exercise price. The grant date fair value of the awards is determined by the Company’s closing stock price on the grant date. Lifeway expenses RSUs over the vesting period. The following table summarizes RSU activity during the three months ended March 31, 2024.</p> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_pn3n3_zvh57WPPIYq8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock-based and Other Compensation (Details - Restricted Stock Units)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B5_zttLcsRkN602" style="display: none">Schedule of RSUs Activity</span> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Restricted Stock Units</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">(In thousands)</td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%">Outstanding at December 31, 2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zuCycQwrMptb" style="width: 13%; text-align: right" title="Restricted stock units outstanding, beginning">207</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pip0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zL2rg3x64PDb" style="width: 13%; text-align: right" title="Weighted average grant date fair value outstanding, beginning">6.89</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z0YtkMkwQ0ag" style="text-align: right" title="Restricted stock units, granted">33</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pip0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zydN2WgKbtOf" style="text-align: right" title="Weighted average grant date fair value, granted">13.73</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Shares issued upon vesting</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pn3n3_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z0TKtUfNoqFi" style="text-align: right" title="Restricted stock units, shares issued upon vesting">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesIssuedUponVestingWeightedAverageFairValue_pip0_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z89i9ia6okT7" style="text-align: right" title="Weighted average grant date fair value, shares issued upon vesting">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pn3n3_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zgHsQzj7PYJ5" style="border-bottom: Black 1pt solid; text-align: right" title="Restricted stock units, forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pip0_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zohAZgl0pHD" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average grant date fair value, forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Outstanding at March 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6xtxNvTLOCb" style="border-bottom: Black 2.5pt double; text-align: right" title="Restricted stock units outstanding, ending">240</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iI_pip0_c20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z2IyzmFdjHHf" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date fair value outstanding, ending">7.82</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Vested and deferred at March 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_iI_pn3n3_c20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zGDAfFkIlum3" style="border-bottom: Black 2.5pt double; text-align: right" title="Restricted stock units, vested and deferred">67</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pip0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHHMcfZjHJO4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date fair value, vested and deferred">5.98</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zDeTZmAEdMe1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended March 31, 2024 and 2023 total pre-tax stock-based compensation expense recognized in the consolidated statements of operations was $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z5sXgkC1kLF7" title="Share-based compensation">233</span> and $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zxLk78ygpoBe" title="Share-based compensation">104</span>, respectively. For the three months ended March 31, 2024 and 2023 tax-related benefits of $<span id="xdx_90A_eus-gaap--DeferredOtherTaxExpenseBenefit_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLGLpdUmQlle" title="Tax related benefits">65</span> and $<span id="xdx_901_eus-gaap--DeferredOtherTaxExpenseBenefit_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z00VNBuOtA61" title="Tax related benefits">29</span>, respectively, were also recognized. Future compensation expense related to restricted stock units was $<span id="xdx_90D_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_iI_pn3n3_c20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zx4vEbiyomA6" title="Compensation expense related to restricted stock units">918</span> as of March 31, 2024 and will be recognized on a weighted average basis over the next <span id="xdx_902_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zWTTG4ISqqR5" title="Weighted average basis term">1.3</span> years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Long-Term Incentive Plan Compensation</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lifeway has established long-term incentive-based compensation programs for certain senior executives and key employees pursuant to the terms of its incentive plans.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>2020 CEO Incentive Award</i> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the fourth quarter 2020, Lifeway awarded a long-term equity-based incentive of $<span id="xdx_90D_ecustom--LongtermEquitybasedIncentive_pn3n3_c20201001__20201231__us-gaap--AwardTypeAxis__custom--CEO2020AwardMember_zbXPTGsPGQzc" title="Long-term equity-based incentive">750</span> to its Chief Executive Officer (the “2020 CEO Award”) depending on Lifeway’s 2020 performance levels compared to the respective targets. The equity-based incentive compensation is payable in restricted stock that vests one-third in April 2022, one-third in April 2023, and one-third in April 2024. The issuance of vested equity awards is subject to approval under the Stock Purchase Agreement dated October 1, 1999. For the three months ended March 31, 2024 and 2023, $<span id="xdx_901_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__custom--CEO2020AwardMember_zt0a7vSoiLD5" title="Share-based compensation">18</span> and $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__custom--CEO2020AwardMember_zbPGBIzGGxKi" title="Share-based compensation">43</span> was expensed as stock-based compensation expense in the consolidated statements of operations, respectively. As of March 31, 2024, the total remaining unearned compensation of $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_iI_pn3n3_c20240331__us-gaap--AwardTypeAxis__custom--CEO2020AwardMember_zWlspWUlurpl" title="Compensation expense related to restricted stock units">6</span> will be recognized in 2024, subject to vesting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>2021 Equity Award</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2021 long-term equity incentive plan compensation is based on Lifeway’s achievement of adjusted EBITDA performance versus the respective target established by the Board of Directors for 2021. Under the 2021 plan, collectively the participants earned equity-based incentive compensation of $<span id="xdx_909_ecustom--LongtermEquitybasedIncentive_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__custom--Plan2021Member_zwJZS8VNMm6c" title="Long-term equity-based incentive">1,069</span> based on Lifeway’s achievement of the respective financial target. The equity-based incentive compensation is payable in restricted stock that vests one-third in April 2022, one-third in April 2023, and one-third in April 2024. For the three months ended March 31, 2024 and 2023, $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__custom--Plan2021Member_zjaLkVj8TL1b" title="Share-based compensation">33</span> and $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__custom--Plan2021Member_zQlCKMpQO6Sl" title="Share-based compensation">84</span> was expensed as stock-based compensation expense in the consolidated statements of operations, respectively. As of March 31, 2024, the total remaining unearned compensation of $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_iI_pn3n3_c20240331__us-gaap--AwardTypeAxis__custom--Plan2021Member_z0m3OQScsSah" title="Compensation expense related to restricted stock units">7</span> will be recognized in 2024, subject to vesting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>2022 Equity Award</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the 2022 long-term incentive plan, participants can earn a specified number of target level Performance Share Units (“PSUs”) contingent upon the achievement of strategic milestones during the three-year Measurement Period, which is fiscal year 2022 to 2024. The strategic milestones are 1) 3-year cumulative net revenue, and 2) 3-year cumulative adjusted EBITDA. The target number of PSU awards are weighted 50% on net revenue and 50% on adjusted EBITDA. Collectively, the participants can earn 125,066 PSUs at the target level. Participants may earn more or less than the target number of shares based on actual results, however the minimum and maximum number of shares that can be earned are bound by minimum and maximum thresholds of net revenue and adjusted EBITDA. The PSU awards will be earned and will vest, if at all, after the end of the three-year measurement period based on achievement of the milestones. The PSU awards do not vest during the three-year measurement period. The PSUs have a grant date fair value of $6.25 dollars per share. For the three months ended March 31, 2024 and 2023, $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__custom--Plan2022Member_zHZ5a3FdujB1" title="Share-based compensation">156</span> and $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__custom--Plan2022Member_zP33maFY8Gzh" title="Share-based compensation">112</span> was expensed as stock-based compensation expense in the consolidated statements of operations, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2022 long-term incentive plan also granted restricted stock unit awards that contain only a service condition and vest on the passage of time in three equal installments on each of the first three anniversaries of the August 31, 2022 grant date. The stock-based compensation expense for these awards is included in the Restricted Stock Units section above.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>2023 Equity Award</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the 2023 long-term incentive plan, participants can earn a specified number of target level Performance Share Units (“PSUs”) contingent upon the achievement of strategic milestones during the three-year Measurement Period, which is fiscal year 2023 to 2025. The strategic milestones are 1) 3-year cumulative net revenue, and 2) 3-year cumulative adjusted EBITDA. The target number of PSU awards are weighted 50% on net revenue and 50% on adjusted EBITDA. Collectively, the participants can earn 115,622 PSUs at the target level. Participants may earn more or less than the target number of shares based on actual results, however the minimum and maximum number of shares that can be earned are bound by minimum and maximum thresholds of net revenue and adjusted EBITDA. The PSU awards will be earned and will vest, if at all, after the end of the three-year measurement period based on achievement of the milestones. The PSU awards do not vest during the three-year measurement period. The PSUs have a grant date fair value of $6.88 dollars per share. For the three months ended March 31, 2024 and 2023, $<span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__custom--Plan2023Member_zeufi3LE7Zyc" title="Share-based compensation">130</span> and $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__custom--Plan2023Member_zAsMDS3ugAU" title="Share-based compensation">0</span> was expensed as stock-based compensation expense in the consolidated statements of operations, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2023 long-term incentive plan also granted restricted stock unit awards that contain only a service condition and vest on the passage of time in three equal installments on each of the first three anniversaries of the June 16, 2023 grant date. The stock-based compensation expense for these awards is included in the Restricted Stock Units section above.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>2024 Equity Award</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the 2024 long-term incentive plan, participants can earn a specified number of target level Performance Share Units (“PSUs”) contingent upon the achievement of strategic milestones during the three-year Measurement Period, which is fiscal year 2024 to 2026. The strategic milestones are 1) 3-year cumulative net revenue, and 2) 3-year cumulative adjusted EBITDA. The target number of PSU awards are weighted 50% on net revenue and 50% on adjusted EBITDA. Collectively, the participants can earn 64,986 PSUs at the target level. Participants may earn more or less than the target number of shares based on actual results, however the minimum and maximum number of shares that can be earned are bound by minimum and maximum thresholds of net revenue and adjusted EBITDA. The PSU awards will be earned and will vest, if at all, after the end of the three-year measurement period based on achievement of the milestones. The PSU awards do not vest during the three-year measurement period. The PSUs have a grant date fair value of $13.73 dollars per share. For the three months ended March 31, 2024 and 2023, $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__custom--Plan2024Member_zoENhUnQ9Ygc" title="Share-based compensation">102</span> and $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__custom--Plan2024Member_z4B2Cc72jPxf" title="Share-based compensation">0</span> was expensed as stock-based compensation expense in the consolidated statements of operations, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2024 long-term incentive plan also granted restricted stock unit awards that contain only a service condition and vest on the passage of time in three equal installments on each of the first three anniversaries of the January 10, 2024 grant date. The stock-based compensation expense for these awards is included in the Restricted Stock Units section above.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Non-Employee Director Plan</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 31, 2022, Lifeway stockholders approved the 2022 Non-Employee Director Equity and Deferred Compensation Plan (the “2022 Director Plan”), which authorizes the grant of restricted stock units (“RSUs”), which will vest on such schedule as the Company, in its sole discretion, shall determine. Each non-employee director of the Company is eligible to be a participant in the 2022 Director Plan until they no longer serve as a non-employee director. As of the date of each annual shareholder meeting, the Company may grant each director a number of RSUs for such year and set the vesting schedule for the RSUs granted. Whether and how many RSUs the Company will grant to directors in any year is subject to the sole discretion of the Company and shall in any event be subject to the 2022 Director Plan’s overall share limits. The maximum aggregate number of shares of common stock that may be issued under the 2022 Director Plan is 500 thousand shares. As of March 31, 2024, <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pn3n3_c20240331__us-gaap--PlanNameAxis__custom--Director2022PlanMember_zr4RxokNarF1" title="Share based remain available to award">430</span> thousand shares remain available to award under the 2022 Director Plan. The aggregate fair market value of shares underlying RSU compensation that may be issued as RSU compensation to a director in any year shall not exceed $170. In addition to the grant of RSUs, the 2022 Director Plan also provides for the deferral by electing participants of all or part of their cash compensation (in 10% increments) into a deferred cash account, and they may defer all or part of their cash and/or RSU compensation (in 10% increments) into a deferred RSU account. Deferred benefits are paid in a lump sum upon the applicable director’s departure from the Board of Directors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Retirement Benefits</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lifeway has a defined contribution plan which is available to substantially all full-time employees. Under the terms of the plan, the Company matches employee contributions under a prescribed formula. For the three months ended March 31, 2024 and 2023, total contribution expense recognized in the consolidated statements of operations was $<span id="xdx_906_eus-gaap--DefinedBenefitPlanContributionsByEmployer_pn3n3_c20240101__20240331__us-gaap--PlanNameAxis__custom--DefinedContributionPlanMember_z1Wf3EmZAeMc" title="Contribution expense">193</span> and $<span id="xdx_909_eus-gaap--DefinedBenefitPlanContributionsByEmployer_pn3n3_c20230101__20230331__us-gaap--PlanNameAxis__custom--DefinedContributionPlanMember_zzvHw30wBuP3" title="Contribution expense">150</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> 3500000 3250000 2640000 <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_pn3n3_ziHaHBNOHNh2" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stock-based and Other Compensation (Details - Option Activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B4_zjuFA4KTdHrl" style="display: none">Schedule of stock option activity</span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted <br/> average <br/> exercise price</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted <br/> average <br/> remaining contractual life</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate <br/> intrinsic value</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(In thousands)</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at December 31, 2023</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfgDu675cQ7c" style="text-align: right; width: 12%" title="Options outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pip0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zsVmNtN1fcm6" style="text-align: right; width: 12%" title="Weighted average exercise price, options outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.42</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="text-align: right; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zbIfp9kvVvQ7" title="Weighted average remaining contractual life, outstanding">2.21</span></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zdztWIvz83jl" style="text-align: right; width: 12%" title="Aggregate intrinsic value, options outstanding beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">121</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pn3n3_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zUFoe2V8rLQa" style="text-align: right" title="Options granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pip0_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zBXGEf5VNi8b" style="text-align: right" title="Weighted average exercise price, options granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pn3n3_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z0J5ST5C7rvk" style="text-align: right" title="Options exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pip0_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z2GrFj5q41Sd" style="text-align: right" title="Weighted average exercise price, options exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pn3n3_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zzOKL1zY2HW" style="border-bottom: black 1pt solid; text-align: right" title="Options forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pip0_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zea0TvXvVCNf" style="text-align: right" title="Weighted average exercise price, options forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at March 31, 2024</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zMs0vnbRnon9" style="border-bottom: black 2.25pt double; text-align: right" title="Options outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pip0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zSWPuYONl6Pg" style="text-align: right" title="Weighted average exercise price, options outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.42</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDuDIU47MKtk" title="Weighted average remaining contractual life, outstanding">1.97</span></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPZzTU4vqp8" style="text-align: right" title="Aggregate intrinsic value, options outstanding ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">276</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at March 31, 2024</span></td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pn3n3_c20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPkkO4qJRMD5" style="text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pip0_c20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zVWypAz7Sc8c" style="text-align: right" title="Weighted average exercise price, exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.42</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zxAvX0XWil78" title="Weighted average remaining contractual life, exercisable">1.97</span></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pn3n3_c20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zsUOrVYywdoc" style="text-align: right" title="Aggregate intrinsic value, options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">276</span></td> <td> </td></tr> </table> 41000 10.42 P2Y2M15D 121000 0 0 0 0 0 0 41000 10.42 P1Y11M19D 276000 41000 10.42 P1Y11M19D 276000 <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_pn3n3_zvh57WPPIYq8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock-based and Other Compensation (Details - Restricted Stock Units)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B5_zttLcsRkN602" style="display: none">Schedule of RSUs Activity</span> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Restricted Stock Units</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">(In thousands)</td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%">Outstanding at December 31, 2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zuCycQwrMptb" style="width: 13%; text-align: right" title="Restricted stock units outstanding, beginning">207</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pip0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zL2rg3x64PDb" style="width: 13%; text-align: right" title="Weighted average grant date fair value outstanding, beginning">6.89</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z0YtkMkwQ0ag" style="text-align: right" title="Restricted stock units, granted">33</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pip0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zydN2WgKbtOf" style="text-align: right" title="Weighted average grant date fair value, granted">13.73</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Shares issued upon vesting</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pn3n3_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z0TKtUfNoqFi" style="text-align: right" title="Restricted stock units, shares issued upon vesting">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesIssuedUponVestingWeightedAverageFairValue_pip0_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z89i9ia6okT7" style="text-align: right" title="Weighted average grant date fair value, shares issued upon vesting">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pn3n3_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zgHsQzj7PYJ5" style="border-bottom: Black 1pt solid; text-align: right" title="Restricted stock units, forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pip0_d0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zohAZgl0pHD" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average grant date fair value, forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Outstanding at March 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6xtxNvTLOCb" style="border-bottom: Black 2.5pt double; text-align: right" title="Restricted stock units outstanding, ending">240</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iI_pip0_c20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z2IyzmFdjHHf" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date fair value outstanding, ending">7.82</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Vested and deferred at March 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_iI_pn3n3_c20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zGDAfFkIlum3" style="border-bottom: Black 2.5pt double; text-align: right" title="Restricted stock units, vested and deferred">67</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pip0_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHHMcfZjHJO4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average grant date fair value, vested and deferred">5.98</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 207000 6.89 33000 13.73 0 0 0 0 240000 7.82 67000 5.98 233000 104000 65000 29000 918000 P1Y3M18D 750000 18000 43000 6000 1069000 33000 84000 7000 156000 112000 130000 0 102000 0 430000 193000 150000 <p id="xdx_80C_eus-gaap--EarningsPerShareTextBlock_zqkQaNAqkUbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 12 - <span id="xdx_82F_z7oLNsQvvgq2">Earnings Per Share</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table summarizes the effects of the share-based compensation awards on the weighted average number of shares outstanding used in calculating diluted earnings per share:</p> <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_pn3n3_zQxbAa0MNHt7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Earnings Per Share (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B8_zkZ6cfMPYfsa" style="display: none">Schedule of weighted average number of shares outstanding</span> </td><td> </td> <td colspan="2" id="xdx_49D_20240101__20240331_zd3JXk6JcAui" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_495_20230101__20230331_zRDRT7oJViE3" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">(In Thousands)</td><td style="font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%">Weighted average common shares outstanding</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">14,691</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">14,645</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Assumed exercise/vesting of equity awards</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">531</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">385</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Weighted average diluted common shares outstanding</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">15,222</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">15,030</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_pn3n3_zQxbAa0MNHt7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Earnings Per Share (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B8_zkZ6cfMPYfsa" style="display: none">Schedule of weighted average number of shares outstanding</span> </td><td> </td> <td colspan="2" id="xdx_49D_20240101__20240331_zd3JXk6JcAui" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_495_20230101__20230331_zRDRT7oJViE3" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">(In Thousands)</td><td style="font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%">Weighted average common shares outstanding</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">14,691</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">14,645</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Assumed exercise/vesting of equity awards</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">531</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">385</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Weighted average diluted common shares outstanding</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">15,222</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">15,030</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 14691000 14645000 531000 385000 15222000 15030000 <p id="xdx_80C_eus-gaap--SegmentReportingDisclosureTextBlock_z7wr4S3dLJS9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 13 – <span id="xdx_827_zU5nyeojILl1">Disaggregation of Revenue and Significant Customers</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lifeway’s primary product is drinkable kefir. The Company manufactures (directly or through a co-manufacturer) and markets products under the Lifeway, Fresh Made, and GlenOaks Farms brand names, as well as under private labels on behalf of certain customers.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company’s product categories are:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 3%"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="width: 92%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drinkable kefir, a cultured dairy product sold in a variety of organic and non-organic sizes, flavors, and types.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">European-style soft cheeses, including farmer cheese, white cheese, and Sweet Kiss.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cream and other, which primarily consists of cream, a byproduct of raw milk processing.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drinkable yogurt, sold in a variety of sizes and flavors.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProBugs, a line of kefir products designed for children.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other dairy, which primarily consists of Fresh Made butter and sour cream.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net sales of products by category were as follows for the three months ended March 31:</p> <table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zqKpBWx78J93" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Disaggregation of Revenue and Significant Customers (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BC_zajg6RS4UTt8" style="display: none">Schedule of sales of products by category</span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In thousands</span></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drinkable Kefir other than ProBugs</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20240101__20240331__srt--ProductOrServiceAxis__custom--DrinkableKefirotherthanProBugsMember_zZT2Ql1uiemi" style="width: 11%; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,533</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20240101__20240331__srt--ProductOrServiceAxis__custom--DrinkableKefirotherthanProBugsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z2lNeg5eMTVg" title="Net sales percentage">82</span>%</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--ProductOrServiceAxis__custom--DrinkableKefirotherthanProBugsMember_zN4as5xiJ6u2" style="width: 11%; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,800</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230331__srt--ProductOrServiceAxis__custom--DrinkableKefirotherthanProBugsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zhN2slJYGl66" title="Net sales percentage">79</span>%</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cheese</span></td> <td> </td> <td> </td> <td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20240101__20240331__srt--ProductOrServiceAxis__custom--CheeseMember_zohOkjW7CEg6" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,515</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20240101__20240331__srt--ProductOrServiceAxis__custom--CheeseMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6wDhcF9zemc" title="Net sales percentage">8</span>%</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--ProductOrServiceAxis__custom--CheeseMember_zJ95yDUszeIf" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,345</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230331__srt--ProductOrServiceAxis__custom--CheeseMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zOMbHuuFDT45" title="Net sales percentage">9</span>%</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cream and other</span></td> <td> </td> <td> </td> <td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20240101__20240331__srt--ProductOrServiceAxis__custom--CreamAndOtherMember_z7zprsCmpwN6" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,816</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20240101__20240331__srt--ProductOrServiceAxis__custom--CreamAndOtherMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zyQynBQWVLAh" title="Net sales percentage">4</span>%</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--ProductOrServiceAxis__custom--CreamAndOtherMember_z9JAUSjKjCQ5" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,920</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230331__srt--ProductOrServiceAxis__custom--CreamAndOtherMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zKco073Kx6Sa" title="Net sales percentage">5</span>%</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drinkable Yogurt</span></td> <td> </td> <td> </td> <td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20240101__20240331__srt--ProductOrServiceAxis__custom--DrinkableYogurtMember_zKc2L1LWSaui" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,536</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20240101__20240331__srt--ProductOrServiceAxis__custom--DrinkableYogurtMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6tV6Kzjp875" title="Net sales percentage">3</span>%</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--ProductOrServiceAxis__custom--DrinkableYogurtMember_zPyJUYCAeek8" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,616</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230331__srt--ProductOrServiceAxis__custom--DrinkableYogurtMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsic15AUBk14" title="Net sales percentage">4</span>%</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProBugs Kefir</span></td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20240101__20240331__srt--ProductOrServiceAxis__custom--ProbugsKefirMember_zDm7dhJILR99" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">866</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20240101__20240331__srt--ProductOrServiceAxis__custom--ProbugsKefirMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zt65tguZ2HS6" title="Net sales percentage">2</span>%</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--ProductOrServiceAxis__custom--ProbugsKefirMember_zXhnUrNdXzVf" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">808</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230331__srt--ProductOrServiceAxis__custom--ProbugsKefirMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z0OI2epN7Amc" title="Net sales percentage">2</span>%</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other dairy</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20240101__20240331__srt--ProductOrServiceAxis__custom--OtherDairyMember_ziOJpNXjQOEf" style="border-bottom: black 1pt solid; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">368</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20240101__20240331__srt--ProductOrServiceAxis__custom--OtherDairyMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsVOwfuG1lS3" title="Net sales percentage">1</span>%</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--ProductOrServiceAxis__custom--OtherDairyMember_z8s2tUvRGsC2" style="border-bottom: black 1pt solid; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">415</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230331__srt--ProductOrServiceAxis__custom--OtherDairyMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zHfQKqMImlWi" title="Net sales percentage">1</span>%</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Sales</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20240101__20240331__srt--ProductOrServiceAxis__custom--NetSalesMember_zVEp6ep9wnO7" style="border-bottom: black 2.25pt double; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,634</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20240101__20240331__srt--ProductOrServiceAxis__custom--NetSalesMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6g5UdEIh1lf" title="Net sales percentage">100</span>%</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--ProductOrServiceAxis__custom--NetSalesMember_z4AxoaQxVfqk" style="border-bottom: black 2.25pt double; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,904</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230331__srt--ProductOrServiceAxis__custom--NetSalesMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zygNWs2Hdb0b" title="Net sales percentage">100</span>%</span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Significant Customers</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sales are predominately to companies in the retail food industry located within the United States. Two major customers accounted for approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zoxbx3OUogm2" title="Concentration risk, percentage">25</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zYJDttEwc2Ei" title="Concentration risk, percentage">24</span>% of net sales for the three months ended March 31, 2024 and 2023, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Geographic Information</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net sales outside the of the United States represented less than 1% of total consolidated net sales for the three months ended March 31, 2024 and 2023. Net sales are determined based on the destination where the products are shipped by Lifeway.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All the Company’s long-lived assets are in the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zqKpBWx78J93" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Disaggregation of Revenue and Significant Customers (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BC_zajg6RS4UTt8" style="display: none">Schedule of sales of products by category</span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In thousands</span></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drinkable Kefir other than ProBugs</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20240101__20240331__srt--ProductOrServiceAxis__custom--DrinkableKefirotherthanProBugsMember_zZT2Ql1uiemi" style="width: 11%; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,533</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20240101__20240331__srt--ProductOrServiceAxis__custom--DrinkableKefirotherthanProBugsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z2lNeg5eMTVg" title="Net sales percentage">82</span>%</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--ProductOrServiceAxis__custom--DrinkableKefirotherthanProBugsMember_zN4as5xiJ6u2" style="width: 11%; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,800</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230331__srt--ProductOrServiceAxis__custom--DrinkableKefirotherthanProBugsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zhN2slJYGl66" title="Net sales percentage">79</span>%</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cheese</span></td> <td> </td> <td> </td> <td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20240101__20240331__srt--ProductOrServiceAxis__custom--CheeseMember_zohOkjW7CEg6" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,515</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20240101__20240331__srt--ProductOrServiceAxis__custom--CheeseMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6wDhcF9zemc" title="Net sales percentage">8</span>%</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--ProductOrServiceAxis__custom--CheeseMember_zJ95yDUszeIf" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,345</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230331__srt--ProductOrServiceAxis__custom--CheeseMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zOMbHuuFDT45" title="Net sales percentage">9</span>%</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cream and other</span></td> <td> </td> <td> </td> <td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20240101__20240331__srt--ProductOrServiceAxis__custom--CreamAndOtherMember_z7zprsCmpwN6" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,816</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20240101__20240331__srt--ProductOrServiceAxis__custom--CreamAndOtherMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zyQynBQWVLAh" title="Net sales percentage">4</span>%</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--ProductOrServiceAxis__custom--CreamAndOtherMember_z9JAUSjKjCQ5" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,920</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230331__srt--ProductOrServiceAxis__custom--CreamAndOtherMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zKco073Kx6Sa" title="Net sales percentage">5</span>%</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drinkable Yogurt</span></td> <td> </td> <td> </td> <td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20240101__20240331__srt--ProductOrServiceAxis__custom--DrinkableYogurtMember_zKc2L1LWSaui" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,536</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20240101__20240331__srt--ProductOrServiceAxis__custom--DrinkableYogurtMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6tV6Kzjp875" title="Net sales percentage">3</span>%</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--ProductOrServiceAxis__custom--DrinkableYogurtMember_zPyJUYCAeek8" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,616</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230331__srt--ProductOrServiceAxis__custom--DrinkableYogurtMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsic15AUBk14" title="Net sales percentage">4</span>%</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProBugs Kefir</span></td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20240101__20240331__srt--ProductOrServiceAxis__custom--ProbugsKefirMember_zDm7dhJILR99" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">866</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20240101__20240331__srt--ProductOrServiceAxis__custom--ProbugsKefirMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zt65tguZ2HS6" title="Net sales percentage">2</span>%</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--ProductOrServiceAxis__custom--ProbugsKefirMember_zXhnUrNdXzVf" style="text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">808</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230331__srt--ProductOrServiceAxis__custom--ProbugsKefirMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z0OI2epN7Amc" title="Net sales percentage">2</span>%</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other dairy</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20240101__20240331__srt--ProductOrServiceAxis__custom--OtherDairyMember_ziOJpNXjQOEf" style="border-bottom: black 1pt solid; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">368</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20240101__20240331__srt--ProductOrServiceAxis__custom--OtherDairyMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsVOwfuG1lS3" title="Net sales percentage">1</span>%</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--ProductOrServiceAxis__custom--OtherDairyMember_z8s2tUvRGsC2" style="border-bottom: black 1pt solid; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">415</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230331__srt--ProductOrServiceAxis__custom--OtherDairyMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zHfQKqMImlWi" title="Net sales percentage">1</span>%</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Sales</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20240101__20240331__srt--ProductOrServiceAxis__custom--NetSalesMember_zVEp6ep9wnO7" style="border-bottom: black 2.25pt double; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,634</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20240101__20240331__srt--ProductOrServiceAxis__custom--NetSalesMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6g5UdEIh1lf" title="Net sales percentage">100</span>%</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--ProductOrServiceAxis__custom--NetSalesMember_z4AxoaQxVfqk" style="border-bottom: black 2.25pt double; text-align: right" title="Net sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,904</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20230331__srt--ProductOrServiceAxis__custom--NetSalesMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zygNWs2Hdb0b" title="Net sales percentage">100</span>%</span></td> <td> </td></tr> </table> 36533000 0.82 29800000 0.79 3515000 0.08 3345000 0.09 1816000 0.04 1920000 0.05 1536000 0.03 1616000 0.04 866000 0.02 808000 0.02 368000 0.01 415000 0.01 44634000 1 37904000 1 0.25 0.24 false false false false